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The synthesis and design of biocompatible nanoparticles for targeted drug delivery and
bioimaging requires knowledge of both their potential toxicity and their transport. For both
practical and ethical reasons, evaluating exposure via cell studies is a logical precursor to in
vivo tests. As a step towards clinical trials, this work extensively investigated the toxicity of
gold nanoparticles (Au NPs) and carbon dot (CD) nanoparticles as a prelude to their in vivo
application, focusing specifically on ocular cells. As a further step, it also evaluated their
whole-body transport in mice. The research pursued two approaches in assessing the toxicity
of engineered nanoparticles and the suitability of their use in targeted delivery and
bioimaging applications: (1) In vitro (using retinal pigment epithelial, corneal, and lens
epithelial cells (2) In vivo (mouse whole body studies).
Part. 1. In the in vitro assessments of Part 1, the biocompatibilities of spherical, rod, and
cubic shaped Au NPs were compared for different exposure concentrations. Spherical Au
NPs were evaluated in particular detail, and a possible toxicity mechanism was proposed,
based on the findings of a colorimetric assay, electrical impedance measurements, and
xviii

confocal imaging analysis. The assay measured the activity of succinate hydrogenase, a
mitochondrial enzyme, while electrical impedance spectroscopy quantified the strength of
cell-cell and cell-substrate attachment, a proxy of viability. Finally, confocal imaging analysis
verified that the NPs were internalized and confirmed the degree of their toxicity.
Collectively, the data indicated that surface area concentration was the critical toxicity
parameter. Subsequently, to create biocompatible Au NPs, a unique end-thiolation of
hyaluronic acid was adapted to create homogenously coated Au NPs. The end-thiolated
hyaluronate (HS-HA) coating not only improved the biocompatibility of the Au NPs but also
enhanced the internalization rate of the larger Au NPs, which could not enter the cells
otherwise.
The first part of this research also studied the synthesis of biocompatible deep red-emissive
CDs for bioimaging applications. For this purpose, a central-composite design response
surface methodology (CCD-RSM) was utilized. A scalable isolation-free microwave
pyrolysis method for synthesizing deep red-emissive nitrogen-doped carbon dots (nCDs)
from citric acid and ethylenediamine was successfully developed and optimized. The
formation of C‒N and the presence of pyrrolic N content proved to be keys to creating redemissive nCDs. Confocal images demonstrated that the nanoparticles could enter healthy
corneal, retinal, and lens epithelial ocular cells, as well as cancerous Chinese Hamster Ovary
cells.
Part 2. Building on the results of in-vitro testing of the engineered Au NPs and nCDs, in Part
2 we developed protocols for injecting both types of NPs in-vivo. Prior to any intravenous or
intravitreal injections, a preliminary study tested the ability of Au NPs to cross the tight
junctions between retinal pigment epithelial cells. Transwell® permeable supports were used
to simulate the blood-retinal barrier (BRB). The results showed that 20 nm Au NPs
xix

successfully crossed the permeable supports covered with confluent retinal pigment epithelial
cells. Based on this finding, both intravitreal and intravenous injections of nascent and HSHA coated Au NPs were tested. The intravitreal injections caused retinal detachment, very
probably due to the mechanical intrusion of the injection needle and the volume, albeit small,
of the injected NPs. Far more significant and encouraging, intravenously injected coated and
uncoated NPs successfully crossed the BRB. As a result of the intravenous injections, it was
observed that both coated and uncoated Au NPs were able to cross the blood-retinal barrier.
As expected, the numbers of HS-HA-coated Au NPs were significantly higher in specific
parts of the retina that contain more CD44 expressing cells, which have cell surface receptors
for internalizing HA. Finally, based on the confocal imaging analysis, the NP concentration
in each retinal layer was quantified as a function of time, post-injection. The NPs reached the
retina in less than 5 minutes and reached a maximum concentration within approximately 20
minutes. Due to the enhanced retention and permeability effect of NPs, 8.5% of the uncoated
and 12.1% of the HA-coated NPs that reach the retina remained after 24 hours.
Next, nCDs with and without the HA coating were injected subcutaneously into post-mortem
mouse and porcine eye globes. Ex-vivo porcine eye images showed that intravitreally injected
nCDs had effectively diffused through the vitreous to the cornea, and post-mortem wholebody mouse images also demonstrated that the nCDs are suitable for bioimaging, excitable in
the NIR region with the sensitivity of 15%.
Cumulatively, our observations indicate that HA coated NPs could potentially deliver other
payloads such as DNAs, mRNAs, proteins, siRNAs, and drugs into the cells which
overexpress CD44 receptors, for example, cancerous and inflammatory cells, thus providing a
platform for targeted treatment and imaging of many severe vision-threatening diseases and
degenerative conditions.
xx

Chapter 1: Introduction

The results of this chapter have been partially compiled in Karakoçak, B. B., Biswas, P., and
Ravi N. (2018). Applications of Gold Nanoparticles in Ophthalmology. Prog. Retin. Eye Res.
In preparation.
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1.1 Background and Motivation
During the past three decades, nanomaterials have received tremendous attention for their
distinctive mechanic, thermal, acoustic, magnetic, electrical, and optical characteristics. At
nanometer scale, materials have a high surface area to mass ratio, which gives them novel
properties that differ markedly from the same properties exhibited at bulk scale. Worldwide,
the nanotechnology sector has achieved a multi-billion US$ market (Markets 2018).
According to a recent study, from 2014 to 2019 the global market for nanoparticles in the
pharmaceutical and biotechnology sectors is expected to increase from $30 to 80 billion by
2019, with a compound annual growth rate of 22.0% (J. 2014). The annual production of
engineered nanoparticles is in the millions of tons, valued at over $15 billion/year (Li et al.
2016).
Recent advances in the synthesis and biomolecular functionalization of engineered
nanoparticles have dramatically expanded their current and potential biomedical applications,
including their use as nanoprobes (Leduc et al. 2013) and nanosensors (Swierczewska et al.
2012). Engineered nanoparticles now play significant roles in bioimaging (Koide et al. 1986,
McKechnie et al. 1986, Grant et al. 1996, Ruiz-Ederra et al. 2005, Chang 2012), photothermal
therapy (Ryu et al. 2012), gene therapy (Shestopalov et al. 2002, Raju et al. 2011), targeted
drug delivery, and tissue engineering (Karthikeyan et al. 2010, Parveen et al. 2012, Kompella
et al. 2013, Naha et al. 2015).
Specific engineered nanoparticle types are prominent in biomedical applications. Gold
nanoparticles (Au NPs) in particular have attractive intrinsic properties, such as high chemical
stability (Gao et al. 2012), convenient surface functionalization (Adokoh et al. 2014), unique
surface plasmon properties (Diebold and Calonge 2010, Parveen et al. 2012) and antiangiogenic properties (Arvizo et al. 2010, Jo et al. 2014).

2

The synthesis of Au NPs is well studied, with established protocols for creating different
shapes and sizes (Turkevich et al. 1951, Kimling et al. 2006, Grzelczak et al. 2008, Tyagi et
al. 2016). However, their toxic potential is debated, and the toxicity mechanism is still an
enigma (Goodman et al. 2004, Alkilany and Murphy 2010, Albanese and Chan 2011, Choi et
al. 2012, Fraga et al. 2014).
As another example, carbon dots (CDs), measuring less than 5 nm in diameter, are the subject
of several recent studies in bioimaging (Luo et al. 2013, Berezin 2014, Cherukula et al. 2016,
Gan et al. 2016).They are particularly interesting for their wavelength dependent
excitation/emission behavior (Jiang et al. 2015, Ding et al. 2016), long fluorescence lifetime
(Dong et al. 2015), good photostability (Zhang et al. 2015), and relatively high
biocompatibility (Tao et al. 2012). With these unique properties, CDs have demonstrated
promise for bioimaging applications.(Hola et al. 2014, Choi et al. 2016, Zhang et al. 2016).
Especially for bioimaging applications, high quantum yield and near-infrared excitability are
key properties for CDs to be worthy of exploring. Up to date, numerous synthesis methods
have been developed for synthesis of CDs such as laser ablation, pyrolysis, electrochemical
oxidation, hydrothermal reactions, and microwave treatment (Zhu et al. 2009, Zhu et al. 2013,
Wang et al. 2014, Wang and Hu 2014, Ding et al. 2016). However, the lack of a facile
synthesis method to create red-emissive CDs with high quantum yield has limited their
widespread biomedical application.

1.1.1 Ophthalmic uses of engineered nanoparticles: Opportunities and
roadblocks
The eye, considered the most complex organ (Fig. 1.1) after the brain, is the window to the
colors of life. The retina is an extension of the central nervous system (CNS) because the
axons of the retinal ganglion cells originate from the optic nerve. Thus, the eye is also
considered to be a part of the central nervous system (London et al. 2013). Eye transplantation
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has not been achieved yet due to the complexity of the optic nerve, which has more than 1.2
million nerve fibers (Sanchez et al. 1986, Sivak et al. 2016). Therefore, curing eye diseases is
crucial as the eye is the most important sensory organ and has a direct effect on the quality of
life.

Figure 1.1 The structure of the “Eye”.
Copyright 2018, Bedia Begüm Karakoçak and Naci Köksal

Nanoparticles can serve as a platform both for ocular drug delivery and for imaging. Since the
1985 study of Wood et al. showing the intrinsic capacity of NPs to adhere to the ocular
surface and interact with the epithelium, nanotechnological agents to treat eye problems have
been sought. NPs can deliver ocular drugs to specific target sites and promise to revolutionize
the therapy for many eye diseases (Barar et al. 2008, Diebold and Calonge 2010, Jo et al.
2011, Gonzalez et al. 2013). Numerous reports to date strongly suggest that ocular medicine
will benefit greatly from the use of nanotechnology (Diebold et al. 2007, Cai et al. 2008,
Conley and Naash 2010, Fischer et al. 2011, Jin Hyoung et al. 2011).
4

In treating the eye, intravenous delivery of nanoparticles is challenged by the first pass losses
through the liver and kidneys, and the presence of the blood-retinal barrier. When agents are
administered topically, the ocular surface epithelium and tear film, labeled in Fig. 1.2, form
external barriers (Barar et al. 2008, Boisselier and Astruc 2009, Choonara et al. 2010, CunhaVaz et al. 2011, Honda et al. 2013, Barua and Mitragotri 2014). Due to these barriers,
intraocular injections are currently the most common route of administration (Abu El-Asrar
and Al-Mezaine 2010, Choonara et al. 2010, Bochot and Fattal 2012, Christoforidis et al.
2012). Topical application remains as an optional route for delivering drugs (Del Amo and
Urtti 2008, Chen et al. 2011, Chantalat et al. 2012, Butler et al. 2013, Cho et al. 2015).

Figure 1.2 Structural features of the eye. Many barriers impede delivery to the retina. Selected agents, such as NPs
loaded with drugs cannot be efficiently delivered to the retina by topical administration, for example, by using eye
drops, because of tear drainage and choroidal blood flow. Systemically administered large NPs enter the retina
with great difficulty because of the strict blood-aqueous barrier and the inner and outer blood-retinal barriers.
Copyright 2018, Bedia Begüm Karakoçak and Naci Köksal.
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Direct drug administration using either of these two routes can fail to achieve a therapeutic
dose, or the dose may not be bioavailable (Avitabile et al. 2001, Duvvuri et al. 2003, Barar et
al. 2008, Diebold and Calonge 2010, Gaudana et al. 2010, Kompella et al. 2010). Untargeted
delivery of drugs may have side effects, and repeated uncomfortable treatments are not well
tolerated by patients. In short, achieving therapeutic drug levels with currently preferred
administration routes is difficult. In this regard, the high surface area to volume ratio of
nanoparticles is of special interest, particularly where the desired therapeutic drug levels can
be achieved without repeated untargeted injections (Diebold et al. 2007, Diebold and Calonge
2010, Kompella et al. 2010, Kompella et al. 2013, Zhou et al. 2013, Azharuddin et al. 2014).
Moreover, for topical administration, nanoparticles may provide improved topical passage of
large and poorly water-soluble molecules (Poon et al. 2001, Atluri and Mitra 2003, Xiong et
al. 2008, Shah et al. 2011).
If the current delivery barriers could be surmounted, ocular disorders such as age-related
macular degeneration, glaucoma, and retinal ischemia be potentially treated (Gaudana et al.
2009, Conley and Naash 2010, Fischer et al. 2011, Gonzalez et al. 2013). Conventionally
developed drugs elicit a limited response due to rapid removal from the eye by local
circulation and eventual systemic absorption. For example, dipivalylepinephrine, flurbiprofen,
and timolol have systemic circulation losses of 65%, 74%, and 80%, respectively (Weisse et
al. 1995). As a result, these drugs, although FDA approved, mostly fail to effectively treat the
target disease (Saettone 2002). Engineering nanoparticles to overcome the current barriers and
increase the delivered drug dose can truly promote the effectiveness of curative treatments
and potentially introduce alternative treatments for most eye diseases (Jo et al. 2013, Luo et
al. 2013, Zhou et al. 2013). Finally, NPs offer the possibility of targeted and controlled drug
release, especially for poorly water-soluble drugs, that defeats the ocular barriers and
effectively reaches the target. In addition to improving the delivery of poorly water-soluble
6

drugs, inherently biocompatible nanoparticle systems can potentially reduce toxicity
compared to the free drug (Diebold and Calonge 2010).

1.1.2 Engineering nanoparticles to reduce their toxicity, overcome ocular
drug delivery barriers, and facilitate imaging
To make full use of nanoparticles, a thorough understanding of their toxic potential is crucial.
Classical approaches to predict the toxicity of nanoparticles take into account the level of
nanoparticle exposure (mass and number concentration), as well as their size, shape, and
coating (Pan et al. 2007, Johnston et al. 2010, Tarantola et al. 2011, Moghadam et al. 2012,
Sabella et al. 2014). It has also been shown that nanoparticle toxicity is dependent on the cell
type (Coulter et al. 2012, Manshian et al. 2015, Schlinkert et al. 2015). Among these toxicity
factors, the incipient nanoparticle exposure concentration, especially given the traditional
concentration metrics for assessing toxicity, remains problematic due to the complex
interactions of nanoparticles with their environment (Biswas and Wu 2005, Suttiponparnit et
al. 2011).
Au NPs have been widely explored in medicine as delivery agents for biopharmaceuticals
(Kim et al. 2011, Kumar et al. 2015). Although Au NPs are usually more biocompatible than
other metal or metal oxide nanoparticles, their positively charged surface disrupts the
negatively charged cell membrane, and their labile surface electrons are involved in reactions
that typically produce reactive oxygen species (ROS), causing cytotoxicity (Moghadam et al.
2012). Moreover, plasma proteins can spontaneously adsorb to nascent Au NPs, affecting the
surface properties of the particles and influencing their interaction with cells (Nel et al. 2009).
As a result, surface modification has been pursued as an essentially ideal way to prevent
protein adsorption (Larson et al. 2012) and nonspecific delivery of Au NPs (Rana et al. 2012),
to decrease their opsonization by the immune system (Papasani et al. 2012), and finally to
mitigate their toxicity.
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Ocular imaging is critical in diagnosing, treating, and monitoring the progress of many eye
diseases (Nadler et al. 2012). Fluorescence-based methods such as indocyanine green (ICG)
angiography remain the gold standard for detecting abnormalities of the choroid vasculature
in healthy and diseased eyes. Optical coherence tomography (OCT), typically employing a
near-infrared wavelength, is a well-established optical imaging technique. It is non-invasive,
non-destructive, and capable of providing micron-scale axial resolution via low-coherence
interferometry (Laviers and Zambarakji 2014). The relatively long wavelength light
penetrates deep into scattering tissue and media. OCT is used in such fields as dermatology,
cardiology, otolaryngology, ophthalmology, and oncology to acquire cross-sectional images
of dermal lesions, cardiac vessels, and the retina. In OCT, imaging agents which fluoresce
with a high quantum yield at near infrared wavelengths are desired. Carbon-based
nanoparticles have been considered as bioimaging agents (Yanai et al. 2012, Saghiri et al.
2015, Saghiri et al. 2015); however, most show intense emission only in the blue-green region
following excitation with ultraviolet or blue light which has a relatively shallow penetration
depth (Bourlinos et al. 2008, Peng and Travas-Sejdic 2009, Wang et al. 2010, Bourlinos et al.
2012, Zhu et al. 2013, Yang et al. 2015, Qu et al. 2017). A technique to create highly efficient
red-emissive carbon dots would significantly extend the reach of ophthalmic imaging. Finally,
for ocular imaging applications, targeted delivery may also be desirable depending on the
disease to be treated, in other words, the type of cells of interest.
Hyaluronic Acid as a Biocompatible Surface Coating for Targeted Delivery of NPs
Many coating conjugates, ranging from synthetic ligands to natural biomolecules have been
used to improve the stability of particles and the efficiency of their delivery to specific cells or
tissues (Manson et al. 2011, Lowe et al. 2015, Yilmaz et al. 2016, Lin et al. 2017). Examples
include polyethylene glycol, polycarboxybetaine, poly(hydroxy functional acrylates), poly(2oxazoline)s, poly(vinylpyrrolidone), and poly(glycerol). However, these coating conjugates
8

suffer from unspecific protein binding and are not specific to cell types, thus making them
unsuitable for targeted drug delivery. In this study, we chose hyaluronic acid (HA) as a
coating material, because it can prevent adsorption of proteins on the surfaces of biomaterials
(Hans and Lowman 2002) and has an antifouling effect that arises from its hydrophilic and
polyanionic characteristics (Lee et al. 2008, Santhanam et al. 2015). HA also scavenges free
radicals and chelates pro-oxidant metals (Glucksam-Galnoy et al. 2012). It exhibits many
desirable physiological properties: For example, it can be either anti-inflammatory or proinflammatory, depending on its molecular weight.
HA plays an essential physiological role as a ligand for several cell-surface receptors. Its
interaction with cluster of differentiation 44 (CD44), a transmembrane receptor (Jaggupilli
and Elkord 2012), is the most well studied. It is present on, for example, the lymphatic vessel
endothelial HA receptor (LYVE-1) (Chen et al. 2005), the receptor for hyaluronate-mediated
motility (RHAMM) (Nedvetzki et al. 2005), and the HA receptor for endocytosis (HARE)
(Pandey and Weigel 2014). Proliferating cells, certain types of epithelial and particularly
cancer cells, express CD44 receptors; therefore, HA-conjugated NPs can be selectively
delivered to these cells while ensuring that the NPs are biocompatible with the target cell.
Low molecular weight HA (~2500 Da) was shown to disrupt endothelial cell barriers (Lennon
et al. 2014). It was also demonstrated that HA aided NPs in passing the BRB transcellularly,
via CD44-receptor-mediated endocytosis (Santiago-Tirado et al. 2017), as well as by
increasing the permeability of tight paracellular junctions (Kirschner et al. 2010). Because the
internalization is based only on the HA coating and not its payload, the HA coating is
expected to act as a Trojan horse for delivering NPs into ocular cells without causing
additional toxicity.
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1.2 Dissertation Outline
This dissertation has two main objectives:
1) To evaluate in vitro toxicity and create biocompatible-engineered gold nanoparticles and
red-emissive carbon dots for targeted delivery and bioimaging applications, respectively.
2) To investigate Au NPs’ and CDs’ effectiveness as delivery and bioimaging agents in-vivo.
Each of the five chapters of the dissertation is self-contained, with an introduction,
experimental section, results, discussion, and conclusions. Chapters 2 and 3 describe
respectively the systematic toxicity assessment of Au NPs and how to overcome this
drawback with an end-thiolated hyaluronate coating. These studies identified the potential
toxicity of Au NPs with ocular tissue, while offering a representative metric for their toxicity
assessment and providing a way to use of Au NPs as delivery agents in ophthalmology. In
Chapter 4, we optimize an isolation-free method for synthesizing red-emissive CDs (red-CDs
with deep red to NIR fluorescence) as bioimaging agents. This work highlights the use a
powerful statistical tool, central-composite design response surface methodology, in
constructing experiments which involve multiple parameters. The tool successfully identified
the critical parameters in the creation of red emissive CDs. Next, in Chapter 5, we create HAconjugated CDs and evaluate their internalization rate as well as their biocompatibility with
ocular cells. Finally, Chapter 6 investigates the fate and transport of Au NPs in the eye, in
vivo, following intravitreal and intravenous injections. It also demonstrates the effectiveness
of CDs as bioimaging agents in ex-vivo porcine eye globes and a post mortem mouse model.
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Chapter 2: Biocompatibility of Gold
Nanoparticles in Retinal Pigment Epithelial
Cell Line

The results of this chapter have been reprinted with permission from Karakoçak, B. B.,
Raliya, R., Davis J. T., Chavalmane S., Wang, W.-N., Ravi, N., Biswas, P. (2016).
Biocompatibility of Gold Nanoparticles in Retinal Pigment Epithelial Cell Line. Toxicol. In
Vitro. 37:61-69. Copyright 2016 Elsevier
Supplementary information along with figures and tables are available in Appendix I
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Abstract
Gold nanoparticles (Au NPs) have been tested as targeted delivery agents because of their
high chemical stability and surface plasmon properties. Here, we investigated the
biocompatibility of Au spheres (5-, 10-, 20-, 30-, 50-. and 100-nm), cubes (50-nm), and rods
(10×90nm) on a retinal pigment epithelial (ARPE-19) cell line. The lethal dose for killing
50% of the cells (LD50) was evaluated using an MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5
diphenyl tetrazolium bromide) assay. At and above LD50, based on mass concentrations, the
confluent cell layer began to detach, as shown by real-time measurements of electric
impedance. We found that the biocompatibility of spheres improved with increasing
nanoparticle size. The Au rods were less biocompatible than 10-nm spheres. Confocal
microscopy showed that cubic (50-nm) and spherical NPs (50- and 100-nm) neither had
cytotoxic effects nor entered cells. Lethal doses for internalized spherical NPs, which were
toxic, were recalculated based on surface area (LD50,A) concentrations. Indeed, when
biocompatibility was expressed as the surface area concentration of NPs, the curve was
independent of size. The LD50,A of Au nanospheres was 23 cm2/ml. Our findings demonstrate
that the sole modulation of the surface area would make it possible to use Au NPs for
therapeutic purposes.
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2.1 Introduction
Materials at the nanometer scale have a large surface area to mass ratio, which gives them
novel properties that differ markedly from those of other material properties with
corresponding bulk sizes. Recent advances in the synthesis and biomolecular functionalization
of engineered nanoparticles have led to a dramatic expansion of their potential biomedical
applications, including their use as nanoprobes (Leduc et al. 2013), nanosensors
(Swierczewska et al. 2012) and in bioimaging (Ruiz-Ederra et al. 2005, Peng et al. 2006),
photothermal therapy (Ryu et al. 2012), gene therapy (Shestopalov et al. 2002, Raju et al.
2011), targeted drug delivery, and tissue engineering (Parveen et al. 2012, Kompella et al.
2013, Austin et al. 2015, Naha et al. 2015). Specifically, gold nanoparticles (Au NPs) are
being used because of their intrinsic characteristics, such as high chemical stability, suitable
surface functionalization, and unique surface plasmon properties (Diebold and Calonge 2010,
Parveen et al. 2012).
Researchers have attempted nanoparticle-mediated drug and gene delivery to tissues of the
eye, including the retina, to treat major eye diseases such as age-related macular degeneration
and diabetes-related retinopathy (Jin Hyoung et al. 2011, Li et al. 2012, Ngwa et al. 2012,
Ngwa et al. 2012, Joris et al. 2013). Moreover, intravitreal injection of Au NPs has been
investigated for retinal imaging and inhibition of angiogenesis to prevent macular
degeneration (Jeong Hun et al. 2009, Farjo and Ma 2010). Au NPs have been shown to be
promising agents for enhanced delivery of anti-VEGF antibody or other antiangiogenic agents
to specific sites in the eye (Hayashi et al. 2009, Jeong Hun et al. 2009, Diebold and Calonge
2010). Currently, intravitreal and topical routes are most commonly used (Hayashi et al.
2009).
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The use of intravitreal injection of nanoparticles depends on the safety of the particles
(Biswas and Wu 2005, Diebold and Calonge 2010, Kompella et al. 2013). Therefore, safety
concerns necessitate a better understanding of the potential toxicity hazards of novel
materials. One method of measuring toxicity is to examine cellular viability (Abe and Saito
1999) by determining the lethal dose concentration (LD50), the dose required to kill 50% of
the cells. Lethal doses of selected nanoparticles will provide guidance as to safe levels of use
for nanomedicine applications.
In this chapter, we report on the in-vitro biocompatibility of Au NPs with spontaneously
arising retinal pigment epithelial (ARPE-19) cells. This cell line is an acceptable alternative to
repeated isolation and standardization of primary RPE cells (Dunn et al., 1996; Pfeffer and
Philp, 2014), provided that its detailed physicochemical characterization is closely similar to
that of primary cells for toxicity evaluation. Although important research has been done on
Au NPs (Bakri et al., 2008b, a; Cho et al., 2011; Pan et al., 2007b; Soderstjerna et al., 2014)
on various cell lines, no studies have correlated the size, shape, and surface area of the
administered Au NPs while reporting biocompatibility with the RPE cells. In the present
study, we provided a comprehensive picture of physico-chemical characteristics of NPs and
correlated these characteristics to their biocompatibility because it is crucial to predict the
response of the targeted retinal cells to the Au NP exposure.
The effect of Au NP shape (spherical, cubic, and rod; size 5-100 nm), and concentration (up
to 5 mg/ml) on toxicity was assessed by MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl
tetrazolium bromide) assay. In our study, the exposure period was a minimum of 72 h, which
is long enough for gold nanoparticles to reach the cells (Bejjani et al. 2005, Cohen et al. 2014)
for biocompatibility assessment. To better understand the effect of Au NP on cell toxicity, the
electrical impedance of the cells was monitored continuously for 96 h. Furthermore, the
presence or absence of NPs inside the cell was verified using plasmonic imaging by confocal
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microscopy. The correlation was developed for LD50 of Au NPs regarding the mass and
surface area concentration to toxicity. A mechanistic description of NP toxicity interactions
with ARPE-19 cells is presented, along with a simple universal toxicity curve that may apply
to all cell types.

2.2 Materials and Methods
The experimental setup for particle generation and measurement (Figure 2.1), methods for
data inversion, and the experimental plan are described as follows.

2.2.1 Synthesis of gold nanoparticles
Au nanoparticles shaped as spheres, cubes, or rods at sizes from 5 to 100 nm were synthesized
using a seed-mediated approach (Jana et al. 2001, Wu et al. 2010). Details are provided in the
supplementary information.

2.2.2 Characterization of nanoparticles and exposure to ARPE-19 cell line
Synthesized NPs were characterized by their size, shape, and agglomeration state by
transmission electron microscopy (TEM). To confirm the size and the morphology of the Au
NPs, micrographs were taken using an FEI Spirit TEM (Hillsboro, OR, USA) operated at 120
kV. The hydrodynamic diameter and zeta potential of NPs in solution before and after their
exposure to cell culture medium was measured using dynamic light scattering (DLS). Batch
mode measurements were done using a Malvern Zetasizer Nano ZS (Malvern Instruments,
Westborough MA). Quantitative determination of gold (Au) concentrations in stock solutions
and aliquots before confocal imaging was done with an inductively coupled plasma
spectrophotometer, ICP-MS (Elan DRC II, Perkin Elmer, Norwalk, CT).

2.2.3 Biocompatibility assessment of the Au NPs with the ARPE-19 cell line
Since animal cell culture is sensitive to microbial contamination, Au NP solutions were
checked for microbial growth before cell exposure. Tests for bacterial and fungal
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contamination, respectively, were performed on nutrient agar and potato dextrose agar plates
both at room temperature and 37°C.
In a flat-bottom, 96-well plates, 150 μL volumes (1.2 × 104 cells per well) of cells were
incubated (37°C, 5% CO2) until confluent (supplementary information, Fig. S1), then exposed
to different concentrations of NPs. Physically characterized particles were dispersed in cell
culture medium containing Dulbecco’s Modified Eagle Medium/Ham’s F-12 (DMEM/F-12),
10% fetal calf serum (FCS), and antibiotics (C-DMEM/F12) to be used for cell exposure. For
each shape and size of Au NPs, concentrations of the exposed solutions were 0.01, 0.05, 0.1,
0.25, 0.5, 0.75, 1, 2.5, and 5 mg/ml. The upper limit of exposure concentration was
determined by NP’s toxic potential reported in the literature (Pan et al. 2007, Hayashi et al.
2009, Jin Hyoung et al. 2011, Choi et al. 2012, Naha et al. 2015). Nanoparticle exposure
duration was a minimum of 72 h.
The viability of ARPE-19 cells, defined as their ability to maintain its growth, was evaluated
using the MTT assay, which is widely used for in-vitro nanotoxicity assessment (Dumortier et
al. 2006, Sayes et al. 2007, Warheit et al. 2007, Conde et al. 2014). This technique, while
requires the acquisition of optical density at a single wavelength has advantages over other
toxicity assays because it requires minimal physical manipulation of ARPE-19 cells and
yields quick, reproducible results. Following the exposure of NPs, 100 µL of MTT (1 mg/mL
in growth medium was added to each well, after which the plate was further incubated for 5 h
at 37°C in 5% CO2. The resulting blue component, produced by the reduction of tetrazolium
salt of MTT by mitochondrial dehydrogenase enzyme, was dissolved in 100 µL dimethyl
sulfoxide (DMSO). The optical density of the colored product was read photometrically using
a spectrophotometer at 540 nm. Possible interactions between the nanoparticles and the
formazan crystals, which form as a result of the reduction of MTT dye, can be minimized by
selection of the proper dissolution solvent, DMSO, and adjusting the dye concentration as
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well as the volume added to each well (Kong et al. 2011, Sylvester 2011). On the other hand,
the spectrophotometer plate readings for both positive controls where the ARPE-19 cells were
not exposed to Au NPs, and negative controls where the cells were exposed to Au NPs but not
treated with MTT were also taken. The results were normalized based on both positive and
negative controls. The percentage viability of ARPE-19 cells was calculated using the
following formula:
Mean optical density of the sample
Biocompatibility (Cell Viability) = (
) × 100 (2.1)
Control optical density
The lethal dose is typically reported as the mass concentration of NPs at which the
biocompatibility is 50%. LD50 values, based on mass concentration, were calculated by using
a four-parameter logistic equation. Data were plotted as sigmoidal dose-response curves using
Systat SigmaPlot 11.0 software. LD50,M values were derived from three independent
experiments in which eight-well replicate measurements were done. In this work, LD50
values are defined based on both mass concentration (LD50, M) and surface area concentration
(LD50,A).
The cellular characteristics were also analyzed using electric cell-substrate impedance sensing
(ECIS), a noninvasive technique that continuously measures the impedance across gold
electrodes present at the bottom of tissue culture wells using various frequencies of alternating
current (Wegener et al. 2000, Arndt et al. 2004). As the cell morphology and attachment via
adhesion proteins (Hall et al. 1987, Borradori and Sonnenberg 1999) to the electrodes in the
bottom of the well changes, the resistance across the electrodes also changes. The change in
resistance at different frequencies from 400 to 64,000 Hz can be measured over time. The
impedance at low frequency (less than 4,000 Hz) represents paths around the cells and, hence,
the layer’s cell-to-cell barrier functions (Arndt et al. 2004). At a frequency of 4,000 Hz, the
contribution of resistance through the cells was dominant and, at much higher frequencies
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(8,000 to 64,000 Hz), the contribution is primarily from Au NPs with medium (Kandasamy et
al. 2010). Hence, a frequency of 4,000 Hz was chosen to monitor cell growth characteristics.
Cells were studied at high density and in confluence to closely mimic the natural structure and
physiology of the retinal pigmented epithelial cell monolayer. Before the addition of
nanoparticles, the confluency was confirmed by ECIS (supporting information, Fig. S1). Cells
were plated in a 96-well ECIS array identical to those plated for the MTT assay. The
resistance of cells was monitored for 24 h to ensure confluency before the addition of Au NPs.
The Au NP solution was introduced on top of the cells at room temperature under sterile
conditions.
All tissue culture data (both MTT and ECIS) were expressed as the mean +/- standard error of
the mean (SEM) values of at least three independent culture experiments. Eight replicates
were performed for each independent cell culture experiment. Statistical significance was
evaluated using ANOVA (analysis of variance) to compare with the respective positive
(untreated cells) and negative (NPs without the cells) control groups. P*< 0.05, P**<0.001,
the significance level, was statistically acceptable.
To confirm the presence of NPs inside cells, we investigated the distribution of the Au NPs at
their critical mass concentrations (LD50, M) using a nanoplasmonic confocal laser scanning
microscope (LEICA TCS-SP8). The gold nanoparticles have surface plasmon resonance
property (SPR). For the size range of 5-100 nm, for gold nanoparticles, the SPR wavelength is
around 520 nm (Huang et al. 2008) depending on the size of the nanoparticles as also
confirmed by our UV-Vis measurements (Supplementary information Fig. S2). Three lasers
were used during Confocal imaging (405, 532, and 635 nm). Thus, the detection range is 405635 nm which is a wide enough range to detect all sizes of Au NPs in this study.
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ARPE19 cells were seeded in CELLviewTM plates at 5×104 cells/well for 24 h. After 72 h of
NP exposure, the cells were fixed and washed with PBS three times before imaging
(supplementary information). During confocal imaging, 45 images were taken through
different optical sections by collecting Z-stacks with a thickness of 100 nm. A control sample
was prepared with and without cells in the absence of nanoparticles.
To identify the difference between the administered and delivered doses, the amount of
nanoparticles that failed to enter the cell was quantified in the aliquot obtained from the PBS
washes prior to confocal imaging. Using ICP-MS, the aliquot was tested for the presence of
Au NPs. The results were presented in supplementary information Fig. S4. The
internalization efficiency of 5-, 10-, 20-, and 30- nm was found to be %96.1±7.92,
%86.3±11.5, %95.88±0.7, %86.81±2.28, respectively. The concentration of Au in the
aliquats were found to be be much lower than the administered dose (the LD50 concentration
of each NP) for 5-, 10-, 20-, and 30- nm Au NPs proving that after a minimum of 72 h of
exposure to Au NPs, the difference between the administered dose and the delivered dose
(intracellular concentration of gold) was negligible, as has also been reported elsewhere
(Bejjani et al. 2005). On the other hand, it was found that only %9.9 ± 5.1 of 50- and
%1.5±0.1 of 100- Au NPs were internalized (supplementary information Fig S4).

2.3 Results and Discussion
2.3.1 Characterization of synthesized NPs
Size and morphology characterization by TEM and UV-Vis analysis
Dimensions and morphology of NPs were analyzed by TEM. The mean diameters of
Au sphere nanoparticles (Au S) were approximately 5, 10, 20, 30, 50, and 100 nm. Cubes
(Au C) were 50 nm, and rod-shaped NPs (Au R) were 90 nm in length and 10 nm in diameter
(Fig. 2.1). These sizes of gold nanorods and nanocubes were selected to compare their
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biocompatibility to gold nanospheres of similar sizes. Standard deviations of the sizes are
reported in the supplementary information, Table S2.
Au NPs showed strong interactions at specific wavelengths of light as a function of their size;
for example, the UV-Vis analysis showed a shift in the absorption peaks that qualitatively
confirmed the measured particle sizes (supplementary information, Fig. S2). As a result, a
range of varying NPs with strict control of size was successfully synthesized for
biocompatibility assessment.

Figure 2.1 Transmission electron micrographs of synthesized NPS: (a) Au 5-nm sphere, (b) Au 10-nm sphere, (c)
Au 20-nm sphere, (d) Au 30-nm sphere, (e) Au 50-nm sphere, (f) Au 100-nm sphere, (g) Au 50-nm cube, and (h)
au 10×90 nm rod.

Hydrodynamic diameter measurements by DLS
The hydrodynamic sizes of all the Au NPs as measured by DLS were larger than their
physical size as determined by TEM measurements due to the adhered solvent molecules on
the particle surface. Also, the hydrodynamic size increased when Au NPs were dispersed in
cell culture medium rather than water.
Surface zeta potential
Zeta potential is one of the crucial parameters for the measure of particles’ stability. To test
the stability of NPs and measure their surface charge, the zeta potential was measured using a
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dielectric cell. Nanoparticles with zeta potentials greater than 20 mV or less than -20 mV
have strong electrostatic repulsion and thus remain stable in solution. Results indicated that
when Au NPs were dispersed in cell culture medium, their zeta potential significantly
decreased, possibly to a new protein corona formation, increasing the possibility of
aggregation. No aggregation was observed after particles had been dispersed for 96 h in both
C-DMEM/F12 and DI water (supplementary information, Table S2). No microbial growth
was detected after 72 h of incubation.

2.3.2 Biocompatibility assessment of the Au NPs with the ARPE-19 cell line
MTT assay measurements
The MTT assay was used to investigate how the shape and size of Au NPs affect the
internalization and viability of ARPE-19 cells. Results clearly showed that Au nanospheres
with diameters of 5, 10, 20, and 30 nm and nanorods of 10×90 nm, even at the low
concentration of 0.05 mg/ml, adversely affected cellular viability (Figure 2.2)
(a)

(b)

(c)

Figure 2.2 (a) Percentage biocompatibility of ARPE-19 cells exposed to Au NPs (Data is represented in log scale
for x axis). (b) ARPE-19 cells’ biocompatibility with Au NPs as a function of surface area and particle diameter,
with biocompatibility (%) as a function of surface area concentration (cm 2/ml) (Data is represented in log scale
for x axis). (c) The critical surface area concentration (LD50,A) for spherical Au NPs was 23 cm2/ml. The data is
normalized using both negative and positive controls. Values are expressed in mean ± for each condition, three
independent experiments were done with eight replicates (n=24, *P<0.05 vs controls).

29

ECIS measurements
Cell attachment behavior was monitored in the presence of spherical Au NPs having
diameters ranging between 5 and 30 nm. Fig. 2.3a to f, respectively, show the resistance at
4,000 Hz over time after the addition of Au NPs of the six different sizes (5, 10, 20, 30, 50,
and 100 nm). The exposure concentration range was narrowed down to 0.01–0.50 mg/ml
based on the MTT assay findings. According to the cell attachment measurements, it can be
inferred that the cells become confluent by the end of the 23rd h (Fig. 2.3a-f). ARPE-19 cells
show no change in resistance compared to control cells in the presence of all concentrations of
the 50 and 100 nm Au NPs (Fig. 2.3e, f).
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(a)

(d)

(b)

(e)

(c)

(f)

Figure 2.3 Electrical cell-substrate impedance sensing measurements for ARPE-19 cells exposed to (a) 5-nm Au
spheres, (b) 10-nm Au spheres, (c) 20-nm Au spheres, and (d) 30-nm Au spheres when, at critical concentrations
previously detected in MTT assay results, cells started to detach from the culture plate. (e) 50-nm Au spheres
with cell detachment unhindered; however, the measured resistance is decreasing as the exposure concentration
increases. (f) 100-nm Au spheres with no occurrence of cytotoxic effect. Values are expressed in mean ± SEM
with each condition tested at least in triplicate (n=24, **P<0.001 vs. controls).

The cells that were exposed to 5 nm Au NPs at 0.030 mg/ml (Fig. 2.3a) and 10 nm Au NPs at
0.057 mg/ml (Fig. 2.3b) followed the same pattern of change in impedance as did the positive
control. However, the impedance of cells in contact with higher concentrations of 5 and 10
nm Au NPs showed a significant decrease after 32 h of exposure (Fig. 2.3a and 2.3b).
Similarly, when the exposure concentration reached the critical LD50,M value of the selected
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nanoparticle, the impedance steadily dropped to baseline over 72-76 h, indicating that the
cells started to round up and detach from the plate soon after NP introduction.
For particles of all sizes, the cells started to detach at their critical exposure concentration, and
the death phase started approximately after the 32nd h of particle addition. This finding
indicated that the MTT assay results, which were measured after 72 h of exposure, were
representative and covered the entire time span of cell death.
Confirmation of internalization of Au NPs inside ARPE-19 cells
Au NPs were tracked inside cells using confocal microscopy. The nanoparticles that could not
enter cells and floated outside of them were quantified as explained in the supplementary
information. Both 2D and 3D confocal images were collected. Due to the space limitation, the
3D images are presented in supplementary information (supplementary information Fig. S3).
According to ICP-MS results (supplementary information Fig. S4) for Au nanorods (10×90
nm) and Au nanospheres with diameters of 5, 10, 20, and 30 nm confirmed that almost all
particles were able to enter cells at their critical LD50,M concentration (Fig. 2.4b-f). We found
that at their critical LD50,M concentration, Au nanospheres with diameters of 50 and 100 nm
and nanocubes of 50 nm were not able to penetrate through the cell membrane. This was
confirmed by both ICP-MS measurements of free-floating NPs in the exposure medium and
confocal microscopy images (Fig. 2.4g, h).
On the other hand, for spherical Au NPs, which were able to cross the cell membrane, we
observed that as NP size increased, their presence inside the nucleus decreased significantly
(Fig. 2.4b-e). Images taken at 60x magnification showed that cells exposed to 5-nm Au
spheres had large vacuole-like structures throughout the cell, which can be attributed to
regional cytoplasm loss (Fig. 2.4b and supplementary information Fig. S3c). Confocal images
supported the results of MTT assays and ECIS measurements, showing that the 50- and 100nm Au spheres, as well as 50-nm nanocubes, did not enter cells. This may explain why 5032

and 100-nm sizes did not exert a cytotoxic effect, even up to a 5 mg/ml exposure
concentration.
(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

Figure 2.4 3D Confocal microscopic images of nanoparticles inside cells after 72 h of exposure. (a) cells without
nanoparticle exposure, (b) ARPE-19 cells exposed to 5-nm Au sphere (LD50,M: 0.030 mg/ml) with green dots
representing Au NPs inside cells in the vicinity of the nucleus and voids (exact areas are shown with white
arrows) representing loss of cytoplasm on the observed layer. (c) ARPE-19 cells exposed to 10-nm Au spheres
(LD50,M: 0.057 mg/ml, with particles inside cells and nuclei. (d) ARPE-19 cells exposed to 20 nm Au spheres at a
critical concentration of LD50,M: 0.113 mg/ml; the presence of particles inside cells and nuclei is confirmed. (e)
ARPE-19 cells exposed to 0.129 mg/ml of 30-nm Au spheres. (f) LD50,M:0.050 mg/ml of 10×90 nm Au
nanorods inside cells and nuclei. (g) 0.129 mg/ml of 50- nm Au spheres. (h) 0.129 mg/ml of 100-nm Au
spheres. Internalization of 50- and 100-nm Au spheres may be hindered by their large size. The available
surface area per unit volume, the key metric for biocompatibility, is much less for 50- and 100-nm Au spheres
compared than for ARPE-19 cells exposed to smaller Au nanospheres. (i) 0.129 mg/ml of Au nanocubes.
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2.4 Discussion
The primary objective of this study was to elucidate the relationship between the structure
(shape and size) and biocompatibility or toxicity of Au NPs with regard to ARPE-19 cells.
Based on our findings, a possible mechanistic description of NP interactions with
internalization into RPE cells is hypothesized (Fig. 2.5).

Figure 2.5 The mechanism of NPs’ mediated cytotoxicity is illustrated here by (a) NP exposure to ARPE-19 cell
growing in DMEM. (b) Dynamic bi-polymer layer (nano-biointerface) (thick and loose blue color coating) that
forms when NPs are mixed with DMEM), creating a superficial surface exposed to the cell membrane. (c-d) NP
internalization by endocytosis in which the pH of the endocytic vesicle is same as cell’s physiological pH. (e)
Fusion of endocytic vesicle with lysosome where pH of lysosome is acidic, (f) Internalized NP in lysosome,
where the protein coating, the nano-biointerface, disappears because of degradation of protein by the hydrolytic
mechanism of the acid hydrolases enzyme of lysosome. (g) NP can cross a single membrane of lysosome and
may penetrate the mitochondrial intermembrane space where the apoptosis signal is initiated. (h)
Cytoplasmically accumulated NPs cause cell death by activating subcellular downstream signaling for apoptosis,
initializing cell shrinkage, cytoplasm decrease, and the beginning of subcellular fragmentation. For ease of
visualizing, the structure of NP and cell is not according to size scale.
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The Au NPs were first suspended in C-DMEM/F12 and exposed to ARPE-19 cells (Fig. 2.5a,
b). The pristine NPs were coated with a layered nanostructure in which a protein corona,
consisting of a dynamic biopolymer layer (nano-biointerface), formed on the NP surface. The
hydrodynamic sizes of all studied Au NPs dispersed in DI water were larger than their
physical sizes as determined by TEM and DLS measurements. That size was further increased
when NPs were dispersed in DMEM cell culture medium (supplementary information, Table
S2). The latter finding demonstrates that the increase in size was probably the result of serum
protein adsorption on the NP surface, as illustrated in Fig. 2.5b. This finding is consistent with
the results of a study by Tarantola et al. (2011) in which spectral shifting and changes in
hydrodynamic diameter changed with solvent type. The change in zeta potential of the
pristine Au NPs, when exposed to cell culture medium, provides further confirmation of the
presence of an outer layer.
Cell membrane receptors recognize Au NPs and signal the beginning of an internalization
process (Fig. 2.5c, d). The interaction of NPs with the external surface of the cell membrane
depends on surface properties such as charge (zeta potential) and coating by components of
C-DMEM/F12. As also reported in previous studies (Dykman and Khlebtsov 2011, Dykman
and Khlebtsov 2012), our results indicate that a possible pathway of internalization maybe
receptor-mediated endocytosis, in which the protein-coated Au NPs are recognized by a
membrane receptor and then internalized.
An interesting shape effect is observed on internalization. Internalization efficiency depends
mainly on the local mean curvature of the particle, the contact angle, and the available area of
contact between particles and cell membrane receptors (Li et al. 2012, Li et al. 2015). Cubic
Au NPs have small local mean curvatures, at which the cell membrane is less strongly bent
compared to spherical Au NPs. Therefore, their internalization into ARPE-19 cells may be
hindered (Li et al. 2015). Au nanospheres with diameters less than 30 nm and rod-shaped (10
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× 90nm) Au NPs are internalized, as shown by their lower biocompatibility (Fig. 2.2a) and
confocal images (Fig. 2.4). Gold nanorods with a particle diameter of 10 nm were found to be
less biocompatible than gold nanospheres of similar size (Fig. 2.2a). The lower
biocompatibility of gold nanorods than nanospheres may be attributable to the disruption of
lipid membranes, leading to loss of cytoplasmic substance and culminating in cell death
(Gratton et al. 2008, Nangia and Sureshkumar 2012). Internalization of NPs depends on cellsurface receptors (Chithrani et al. 2006) and occurs by direct penetration or passive density
gradient diffusion. Both internalization mechanisms are specific to particle dimensions while
the cell membrane receptors and lipid bilayer barriers are specific to cell type.
Inside the cell, Au NPs fuse with the lysosome (Fig. 2.5e, f). The low pH (4.5) in the
lysosome, where the digestive protease enzymes are active, results in degradation of the
protein layer, but not the nanoparticle core (Luzio et al. 2007, Sabella et al. 2014). The
resulting Au NP, stripped of its protein corona, leaves the lysosome with a new lysosomal
corona and penetrates the mitochondrial membrane (Fig. 2.5g). Mitochondria are the central
coordinators of cell death and affect metabolic activity. This is the basis of our MTT assay
measurements of the enzymatic activity in mitochondria (Fig. 2.2a).
We also investigated the effect of size (5 to 100 nm) of spherical Au NPs. Our data (Fig. 2.2a)
indicates that for the same mass concentration of Au NP, the biocompatibility is higher as size
increases (in the range of 5 to 30 nm). At the same mass concentration of different sizes, the
number of NPs and the total surface area concentration is different. To better elucidate the
results, we plotted the biocompatibility data as a function of the surface area concentration for
all the Au spheres that exerted significant toxicity (Fig. 2.2b). As can be seen, the data
collapses into a single curve irrespective of sphere size. As long as the surface area
concentration was similar, the biocompatibility values were the same for NPs of different
sizes (23 cm2/ml).
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Although our detailed search of the literature identified no studies of ocular cells, we found
studies in which the biocompatibility of different sizes of Au NPs was reported with different
cell types. For example, Pan et al.(Pan et al. 2007) studied the biocompatibility of different
sizes of Au NPs with HeLa cells. We plotted their biocompatibility data as a function of the
surface area concentration of the Au NPs and found a similar trend (Fig. 2.6a). In another
case, (Misawa and Takahashi 2011) reported a similar surface area dependence with the ROS
(reactive oxygen species) generation by different sizes of Au NPs (Fig. 2.6b). These authors
also emphasized that the key parameter should be the surface area concentration rather than
the mass concentration of NPs. These findings indicate that the surface area concentration is
the determinant metric of biocompatibility in the range of particle sizes studied. The observed
toxicity was a result of the surface interactions inside the cell, which is directly correlated to
the surface area concentration of the pristine NPs.

Figure 2.6 The surface area concentration required to affect 50% of the cells (LD 50,A) is independent from
particle size, as is ROS generation. (a) LD50 based on surface area concentration (cm2/ml) versus particle size for
two different data sets in which the biocompatibility of Au NPs was tested on different cells. Pan et al. 2005,
tested the biocompatibility of Au NPs with HeLa cells whereas we exposed retinal cells to Au NPs. The critical
surface area concentration for retinal cells was 23 cm2/ml; the LD50,A amount for HeLa cells was 83 cm2/ml. (b)
Misawa et al. (2011) measured ROS generation for different sizes of Au NPs at different concentrations. The
ROS generation is plotted as a function of surface area concentration. (Data is represented in log scale for x
axis).
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Au nanospheres found to be nonbiocompatible were further tested by ECIS, so that cell
adhesion was monitored in real time (Fig. 2.3). Most biocompatibility assays are end-point
assays in which cell viability is measured by the end of a certain exposure period; with ECIS
measurements, however, cell attachment behavior was recorded throughout the entire
exposure period without terminating the experiment (Yun et al. 2010, Kling et al. 2014, Liang
et al. 2016). Cell attachment behavior is crucial for biocompatibility assessment because it
provides a direct measure of cellular activity. When a cell enters the apoptosis phase, the
integrity of the cell structure cannot be maintained, and the adhesion proteins start losing their
functionality (Borradori and Sonnenberg 1999). At critical exposure concentrations, which
were determined via MTT assay measurements, the cells started to detach from the plate,
resulting in a decrease in impedance (Fig. 2.3). The ECIS measurements were in perfect
agreement with the MTT assay findings.
The particles tend to escape from intracellular trafficking when they are a part of endocytic
vesicles (Shang et al. 2014). Once they escape from these vesicles, they can cause damage to
the nucleus (Fig. 2.5h), which is consistent with our findings since the particles were inside
nuclei (Fig. 2.4b, c, d, e). It is hypothesized that they activate cell-induced apoptosis
(programmed cell death) signals, which lead to cell death (Kim et al. 2009, Shang et al. 2014).
Larger Au spheres were subjected to retarded internalization and, upon entering the cytosol,
could not enter mitochondria or nuclei because of their larger sizes (Fig. 2.5g and 2.5h). This
led to higher biocompatibility results.
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2.5 Conclusions
Use of Au NPs is being explored for treatment or imaging of the retina. However, there has
been no detailed study on the biocompatibility of Au NPs with retinal cells. In this study, we
report the in-vitro biocompatibility of Au NPs exposed to cells of the retinal pigment
epithelium. The results indicate that NP biocompatibility depends on both the shape and the
size of nanoparticles. Cubic Au nanoparticles with a size of 50 nm and spherical Au
nanoparticles with diameters of 50 and 100 nm were found to be biocompatible up to an
exposure concentration of 5 mg/ml. Au spheres with diameters of 5-30 nm and rod-shaped Au
NPs of 10×90nm exert toxicity in concentration ranges from 0.01 to 0.2 mg/ml. Sizedependent biocompatibility trends were also found for spherical Au NPs with diameters of 5
to 30 nm. At the same mass concentration, the compatibility of Au NPs decreased with
decreasing particle size.
The key observation, however, is that when the concentration is expressed as a function of
surface area per unit volume, the effect of size is no longer relevant. For similar surface area
concentrations, Au NPs in the range of 5–30 nm had almost the same biocompatibility.
Similar surface area dependence has been observed in other cited works. We recommend that
to use Au NPs intracellularly for therapeutic purposes; it may be necessary only to modulate
the surface area. The overall assessment and generalization of cytotoxicity is, however, more
complex and depends on the various parameters and factors we have discussed here. The
reported critical doses for specific shapes and sizes of Au NPs and the proposed possible
toxicity mechanism can serve as a guide when Au NPs will potentially be used in ophthalmic
studies, especially when targeted to retinal cells.
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Chapter 3: Hyaluronate Coating as a
Solution to Toxicity of Gold Nanoparticles

The results of this chapter have been reprinted with permission from Karakocak, B. B., Liang,
J., Biswas, P., Ravi N. (2018). Hyaluronate Coating Enhances the Delivery and
Biocompatibility of Gold Nanoparticles. Carbohydr. Polym. 186:243-251. Copyright 2018
Elsevier
Supplementary information along with figures and tables are available in Appendix II.
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Abstract
For targeted delivery with nanoparticles (NPs) as drug carriers, it is imperative that the NPs are
internalized into the targeted cell. Surface properties of NPs influence their interactions with
cells. We examined the responses of retinal pigment epithelial cells, NIH 3T3 fibroblast cells,
and Chinese hamster ovary cells to gold nanoparticles (Au NPs) in their nascent form as well
as coated with end-thiolated hyaluronate (HS-HA). The grafting density of (HA-HS) on Au
NPs was calculated based on total organic carbon measurements and thermal gravimetric
analysis. We imaged the intracellular NPs by 3D confocal microscopy. We quantified viability
and generation of reactive oxygen species (ROS) of the cells to Au NPs and monitored cellsurface attachment via electrical cell-substrate impedance sensing. The results confirmed that
receptors on cell surfaces, for HA, are critical in internalizing (HA-S-Au NPs), and HA may
mitigate ROS pathways known to lead to cell death. The 50- and 100-nm HA-S-Au NPs were
able to enter the cells; however, their nascent forms could not. This study shows that the
delivery of larger Au NPs is enhanced with HS-HA coating and illustrates the potential of HAcoated NPs as a drug delivery agent for inflamed, proliferating, and cancer cells that express
CD44 receptors.
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3.1 Introduction
Gold nanoparticles (Au NPs) have been widely explored in medicine as potential delivery
agents for various biopharmaceuticals (Kim et al. 2011, Kumar et al. 2015). Although Au NPs
are usually more biocompatible than other metal or metal oxide nanoparticles, their inherent
positively charged surface disrupts the negatively charged cell membrane, while their
production of reactive oxygen species (ROS) causes cytotoxicity (Moghadam et al. 2012).
Moreover, plasma proteins can spontaneously adsorb to nascent Au NPs, affecting the surface
properties of the particles and their interaction with cells (Nel et al. 2009). As a result, surface
modification is essential ideally to prevent protein adsorption (Larson et al. 2012), and
nonspecific delivery of Au NPs (Rana et al. 2012), to decrease opsonization by the immune
system (Papasani et al. 2012), and finally mitigate their toxicities.
Many coating conjugates, ranging from synthetic ligands to natural biomolecules, have been
used to improve the stability of particles and their delivery to specific cells or tissues (Yilmaz
et al. 2016, Lin et al. 2017). Our focus is on hyaluronic acid (HA) as a coating material. HA is
a bioactive linear polysaccharide that prevents adsorption of proteins on surfaces of
biomaterials (Hans and Lowman 2002) and has an antifouling effect that arises from its
hydrophilic and polyanionic characteristics (Lee et al. 2008, Santhanam et al. 2015). HA also
scavenges free radicals and chelates pro-oxidant metals (Glucksam-Galnoy et al. 2012). HA
serves as a ligand for several cell-surface receptors and thereby has an important
physiological role. Cluster of differentiation 44 (CD44) is the most well-studied cell
membrane receptor (Jaggupilli and Elkord 2012). It is present on, for example, the lymphatic
vessel endothelial HA receptor (LYVE-1) (Chen et al. 2005), the receptor for hyaluronatemediated motility (RHAMM) (Nedvetzki et al. 2005), and the HA receptor for endocytosis
(HARE) (Pandey and Weigel 2014). The type of HA receptor on the cell membrane depends
on the function of the tissue.
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The role of HA receptors in healthy and diseased cells is not well understood. CD44 had been
identified during the development, differentiation, and proliferation of cells, for example, the
neural retina and in Muller cells (Chaitin and Davis 1995). CD44 has also been found under
pathologic conditions, such as inflammation and proliferative vitreoretinopathy, where retinal
pigment epithelial (RPE) cells actively proliferate in the subretinal space, on the surface and
undersurface of the retina, and in the vitreous cavity. Hence, RPE cells exhibit significantly
higher CD44 receptors compared to their quiescent and stationary state (Moysidis et al. 2012).
Furthermore, it has been reported that cancer cells also express CD44 receptors and have a
significant regulatory role in almost all cancer types (Kesharwani et al. 2015, Wang et al.
2016). It is now well recognized that a threshold of CD44 expression is required before HA
binding is observed (Perschl et al. 1995, Tzircotis et al. 2005). Therefore, cells like NIH 3T3,
which express relatively less number of CD44 receptors, may lack HA binding while cells
like Chinese hamster ovary (CHO) cells with high CD44 receptor density show strong HA
binding (Katoh et al. 1995, Tzircotis et al. 2005).
In the previous chapter, we have found that for a fixed total surface area, Au NPs (particle
diameter, dp < 50 nm) were toxic to retinal pigment epithelial cells, independent from the
particle size (Karakocak et al. 2016). The toxicity of Au NPs arises from reactive oxygen
species (ROS) activity, which was shown to be correlated to the available total surface area
(Pan et al. 2007, Jiang et al. 2008). HA is a known free radical quencher; it is natural and
consequently biocompatible (Balogh et al. 2003). Our objective in the current work is to
expand the usefulness of Au NPs by mitigating their toxicity via coating them with HA. As
expected, we observed that HA coating significantly enhanced the biocompatibility of Au
NPs; unexpectedly, the coating also greatly improved the internalization of larger Au NPs,
which in their nascent form could not enter the cell. The outcomes of this study could be
valuable in treating inflamed, proliferating, or cancer cells that express CD44 receptors.
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3.2 Materials and Methods
3.2.1 Reagents
1-Ethyl-3-[3-(dimethylamino)propylcarbodiimide (EDC), sodium citrate, hydrogen
tetrachloroaurate (HAuCl4), cystamine dihydrochloride, sodium cyanoborohydride
(NaBH3CN), Dulbecco’s modified Eagles’s medium/nutrient mixture F-12 Ham
(DMEM/F12), trypsin-ethylenediaminetetraacetic acid (EDTA) solution 10x, and fetal calf
serum (FCS), and DAPI for nucleic acid staining were obtained from Sigma-Aldrich (St.
Louis, MO). ARPE-19 (Retinal pigment epithelial) (ATCC® CRL¬ 2302™), NIH 3T3
(ATCC® CRL¬ 1658TM) and CHO (CCL¬ 61™) cells were purchased from American Type
Culture Collection (Manassas, VA). Dithiothreitol (DTT) was obtained from Duchefa
Biochemie (Haarlem, Netherlands). HiLyte-FluorTM 647 amine was purchased from AnaSpec
(San Jose, CA). Sodium hyaluronate having a molecular weight of 10,000 Da was obtained
from Lifecore (Chaska, MN). The Apo Tox-GloTM and ROS-GloTM H2O2 assay kits were
purchased from Promega Biosciences (San Luis Obispo, CA). All chemicals and reagents
were of analytical grade.

3.2.2 Synthesis of Au NPs
We synthesized Au NPs by the citrate reduction method (Frens 1973, Kimling et al. 2006).
HAuCl4 (10 mg) was dissolved in 90 ml of deionized (DI) water, and this solution was heated
to boiling. We added sodium citrate solution (250 mM) to the boiling solution in amounts
ranging from 400 µl to 900 µl and stirred for 20-30 min until the solution became wine-red.
The solution was then left undisturbed in the dark for 24 h at room temperature. Subsequently,
Au NP solutions were centrifuged at 10,000 rpm for 20 min and suspended in DI water. We
confirmed the final size using transmission electron microscopy (TEM) analysis and dynamic
light scattering (DLS) measurements. The detailed procedure for particle size measurements
is given as supporting information.
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3.2.3 Preparation of end-thiol modified HA (HS-HA)
We prepared HS-HA by reductive amination as described elsewhere (Lee et al. 2012, Kumar
et al. 2015). HA (MW: 10,000 Da, 100 mg) and cystamine dichloride (60 mg) were dissolved
in 0.1 M borate buffer (10 ml, pH 8.5) with 0.4 M NaCl and stirred for 2 h. NaBH3CN was
added to the solution at a final concentration of 0.2 M and reacted at 50°C for three days. The
reaction mixture was then incubated with 0.1 M DTT for 12 h to introduce a free thiol group
(Fig. 1). The resulting solution was dialyzed against a large excess of 0.1 M NaCl solution for
one day, 25% ethanol for one day, and pure water for one day to remove unreacted chemicals.
The efficiency of thiol-end functionalization of HA was higher than 90%, and the ratio of
[SH] to [HA repeating units] was 0.025 as determined by Ellman’s assay. Physicochemical
properties of the HS-HA were obtained using Proton Nuclear Magnetic Resonance (1HNMR), Fourier Transform Infrared (FTIR) spectroscopy, and Gel Permeation
Chromatography (GPC) analysis. Please refer to supporting information for details of
Ellman’s assay, 1H-NMR, FTIR, and GPC analysis.

3.2.4 Conjugation of HS-HA with Au NPs and quantification of the coating
Before initiating the conjugation process, we calculated the average number of HA molecules
(MW: 19.69 kDa, 5.42 nm hydrodynamic radius (Rh)) that can bind to one Au NP (particle
size based on the TEM and DLS measurements). From that, we calculated the approximate
HA to Au NP conjugation mass ratio and ensured that we used at least 1.5x in excess of this
amount. HS-HA was added dropwise to the dispersed Au NPs in DI water at room
temperature with moderate stirring. The solution was stirred overnight. The HA-Au NP
conjugate was further purified by centrifuging it twice at 10,000 rpm for 20 min to remove
unbounded HA molecules and was finally redispersed in DI water. To take further
measurements in the solid phase, the coated nanoparticle solution was lyophilized for two
days at -105 oC. We used total organic carbon (TOC) and thermal gravimetric analysis (TGA)
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to determine the amount of coating around the nanoparticles. Please refer to supporting
information for details of TOC and TGA analysis.
The number of bound HA molecules per unit surface area, grafting density (σ) was calculated
based on both TOC (σTOC) and TGA (σTGA) measurements as described previously (Benoit et
al. 2012). In summary, first, the number of Au NPs in a sample was calculated based on the
hydrodynamic diameter of the Au NP and the density of Au. Next, the total available surface
area of Au NPs in a sample for HA molecules to bind was determined. The number of HA
molecules present in a sample was calculated taking the molecular weight of HA which is
determined by GPC analysis. Finally, grafting density was calculated by dividing the number
of HA molecules in a sample to the available surface area of Au NPs.

3.2.5 Investigation of the internalization of NPs
The cellular internalization of coated and nascent Au NPs was determined by exposing NPs to
ARPE-19, NIH 3T3, and CHO cell lines. This was followed by careful washing to remove
NPs that may have reached and been adsorbed on the cell surface (Cho et al. 2011). The
intracellular concentrations of Au were quantified with an ELAN DRC II Inductively coupled
plasma mass spectrometry (ICP-MS) (Perkin Elmer, Inc., USA). To identify the difference
between the administered and delivered doses, the number of nanoparticles that failed to enter
the cell, as well as the specific Au NP intracellular concentrations, were quantified in aliquots
from the phosphate buffer saline (PBS) washes done before confocal imaging. Using ICP-MS,
the aliquots were tested for the presence of Au NPs.

3.2.6 In-vitro toxicity measurements on ARPE-19 cells with MTT, ApoToxGloTM, and ROS-GloTM H2O2 assays
Cell metabolic activity, and hence the viability of retinal cells in the presence of Au NPs, was
assessed with MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl tetrazolium bromide). The
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relative amount of apoptotic cells and ROS generation were measured, respectively, by
ApoTox-Glo™ and ROS GloTM H2O2 assays. See the supporting information for the details

3.2.7 Confocal microscopy analysis
To confirm the presence of NPs inside cells, we investigated the distribution of Au NPs at
their critical mass concentrations (LD50,M), determined previously (Karakocak et al. 2016),
using a nanoplasmonic confocal laser scanning microscope (Leica TCS-SP8). Au NPs have a
surface plasmon resonance property (SPR). For Au NPs in size range of 5-100 nm, the SPR
wavelength is around 520 nm (Huang et al. 2008), depending on the sizes of the
nanoparticles. See the supporting information for the details.

3.2.8 Cell attachment measurements by electrical impedance spectrometry
(ECIS)
We analyzed the biocompatibility of Au NPs as they were exposed to ARPE-19 cells using
ECIS, a noninvasive technique that measures the impedance across gold electrodes at the
bottom of tissue culture wells, using a range of frequencies of alternating current (Wegener et
al. 2000, Arndt et al. 2004). As adhesion proteins changed the cell morphology and
attachment to the electrodes in the bottom of wells, the resistance across the electrodes also
changed (Borradori and Sonnenberg 1999, Santhanam et al. 2016). The change in resistance at
frequencies ranging from 400 to 64,000 Hz was measured over time. Low-frequency
impedance can be used to monitor the solution paths around the cells, and hence the layer’s
cell-to-cell barrier functions (Wegener et al. 2000). The addition of Au NPs complicates the
impedance of the system. However, at a frequency of 4,000 Hz, the contribution to resistance
from cells was dominant over the contribution to resistance from Au NPs with the medium
(Kandasamy et al. 2010). Therefore, we chose a frequency of 4,000 Hz to monitor cell growth
and biocompatibility.

51

3.2.9 Statistical analysis
Results are presented as means ± standard deviation on the graphs for experiments done at
least with three biological replicates per condition or group. First, each test result (viability
measurements, the relative amount of apoptotic cells, and ROS generation) was compared
with the corresponding negative (untreated cells) and positive (NPs without the cells) control
groups with Student’s t-test. P* < 0.05, the significance level, was statistically acceptable.
Second, Two-Factor ANOVA (analysis of variance) was used to evaluate the results of
viability measurements, the relative number of apoptotic cells, and ROS generation. For cell
attachment measurements, eight replicates were performed for each independent experiment.
Statistical significance was evaluated using ANOVA to compare the results with the
respective negative (untreated cells) and positive control (only cell media) groups. P* < 0.05,
the significance level, was statistically acceptable.

3.3 Results and Discussion
3.3.1 Synthesis of end-thiolated hyaluronic acid (HS-HA)
HS-HA was synthesized by a previously reported method (Lee et al. 2012), outlined in Fig.
3.1. HA has multiple hydroxyl and carboxyl groups, but only the end six-member ring can
open up and form an aldehyde group.
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In the presence of borate buffer (pH 9), the hemiacetal end group of HA
opens up and forms an aldehyde:

Schiff base forms
with cystamine

Reduced with NaBH3CN to form
a more stable amine compound

Figure 3.1 HS-HA synthesis chemistry. In the presence of borate buffer at pH 9, the terminal cyclic hemiacetal
ring opens and changes to a linear aldehyde form. A Schiff base forms with cystamine. Thus, the terminal
saccharide reverses between two states to reach the final form. The Amadori compound, sodium
cyanoborohydride (NaBH3CN), is added, and then Dithiothreitol (DTT) is added to reduce the disulfide and
produce HS-HAs.

We took advantage of this lone functional group, modifying it with an amine to introduce an
end thiol group and covalently binding it to Au (Fig. 3.2). Ellman’s assay results confirmed
~90% of thiolation of HA, and the molar ratio of SH to HA was found to be ~0.025. However,
1

H-NMR and FTIR analysis could not clearly detect the end-thiol content of hyaluronate as

[SH]/[HA repeating units] is low (Fig. S1 and Fig. S2). On the other hand, based on gel
permeation chromatography (GPC) analysis, we determined that the hydrodynamic radius of
HS-HA was 5.42 nm. Its number average molecular weight was 15.51 kDa, its polydispersity
1.27, and its intrinsic viscosity was 0.58 dl/g (Table 3.1). The Mark-Houwink constant
changes linearly with the logarithm of MW of HA which can correspond to a change in
conformation of HA from a random coil to a rigid structure (La Gatta et al. 2010).
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The Mark-Houwink constant, based on GPC analysis of the HS-HA, was 0.70, suggesting the
presence of a random coil.

-SH (thiol group)

HA (Hyaluronate)

Au NP
End-thiolated
HA (HS-HA)

Figure 3.2 Illustration of coated Au NPs with end-thiolated HA (HS-HA), where the thiol group at the end of
each HA chain is attracted to the Au NP surface.

Table 3.1 Gel permeation chromatography results for HS-HA
Parameter

Value

Number average molecular weight (Mn)

15.51 kDa

Weight average molecular weight (Mw)

19.69 kDa

Polydispersity

1.27

Hydrodynamic radius

5.42 nm

Intrinsic viscosity

0.58 dl/g

Mark-Houwink constant

0.70
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3.3.2 Synthesis of Au NPs conjugated with HS-HA and confirmation of the
presence of the coating
We synthesized Au NPs with sizes of 5-, 10-, 20-, 50-, and 100-nm, the sizes most preferred
for targeted drug delivery studies (Karthikeyan et al. 2010, Ngwa et al. 2012). The highresolution TEM (HR-TEM) images of the uncoated Au NPs can ben found in supporting
information (Fig. S3). The Au NPs were conjugated with HS-HA (see Methods). The amount
of coating on Au NPs was determined with TOC analysis and TGA. These two approaches are
well suited to probe the content of inorganic and organic compounds on nanoparticle surfaces
(Benoit et al. 2012). The presence of the coating was first confirmed and quantified by TOC
measurements by determining the extent of organic and inorganic carbon. Because inorganic
carbon was negligible, the total carbon content was equivalent to the organic carbon content
which was attributed to HA coating. To further confirm and quantify the presence of the
coating, we used TGA which records the change in mass as a function of temperature. The
peak at ~280 oC corresponded to the decomposition of HA (Fig. 3.3). The exact quantity of
the coating was determined by calculating the change in mass around the temperature at
which HA is known to decompose (Ahire et al. 2016).

σ (# HA molecules/nm2)
Au dp (nm)

TOC

TGA

3.75 ± 0.9

0.18 ± 0.04

0.16 ± 0.03

7.43 ± 3.2

0.09 ± 0.02

0.10 ± 0.02

13.30 ± 3.2

0.05 ± 0.01

0.06 ± 0.01

48.51 ± 19.4

0.03 ± 0.01

0.03 ± 0.01

82.55 ± 24.6

0.03 ± 0.01

0.03 ± 0.01

Figure 3.3 Thermal gravimetric analysis plot for the HS-HA coated Au NPs. HA decomposition occurs at around
280 oC, and Au NPs melt approximately at 500 oC. Au NP grafting density (the number of HA molecules/nm2)
determined by TOC and TGA measurements. Errors provided reflect standard deviation of the replicate error in
repeated measurements of the sample. At least two measurements were taken for each analysis technique.

5nm,

10 nm

20 nm,
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50 nm,

100 nm

As detailed in a previous study (Benoit et al. 2012), we calculated the grafting density of HA
molecules, the number of bound HA per unit surface area (# HA molecules/nm2) based on
results of both TOC (σTOC) and TGA (σTGA) measurements (Fig. 3.3 and Table S1). The results
showed that, for both measurement techniques, the number of HA molecules adsorbed per
unit surface area of Au NP decreases as the particle size increases. This trend may be
attributed to the HA-HA interactions which could be geometrically minimized due to the
increased curvature of the smaller particles (Nasir et al. 2015). One should note that these
calculations were based on two main assumptions: Au surface is smooth, even though it is
known that the surface of Au has irregularities at the atomic scale (Loskutov et al. 2009) and
secondly, end-thiolation allows only a single covalent attachment per HA molecule. We do
not have any evidence on the orientation of HA on the surface of Au. However, polymers
with a single point attachment to the core nanoparticle generally take on brush-like
confıguration (Benoit et al. 2012 and Dukes et al. 2010).

3.3.3 Characterization of HS-HA conjugated Au NPs
The hydrodynamic sizes and zeta potential of both nascent and coated Au NPs in DI water
and DMEM were measured by dynamic light scattering (DLS) analysis (Figs. S4 and S5).
When the nascent particles were dispersed in cell medium, the results indicated a substantial
increase in particle size and a decrease in zeta potential. The HS-HA coating also had a major
effect on particle size. The increase in size for nascent NPs in cell culture media was
attributed to nonspecific protein adsorption on the Au NP. When the Au NPs are coated with
HS-HA, and then dispersed in DMEM, the extent of protein adsorption was less, which is
consistent with the known property of HA to decrease protein adsorption (Pitarresi et al.
2007).
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3.3.4 Cellular uptake of nascent and coated Au NPs
Our uptake studies were based on the measurement of intracellular gold concentration. We
had previously determined the critical mass (LD50,M) concentration of Au nanoparticles of
different sizes and used these critical mass concentrations in the rest of the cellular
experiments, including the uptake study (Karakocak et al. 2016). Our earlier study with RPE
cells indicated that the LD50,M concentrations of Au NPs with sizes of 5-, 10-, 20-nm were,
0.03 mg/ml, 0.08 mg/ml, and 0.11 mg/ml respectively (Karakocak et al. 2016). Furthermore,
Au NPs 50 nm and 100 nm in diameter did not exert any toxic effect up to 5 mg/ml, because
they did not enter the cells. Here, we extended our study using two additional different cell
lines: ARPE-19 cells and CHO cells with high-density CD44 receptors (Jaggupilli and Elkord
2012) and NIH 3T3 cells with relatively less CD44 receptors (Culty et al. 1992) to investigate
the CD44 receptor-mediated internalization of 50-nm Au NPs.
According to the ICP-MS results, the number of NPs internalized by ARPE-19 cells changed
with the presence of the coating. Indeed, the coating played a significant role, especially for
particles with diameters larger than 50 nm. Nascent particles with a diameter larger than 50
nm were not able to enter cells (Fig. 3.4A). However, when the same particles were coated
with HS-HA, their size increased to 58.41 nm in DMEM, and the number of particles
internalized by the retinal cells increased considerably (Figs. S4 and S6). Conversely, HS-HA
coating increased the size of smaller Au NPs significantly and slightly decreased the number
of intracellular Au NPs (Figs. S4 and S6). This difference may be attributed to increase of the
coated NP size and the presence of HA coating, therefore the internalization pathway of
nanoparticles is predominantly CD44 receptor-mediated endocytosis (Almalik et al. 2013).
To test whether the internalization was CD44 receptor-mediated, nascent (53.81-nm) and
coated (58.41-nm) Au NPs in DMEM were exposed to two more cell lines: NIH 3T3 cells,
which have significantly fewer CD44 receptors than ARPE-19 cells, and CHO cells which are
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also known to express CD44 but a cancer cell line, unlike ARPE-19 cells (Culty et al. 1992).
The amount of HA-S-Au NPs internalized by NIH 3T3 cells was significantly less than the
amount internalized by ARPE-19 and CHO cells. Therefore, it can be concluded that the
internalization of Au NPs coated with HS-HA depends on the density of cell-surface receptors
for HA, in this case, CD44 (Fig. 3.4B).

Figure 3.4 (A) Cellular uptake of Au NPs of different sizes, with and without HS-HA coating by ARPE-19 cells.
(B) 50 nm Au NPs (0.11 mg/ml) exposed to ARPE-19, NIH 3T3, and CHO cells with and without pretreatment
with 10x HS-HA. CD44 receptor density of NIH 3T3 cells is significantly less than that of ARPE-19 cells;
therefore, blocking the CD44 receptors of NIH 3T3 cells did not significantly affect internalization of HA-S-Au
NPs, unlike the results for ARPE-19 and CHO cells. Overall, cells like ARPE-19 and CHO cells, which express
high enough number of CD44 receptors and meet the threshold for HA binding, internalize more coated NPs
than NIH 3T3 cells. ARPE-19 cells exposed to
HA-S-Au NPs,
Nascent Au NPs, ARPE-19 cells
treated with 10x HS-HA, and then exposed to HA-S-Au NPs.

As a step toward confirming this finding, all cells were treated with 10x HS-HA, to saturate
the CD44 receptors, and then exposed to 50-nm HA-S-Au NPs. As expected, we found that
the number of internalized particles was significantly decreased (Fig. 3.4B). Cell membrane
receptors and lipid bilayer barriers are specific to cell type. Because of the presence of CD44
receptors, the amount of internalized HA-S-Au NPs was significantly different in various
types of cells. As the size of the nanoparticles decreases, the internalization pathway may
involve passive diffusion; however, as particle size increases, receptor-mediated endocytosis
may become more prominent (Zhang et al. 2009, Panariti et al. 2012, Gupta and Rai 2017).
For smaller particles, there are alternate size-dependent internalization paths that do not
involve CD44 receptors. Therefore, the internalized number of coated nanoparticles may
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slightly decrease because of the increased size of coated Au NPs (Figs. S5 and S7). For RPE
cells, we found that internalization of 5-, 10-, and 20-nm particles was only minimally
decreased by the presence of the coating. In contrast, internalization of 50- and 100-nm HSHA coated Au NPs was significantly increased (Fig. 4A). Furthermore, when we blocked the
receptors for HA by adding excess HA to saturate the receptors before administering HA-SAu, there was less internalization (Fig. 4B). Thus, although several pathways exist for
internalization of nanoparticles, CD44-mediated endocytosis is particularly important for
larger particles. This finding is noteworthy in that coating with HA provides a “Trojan horse”
approach to the delivery of large Au NPs and possibly to other hydrophobic particles into cells
with receptors for HA.

3.3.5 The fate of nascent and coated Au NPs in the cells
To confirm the presence of NPs inside cells, we investigated the distribution of Au NPs using
a nano-plasmonic confocal laser scanning microscope (Leica TCS-SP8) (see Methods). We
first studied the effect of exposure of different sizes of nascent and coated Au NPs to ARPE19 cells.
Per the 2D and 3D confocal images (Figs S6 and S7, respectively), it can be inferred that for
smaller NPs (dp < 50 nm), the presence of an HA coating slightly decreased the number of Au
NPs inside retinal cells. Nascent particles with diameters of 50 nm and above could not enter
retinal cells (Figs. S6H/S7H and S6J/S7J). However, when these particles were coated with
HA, their presence within cells significantly increased (Figs. S6I/S7I and S6K/S7K), as also
confirmed by the ICP-MS results shown in Fig. 3.4. In other words, the HA coating enabled
NPs larger than 50-nm (58.41 nm in DMEM) to enter retinal cells (Fig. 3.5), even though
DLS measurements showed that the size of these particles had significantly increased (Figs S4
and S5). This lends credence to the hypothesis that internalization of larger HS-HA coated Au
NPs occurs via the HA receptor-mediated CD44 pathway. Because large HS-HA-coated
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particles can enter cells, they can efficiently deliver a greater payload than previously reported
targeted drug delivery vehicles (Diebold and Calonge 2010).

Figure 3.5 3D Confocal microscopy images of Au NPs with ARPE-19 cells. The red staining corresponds to
actin, the nucleus is blue, and Au NPs are green. ARPE-19 cells exposed to (A) no particles, the negative
control. 50-nm (B) nascent Au NPs (C) HA-S-Au NPs (D) ARPE-19 cells pretreated with 10x HS-HA and then
exposed to 50-nm HA-S-Au NPs. The HS-HA coating significantly enhanced the intracellular concentration of
Au NPs, whereas when the same particles were exposed to the retinal cells after blocking the CD44 receptors,
the amount internalized is significantly decreased. The exposure concentration was selected as 0.11 mg/ml. Scale
bars are 20 µm.

Additionally, our observations also extend to non-ocular tissues. Nascent and HS-HA-coated
50-nm Au NPs were administered to NIH 3T3 cells and CHO cells. Both ICP-MS findings
(Fig. 3.4B) and 3D confocal microscopy (Figs. S8 and S9) showed that significantly increased
number of particles entered NIH 3T3 and CHO cells. This observation confirmed our
hypothesis that the number of HA-S-Au NPs internalized is dictated by the presence or
absence of the relevant receptors on the cell membrane (in this case, CD44).
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3.3.6 Biocompatibility assessment of HS-HA-coated Au NPs with ARPE-19
cells
We next studied the biocompatibility of HS-HA Au NPs with ARPE-19 cells. Three different
independent end-point assays were used: viability based on enzymatic activity in
mitochondria; the percent of apoptotic cells based on caspase 3/7, and activity ROS
generation, which is proportional to luciferase activity (see Methods). The results indicated
that nascent Au NPs with diameters smaller than 50 nm were not biocompatible above 0.03
mg/ml (Fig. 3.6A), initiated apoptotic cell death (Fig. 3.7A), and induced ROS generation
(Fig. 3.7C). On the other hand, no toxicity was observed for HA-S-Au NPs with a
concomitant negligible generation of ROS (Figs. 3.6B, 7B, and 7D). Most of the toxicity of
Au originate from ROS production because of its surface chemistry in the cell’s cytoplasm
(Balogh et al. 2003). Coating with HA significantly decreases the available surface on Au by
steric hindrance. In addition, HA and its degradation products (tetrasaccharides) have an
exceptional ability to quench free radicals (Balogh et al. 2003). Thus, any ROS formed at the
surface of Au NPs has very little opportunity to escape the HA coating, as was confirmed by
our ROS GloTM H2O2 assay results (Figs. 3.7C and 7D).
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Figure 3.6 Biocompatibility results of (A) nascent Au NPs and (B) HA-S-Au NPs. HS-HA coating significantly
increased the compatibility of NPs with ARPE-19 cells. Values are expressed in mean ± SEM for each
condition; three independent experiments were done with eight replicates (n = 24; Student’s t-test, *P < 0.05
versus controls). The results were compared to each other using two-factor ANOVA analysis. For nascent
particles, in terms of both particle size and exposure concentration, the results were significantly different from
each other (*P < 0.05). For coated particles, the results were found to be independent of the exposure
concentration (**P > 0.05) but statistically different among each nanoparticle size tested (P* < 0.05)
5nm,

10 nm,

5nm,
ıııııııı

untreated cells,

10 nm,

20 nm,

50 nm,

20 nm,

100 nm
50 nm,

100 nm

media (DMEM) only

Cell morphology was observed by 3D confocal microscopy. There was a significant structural
change in cytoskeleton fibers (actin) in retinal cells exposed to nascent NPs (dp < 50 nm)
(Fig. S7). The nuclear morphology was disrupted, and the density of actin significantly
decreased (see supporting information, Figs. S7B, S7D, S7F). In a previous study degradation
of actin was linked to cell death (Tezel et al. 1999), consistent with our confocal imaging
observations.
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Cells exposed to HA-S-Au NPs maintained good actin density and intact nuclei (Figs. S7C,
S7E, S7G, S7I, S7K). These observations are consistent with our biocompatibility results,
which indicated that coated Au NPs are not toxic and do not initiate apoptosis.

Figure 3.7 Measurement of apoptotic cells amounts using the Apo Tox-GloTM assay when the cells are exposed
to (A) nascent Au NPs and (B) HA-S-Au NPs. Measurement of ROS levels using the ROS GloTM H2O2 assay,
when the cells are exposed to (C) nascent Au NPs and (D) HA-S-Au NPs. The HS-HA coating prevented both
apoptosis and ROS generation in ARPE-19 cells for all particle sizes tested. (n = 24; Student’s t-test, *P < 0.05
versus controls). The results were compared to each other using two-factor ANOVA analysis. In both
measurements, for nascent particles, in terms of both particle size and exposure concentration, the results were
significantly different from each other (*P < 0.05). For coated particles, the results were found to be independent
of the exposure concentration (**P > 0.05) but statistically different among each nanoparticle size tested (*P <
0.05).
5nm,

10 nm,

20 nm,

50 nm,
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3.3.6 Cell attachment behavior with ECIS measurements in response to Au
NPs
We monitored retinal cells’ attachment in the presence of both nascent and coated Au NPs via
electrical impedance measurements. Retinal cells exposed to nascent NPs less than 50 nm in
diameter, at their critical LD50, M concentrations, almost immediately started to detach from
the plate (Fig. 3.6C). On the other hand, cell attachment was not hindered when the ARPE-19
cells were exposed to HA-S-Au NPs (Fig. 3.6D). Following the addition of HA-S-Au NPs,
the impedance curves, which show the real-time cellular response, fall in line with the
negative control group, in which neither coated nor nascent NPs were exposed to the cells
(Fig. 3.6D). The cell attachment behavior is directly correlated to cell viability. Therefore, it
can be inferred that cell viability is not compromised in the presence of HA-S-Au NPs. As a
result, it is clear that not only HA coating plays a significant role in the internalization of Au
NPs, but also that its presence, independent of particle size and the amount of Au NPs inside a
cell, protects the cell from ROS damage, does not initiate cell death.

3.4 Conclusions
Our TOC and TGA results indicated that we successfully coated Au NPs with HS-HA. The
grafting density varied from 0.18 to 0.03 # of HA molecules/nm2 as the size of Au NPs
increased from 5 to 100 nm. HS-HA coating decreased Au NPs’ toxicity to the cells. The
improved biocompatibility is associated with HA’s ability to act as a free-radical quencher as
revealed by our ROS measurements. The native 50- and 100-nm Au NPs could not enter the
cell; however, the HS-HA coating enabled their entry in the cells via CD44 receptors, acting
as a Trojan horse for the larger particles. The endocytosis of large particles coated with HSHA is a significant observation for targeted drug and gene delivery applications.
Internalization was a function of the density of CD44 receptors as evidenced by percent
internalization results with three different cell lines: CHO>ARPE-19>NIH 3T3.
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In conclusion, we showed that HS-HA coating facilitates entry of Au NPs in size range of 5100 nm into cells that express CD44 receptors and renders the NPs biocompatible. This
observation portends that HS-HA can be used as a biocompatible carrier to deliver larger
payloads for treating inflamed, proliferating, and cancer cells that are associated with
increased expression of CD44 receptors.
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Chapter 4: Nitrogen-doped Carbon Dots as
a Biocompatible Alternative for Bioimaging

The results of this chapter have been reprinted with permission from Karakocak, B. B.; Liang,
J.; Kavadiya, S.; Berezin, M. Y.; Biswas, P.; Ravi, N. Optimizing the Synthesis of RedEmissive Nitrogen-doped Carbon Dots for Use in Bioimaging. ACS Appl. Nano Mater. DOI:
10.1021/acsanm.8b00799. Copyright 2018 American Chemical Society
Supplementary information along with additional figures and tables are available in
Appendix III
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Abstract
Synthesizing highly efficient red-emissive carbon dots (CDs) is a challenge that still impedes
widespread applications of CDs in bioimaging. Herein, we demonstrate a facile, isolation-free
synthesis of deep red (600-700 nm) emissive nitrogen-doped CDs (nCDs) based on
microwave-assisted pyrolysis of citric acid and ethylenediamine. The duration of pyrolysis,
the molar ratio of acid to amine, and the concentration of reactants were optimized by means
of Central Composite Design and Response Surface Methodology (CCD-RSM) to yield deep
red to near-infrared fluorescence. We demonstrated their applicability on three different cell
lines (retinal epithelial, lens epithelial, and Chinese hamster ovary cells (CHO)). We
measured the viability, the generation of reactive oxygen species, and percentage of apoptotic
cells to determine their level of toxicity in cell culture. Confocal images showed that the
nCDs fluoresced at different wavelength depending upon the excitation wavelength and were
excitable up to 635 nm. Furthermore, the ex vivo imaging of porcine ocular globes and postmortem imaging of a whole mouse exemplified the utility of nCDs.
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4.1 Introduction
Carbon dots, a rising star in the bioimaging field (Luo et al. 2013, Berezin 2014, Cherukula et
al. 2016, Gan et al. 2016), have attracted considerable attention due to their numerous and
unique intrinsic properties such as wavelength dependent excitation/emission (Jiang et al.
2015, Ding et al. 2016) a long fluorescence lifetime (Dong et al. 2015) good photostability
(Zhang et al. 2015) and high biocompatibility (Tao et al. 2012). With these unique properties,
carbon dots (CDs) have demonstrated promise for bioimaging applications.(Hola et al. 2014,
Choi et al. 2016, Zhang et al. 2016) Even though, many kinds of CDs have been reported;
most show intense emission only in blue-green regions following excitation with ultraviolet or
blue light (Bourlinos et al. 2008, Peng and Travas-Sejdic 2009, Wang et al. 2010, Bourlinos et
al. 2012, Zhu et al. 2013, Yang et al. 2015, Qu et al. 2017). The well-known blue
autofluorescence of native biological matrix and the severe photodamage caused by
ultraviolet excitation further hinder their application. Although, there have been a handful of
attempts to create red-emissive CDs (Nie et al. 2014, Ge et al. 2015, Ding et al. 2016, Sun et
al. 2016, Feng et al. 2017, Miao et al. 2017), either the excitation was limited to green light or
the synthesis method was quite involved. Therefore, it remains highly desirable to achieve
red-emissive CDs that can be excited with longer wavelengths, penetrating deep in tissue
without causing damage to the target cell/tissue/organ, via a truly facile synthesis method.
Various methods for creating CDs, ranging from relatively simple to rather complex
procedures, have been reported (Luo et al. 2013, Nie et al. 2014, Ding et al. 2016, Feng et al.
2016, Feng et al. 2017, Lin et al. 2017, Lin et al. 2018). Certain synthesis methods produce
great variety of CDs with a broad distribution of fluorescence emission, and hence necessitate
separation (i.e., silica column chromatography (Nie et al. 2014, Ding et al. 2016, Feng et al.
2017), capillary electrophoresis (Hu et al. 2013)) to isolate those nanoparticles with desired
optical properties. For clinical applications, it would be ideal to scale up the synthesis,(Wang
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and Hu 2014) preferably using a simple method involving commercially available reactants
and environmentally friendly techniques (Xu et al. 2014). Among existing methods,
microwave pyrolysis has the distinct advantages of shorter reaction times, milder reaction
conditions, lower energy consumption, better stability, easy reproducibility, and higher
product efficiency (Zhu et al. 2009, Zhai et al. 2012, Hu et al. 2013). Thus, microwave
pyrolysis exhibits great promise as opposed to other synthesis methods which are quite
involved and require isolation of the desired red-emissive CDs.
In this study, we optimized an isolation-free method of synthesizing red-emissive CDs (redCDs) with deep red to near-infrared (NIR) fluorescence (600 - 700 nm). Such longwavelength emitters are highly desired in optical imaging of tissue, due to the decreased
interference from tissue autofluorescence at longer wavelengths (Hola et al. 2014,
Ostadhossein and Pan 2017). The deep-red emitters were based on nitrogen-doped carbon
dots (nCDs) prepared by microwave-assisted pyrolysis of a mixture of citric acid and aliphatic
diamines without the need for intensive isolation of the red-emissive nCDs. The duration of
pyrolysis, the molar ratio of acid to amine, and the concentration of reactants were optimized
to maximize fluorescence efficiency. The biocompatibility of the nCDs was assessed on three
different cell lines by measuring cell viability, generation of reactive oxygen species (ROS),
and the extent of apoptosis. Confocal microscopy images of the three cell lines showed that
the nCDs were excitable also at different wavelengths including the NIR region. Finally, to
demonstrate the potential of red-nCDs as bioimaging agents, the nCDs were injected
intravitreally into ex vivo porcine ocular globes and subcutaneously in euthanized mice, where
they are easily detected.
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4.2 Methods
4.2.1 Materials
All chemicals were used as received. Ethylenediamine (EDA) (99%, cat# E26266), and
Rhodamine 6G (99%, cat# 252433) were purchased from Sigma-Aldrich. Citric acid (CA)
was purchased from J.T. Baker Chemical Co. Dulbecco’s modified Eagles’s medium/nutrient
mixture F-12 Ham (DMEM/F12), trypsin-ethylenediaminetetraacetic acid (EDTA) solution
10x, and fetal calf serum (FCS), TritonTM X-100, phosphate buffer saline (PBS), 100x
antibiotic-antimycotic solution, and thiazolyl blue tetrazolium bromide (MTT) (98%, cat#
M2128) were obtained from Sigma-Aldrich (St. Louis, MO). SlowFade® Gold Antifade
Mountant with DAPI (cat# S36938) was purchased from Thermo Fisher Scientific (St. Peters,
MO). Retinal pigment epithelial (ARPE-19) (ATCC® CRL¬ 2302™), lens epithelial cells
(ATCC® CRL¬ 11421TM), and CHO (CCL¬ 61™) cells were purchased from American Type
Culture Collection (Manassas, VA). ApoTox-Glo™ (cat# G6320) and ROS GloTM H2O2 (cat#
G8820) assays were purchased from Promega Corporation (Madison, WI).

4.2.2 Synthesis of nCDs
We evaluated the effect of three factors in the synthesis of nCDs – the molar ratio of amine to
acid, the duration of pyrolysis (microwave exposure time), and the concentration of the
reactants on creating red-nCDs. For this, a Central-Composite Design Response Surface
Methodology (CCD-RSM) design was utilized (Stat-Ease, Design-Expert® software, version
9.0). Each factor was varied at five levels: amine/acid (molar ratio) = 0.30, 0.48, 0.75, 1.02,
and 1.20; microwave exposure time = 70 s, 75 s, 88 s, 95 s, and 100 s; and concentration of
citric acid (wt/v %) = 8.0, 8.8, 10.0, 11.2, and 12.0. There were twenty runs of carbon dots
synthesis, as tabulated in Table S1.
A stock solution of 12 wt/v % of citric acid was prepared by dissolving 28.39 g of citric acid
in 220 mL of water. The desired amount (see Table S1) of this stock solution was added to a
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glass beaker (capacity 100 mL), then DI water was added to make the volume up to 10 mL,
and then the desired amount of ethylenediamine (see Table S1) was added. The mixture was
shaken and heated in a microwave oven (General Electric, 1,100 watts) for a varying
durations as listed in Table S1. Products of these 20 different synthesis experiments yielded a
brittle solid, whose color varied from yellow to brown. This solid was dissolved in 3 mL of
water and transferred to a 20 mL vial. The beaker was rinsed with another 2 mL of water, and
the liquids were combined. The solution was dialyzed against water (Molecular weight cut-off
(MWCO) = 500 Da, Spectra Por 131084 Biotech-Grade CE dialysis tubing) for 24 hours.

4.2.3 Physico-chemical characterization of nCDs
The morphologies and the size of the synthesized nCDs were examined by high-resolution
transmission electron microscopy (HR-TEM, Tecnai TM Spirit, FEI Co.), operated at 200 kV
accelerating voltage. Atomic force microscopy (AFM) was carried out using Veeco
Dimension 3100 V (Parkafm, Santa Clara, CA). For AFM analysis, the sample was prepared
by electrospraying (6 kV) ~5 µL of nCDs solution (0.625 µg/mL) on Si wafer to get a clear
snapshot of individual nCDs. Dynamic light scattering (DLS) analysis was conducted with a
Malvern Zetasizer Nano ZS (Malvern Instruments, Westborough, MA) equipped with a
backscattering detector (173º) to measure hydrodynamic sizes and zeta potential of
synthesized nCDs. For DLS measurements, the samples were dispersed in water, sonicated for
15 min, filtered through a prerinsed 0.22 μm polyethersulfone filter. At least three
measurements per sample were taken.
UV-Vis absorption spectra were recorded on a Thermo Fisher Biomate 3 UV-Vis
spectrophotometer. Fluorescence spectra were measured on a SpectraMax Gemini EM
fluorescence reader at ambient conditions. The photoluminescence (PL) emission was
determined with a Varian Cary 5000 spectrophotometer. For the measurement of fluorescence
homogeneity of the sample and resolving fluorescent impurities, 3D emission-excitation maps
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of synthesized nCDs were recorded using a fluorescence excitation-emission spectroscopy
method. The measurements were conducted using Vis-NIR (300-1600 nm) spectrofluorometer
equipped with an imaging spectrograph iHR320 and a diode array deep-cooled CCD detector
Synapse (all from Horiba Jobin Yvon Inc.). Emission spectra acquired at different excitation
were corrected for the excitation light intensity. For optical measurements, the samples were
diluted until clear and sonicated for 5 minutes before the measurements. At least three
measurements per sample were taken.
The quantum yield (ΦS), the ratio of photons emitted to photons absorbed, of the nCDs in
water was determined by a comparative method with Rhodamine 6G as a reference at 540 nm
excitation in a 10-mm quartz cuvette. To minimize self-absorption, the absorbance was kept
under 0.1 au. Integrated PL intensity in the range of 590-720 nm vs. absorbance was plotted at
different concentrations. The ΦS of the nCD samples was calculated using the following
equation(Brouwer 2011):
𝐺𝑟𝑎𝑑𝑠 𝜂𝑆2
𝜙𝑆 = 𝜙𝑅 (
)( )
𝐺𝑟𝑎𝑑𝑅 𝜂𝑅2

(𝐸𝑞. 1)

where the subscripts S and R refer to the sample and reference, respectively. Grad is the
gradient from the plot of integrated PL intensity against absorbance, and η is the refractive
index of the solvent, which is deionized water for both the reference and nCDs solutions.
For molecular weight distribution study, matrix-assisted laser desorption/ionization-time of
flight (MALDI-TOF) mass spectrometric analysis of the nCDs was performed with a Bruker
UltraFlextreme MALDI-TOF instrument with SmartbeamTM Laser (337 nm) in the positiveion mode using 2,5 dihydroxybenzoic acid (DHB) as a matrix. The chemical composition of
nCDs was determined with X-ray photoelectron spectra (XPS) using a Kratos Axis Ultra
spectrometer (DLD, Japan) and a monochromatic Al Kα source (1486.6 eV).
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4.2.4 In-vitro Cytotoxicity measurements on Retinal Pigment Epithelial
(ARPE-19), lens epithelial, and Chinese Hamster Ovary (CHO) Cells with
MTT, Apotox-GloTM, and ROS-Glo™ H2O2 assays.
Cell metabolic activity, and hence the viability of cells in the presence of nCDs (0.01-0.6
mg/ml), was assessed with MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl tetrazolium
bromide). The relative amounts of apoptotic cells and reactive oxygen species (ROS)
generation were measured by ApoTox-Glo™ and ROS GloTM H2O2 assays, respectively. Each
test result (viability measurement, the relative amount of apoptotic cells, and ROS generation)
was compared with the corresponding negative (untreated cells) and positive (NPs without the
cells) control groups with Student’s t-test. P* < 0.05, the significance level, was statistically
acceptable. Please refer to the Supplementary Information for further details of the
cytotoxicity analysis.

4.2.5 In-vitro Imaging of Cells Treated with nCDs
To confirm the presence of nCDs inside cells, we investigated the distribution of nCDs at
0.01-0.6 mg/mL, using a nanoplasmonic confocal laser-scanning microscope (Leica TCSSP8). Four laser wavelengths (405, 488, 532, and 635 nm) were used during confocal
imaging.
Retinal epithelial, lens epithelial, and CHO cells were separately seeded in CELLviewTM
plates at 5 × 104 cells/well for 24 h. After 24 h of nCD exposure, nCDs that were adsorbed on
the cell surface or failed to enter the cells were removed by careful washing with 1x PBS
three times. The cells were then fixed by immersion in 4% paraformaldehyde (PFA) as the
cross-linking solution for 10 min at room temperature and washed with 1x PBS three times
before imaging. For the cell fixation details and preparation for confocal imaging, see the
Supplementary Information. A negative control sample (untreated cells) was prepared with
cells in the absence of nCDs.
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4.3 Results and Discussion
4.3.1 Effects of synthesis conditions on short and long-wavelength emission
abilities
Microwave-assisted pyrolysis of organic compounds is a rapid, facile, and cost-effective
method for synthesizing CDs (Zhai et al. 2012, Hu et al. 2013, Xu et al. 2014). Generally, a
carbon source (a compound containing carbon atoms) and a nitrogen source (a compound
containing nitrogen atoms) are dissolved in an aqueous solution, and the mixed solution is
heated in a microwave oven. Various types of carbon sources and nitrogen sources have been
used in this method, as reported in the literature (Wang and Hu 2014). Among them, using
citric acid as the carbon source and a diamine or multi-amine as the nitrogen source has been
demonstrated as a successful combination (Zhai et al. 2012). The amine molecules serve as a
surface passivating agent and an N-doping precursor. nCDs that were synthesized with this
method exhibited excitation-dependent PL (Goh et al. 2012, Zhai et al. 2012). The excitationdependent emission is due to the heterogeneity of the chemical composition of CDs, in other
words, the formation of different functional groups on the surface (Gan et al. 2016, Sharma et
al. 2016). Zhai et al. investigated several amine molecules and determined that using 1,2ethylenediamine led to the highest PL intensity (Zhai et al. 2012). They also varied the
amine/acid ratio from 0 to 1.33 and determined that an NH2/COOH (amine/acid) ratio of 0.67
resulted in the strongest emission. Since then, other groups have also used a similar
amine/acid ratio (0.67-0.75) in their research (Zhu et al. 2013, Shi et al. 2014, Jia et al. 2016).
However, Zhai’s approach was limited to nCDs with a relatively short wavelength optical
property with excitation/emission combination (λex∕em = 350/460). For in vivo imaging,
however, such a short wavelength cannot penetrate through the skin and tissues, and it might
be harmful to cells at longer exposure times.(Hola et al. 2014) Therefore, we developed nCDs
for long wavelength optical activity with deep red fluorescence (λex∕em = 540 nm/600 nm)
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PL. To optimize the composition of nCDs, we varied three critical factors: amine/acid ratio,
citric acid (CA) concentration, and reaction time.
Design of Experiment (DOE) (Liang et al. 2015, Santhanam et al. 2015) (Design Expert®
software, version 9.0, Stat-Ease, Minneapolis, MN) was used to outline the optimization space
and develop a relationship between the responses of interest and associated factors : the molar
ratio of amine to acid, the microwave exposure time, and the concentration of the reactants. In
central-composite design we used three factors were varied at five levels, resulting in 20 runs
(Table S1). We characterized the PL of the 20 products at both a short wavelength (λex∕em =
350 nm/460 nm) and a long wavelength (λex∕em = 540 nm/600 nm), (Table S1). The details
of optimization design and statistical analysis are provided in Supplementary Information.
According to the statistical analysis, the PL at λex∕em = 350 nm/460 nm could be adjusted by
changing the amine/acid ratio and by changing the reaction time; however, changing the
concentration of CA within our experimental range did not have a significant effect. Our
optimized amine/acid ratio (0.75) is close to the finding from Zhai’s work (0.67), this small
difference in ratio (0.75-0.67) may be due to their longer microwave exposure time (88
seconds versus 120 seconds) and lower microwave power (1,100 versus 700 W). Using our
model, one can precisely predict and control the PL of CDs. Our model also allows changing
the value of one factor within a certain range while maintaining the same PL intensity, by
changing the other factor on the basis of this equation (Eq. S1). Therefore, the reaction
conditions can be tailored to meet specific requirements or limitations.
Furthermore, we determined whether the long wavelength PL follows a similar acid/amine
trend to that at a short wavelength as the experimental conditions change (Fig. 4.1A). Our
investigation shows it does not, which is a very interesting and valuable result (Fig. 1A vs
Fig. 1B). Unlike the PL at short wavelengths, the analysis of the PL at long wavelengths
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(λex∕em = 540 nm/600 nm) suggested that the linear model was the most appropriate among
all polynomial regression models (Fig. 4.1B). The maximum PL for longer wavelength was
observed at amine/acid ratio of 1.20. By using the statistical analysis, we determined that the
PL at λex∕em = 540 nm/600 nm was mostly affected by the amine/acid ratio. Generally, the
emission at 600 nm can be increased by increasing the amine/acid ratio (Eq. S2). The reaction
time has a positive effect on the emission at high amine/acid ratio, while it has a negative
effect when the amine/acid ratio is low. However, the overall effect of reaction time is much
weaker than that of amine/acid ratio. We also determined that the concentration of CA did not
have a significant effect.
A)

B)

Figure 4.1 Schematic CCD-RSM design responses. (A) λex = 350 nm, λem = 460 nm. (B) λex = 540 nm, λem =
600 nm.
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The surface charge of nanoparticles has been shown to be associated with their PL
performance (Zhai et al. 2012, Hu et al. 2013, Zhu et al. 2013). Hu et al. utilized a capillary
electrophoretic method to characterize the surface charge of CDs synthesized from EDA and
CA (Hu et al. 2013). They determined that the amine/acid ratio significantly affected the
surface charge of nCDs. When the amine/acid ratio is within 0.25-0.8, positively, neutral, and
negatively charged nCDs were generated. According to their results, at higher amine/acid
ratio predominantly neutral and positively charged nCDs were formed. They concluded that
species with a higher fraction of positively and neutrally charged nCDs exhibited stronger
fluorescence than negatively charged nCDs when measured at a wavelength of λex∕em = 488
nm/550 nm.
Similar to Hu’s results, our findings also indicated that neutral and positively charged nCDs
are more likely to be excited at a longer wavelength. The synthesis of nCDs with an
amine/acid ratio of 1.20 yielded predominantly neutral and positive emitters, accounting for
the strong wavelength emission of our product. The major contribution of our work is that we
optimized the synthetic parameters for nCDs that we were able to obtain nCDs with deep-red
to NIR emission without their isolation, i.e., by capillary electrophoresis as used by Hu and
colleagues.

4.3.2 Maximization of nCD red fluorescence intensity
Since the PL at λex∕em = 540 nm/600 nm showed a linear increase when the amine/acid ratio
was increased in the range of 0.48 to 1.20, we sought to further increase the PL at long
wavelength by extending the range from 0.25 to 3.0. We synthesized another six batches of
nCDs with amine/acid ratios of 0.25, 0.5, 1.0, 1.5, 2.0, and 3.0 while keeping the reaction time
at 88 seconds and CA% at 10%. However, the batch with amine/acid = 3.0 formed an oily
product, which was not completely soluble in water. Thus, amine/acid = 3.0 was eliminated
from further study. We determined that the PL at λex∕em = 540 nm/600 nm showed a
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significant increase with increasing amine/acid ratios in the range of 0.5 to 2.0 (Fig. 4.2). In
addition, although the PL intensity showed a linear increase in the range of 0.5-1.0, as
demonstrated in the DOE (Fig. 4.1), it approached to a maximum at an amine/acid ratio of
1.20 (Fig. 4.1B). As we found that our synthesis of nCDs with amine/acid ratio of 2.0 yielded
longer-wavelength excitable nCDs, which can be explained by the presence of predominantly
neutral and positive nCDs,(Hu et al. 2013) accounting for the strong wavelength emission of
our product.

A)

B)

Figure 4.2 (A) Absorbance and (B) PL emission intensities of nCDs at different concentrations with varied
amine to acid ratios.

Fluorescence excitation-emission spectroscopy using excitation-emission matrix analysis
showed that the nCDs demonstrate characteristic excitation-dependent fluorescence behavior
(Fig. 4.3). Such method, in which a series of emission spectra are collected over a range of
excitation energies is commonly used to resolve multicomponent fluorescent mixtures
(Bachilo et al. 2002, Nevin et al. 2009). The 3D fluorescence spectra revealed the
heterogeneity of the emitters at a low amine to acid ratio as indicated by the non-symmetrical
and broad shape of the emission. This shape signifies the presence of multiple types of
emissive species (i.e., neutral and positively charged) (Fig. 4.3, B-D). The heterogeneity
disappears entirely at the high amine to acid ratio = 2.0 (Fig. 4.3E) indicating the formation of
a single emitter (i.e., predominantly positively charged). It is worth noting that as the
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amine/acid increased, the emission shifts towards NIR region reaching almost 750 nm (Fig.
4.3E). The insets of the figures present nCDs in an aqueous suspension. Changing the
NH2/COOH ratio exhibited different colors of nCDs in an aqueous suspension. The surface
characteristics of nCDs have changed leading to a shift in emission as demonstrated by the 3D
fluorescence spectra, and the observed colors of the final products are also consistent with this
behavior.
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A)

B)

C)

D)

E)

Figure 4.3 Fluorescence excitation-emission spectroscopy of nCDs with amine/acid ratios of (A) 0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00. The peak for excitation and
emission shifts towards near infrared region as the amine to acid ratio increases. All spectra were corrected for the lamp intensity. The insets of each figures represents
synthesized nCDs in DI water, from left to right, the NH 2/COOH ratio is increasing from 0.25 to 2.00.

84

4.3.3 Characterization of long wavelength nCDs
The HR-TEM images display size distribution 4.05±0.46 nm, and the images reveal that the
nCDs have a lattice spacing of 0.15 nm (Fig. 4.4A). This indicates that the nCDs are not
amorphous but exhibit long-range ordering. The AFM analysis showed that the particle size
of nCDs with amine/acid ratio of 2.0 was less than 5 nm (Fig. 4.4B). Both single carbon dots
(marked with white circles) and aggregates of carbon dots were observed in AFM analysis.
Fig. 4.4C presents the size distribution of carbon dots, which was determined by measuring
the height of 50 single carbon dots observed under AFM. The size distribution suggests the
average particle size of 2.99 ± 0.77 nm, with peak size between 2-2.5 nm. On the other hand,
according to the DLS analysis, hydrodynamic sizes of the nCDs were found to be ranging
from 0.87 ± 0.26 nm to 5.23 ± 1.25 nm in DI water with increasing amine to the acid ratio
(Fig. 4.5 and Fig. S1). Furthermore, zeta potential analysis revealed that with increasing
amine/acid ratio, the zeta potential of nCDs increased from -4.16 ± 7.76 mV to 45.15 ± 8.05
mV (Fig. 4.5 and Fig. S2). The increase in zeta potential with increasing amine/acid ratio
supports the hypothesis that nCDs with high amine/acid ratio yielded neutral and positive
nCDs with strong red emission.

A)

85

B)

C)

Figure 4.4 (A) HR-TEM image of nCDs with amine/acid ratio of 2.0. The particle size distribution is determined
to be 4.05±0.46 nm. The lattice spacing is found to be 0.15 nm. (B) AFM images of nCDs with amine/acid ratio
of 2.0. The diameter of nCDs is less than 5 nm. (C) Size distribution of nCDs which was determined by
measuring the height of 50 single carbon dots observed under AFM

B)

A)

Figure 4.5 Dynamic light scattering analysis of nCDs with NH2/COOH of 0.25, 0.75, 1.00, 1.50, and 2.00: (A)
Hydrodynamic particle size measurement results. (B) Zeta potential measurement results.

Next, we identified the mass of nCDs using MALDI-TOF mass spectroscopy. As shown in
Fig. S3, the molecular ions with the highest intensities are m/z =799.6, 1215.0, and 1512.0 for
the nCDs with amine/acid ratios of 0.5, 1.0, and 2.0 respectively. The nCD molecular weights
determined with MALDI-TOF, increased with increasing amine/acid ratios of 0.5, 1.0, and
2.0, were in accordance with the DLS findings.
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The XPS analysis was performed to identify the bonds present on the surface of nCDs. The
broad spectrum confirmed the presence of carbon, oxygen, and nitrogen (Fig. S4). Further,
high-resolution XPS was performed to identify the type carbon and nitrogen bonds. The highresolution C1s figures of nCDs with different amine/acid ratio reveal that as the amine to acid
ratio increased, different types of bonds were formed on CD surfaces (Fig. 4.6). As shown in
Fig. 4.6, the C1s core level peak of the nCDs shows two main peaks at 284.0±0.3 eV (C=C)
and 284.5±0.4 eV (C–C), aromatic and aliphatic carbons, respectively. The next peaks at
higher binding energy indicate the existence of oxygen groups, including C–O (hydroxyl
carbon) at 285.5±0.4 eV, C–O–C (epoxy carbon) at 286.5±0.5 eV, and C=O (carbonyl
carbon) at 287.5±0.5 eV (Fig. 6). As the amine/acid was increased, C–O–C bonds (286.5 ±0.5
eV) disappeared, and starting from amine/acid ratio of 1.00, C–O/C–N bonds (285.5±0.4 eV)
were detected. The XPS results clearly indicate that there is a significant change in bonds
formed on nCD surfaces as the amine to acid ratio changes. The high-resolution N1s results
show that the pyrrolic nitrogen content in nCDs was increased significantly as the amine/acid
ratio increased from 0.25 to 2.0 (Fig. S5). It has been shown that specifically cyclic
polypyrroles such as pyrrolopyrole cyanines are fluorescent and emit light beyond 500
nm.(Berezin et al. 2009) It is not possible to provide the exact mechanism of pyrolysis and an
accurate molecular structure of the products since pyrolysis is essentially a burning process.
However, based on the structure of citric acid, one of the most probable products (or moieties)
contributing to deep-red-emissivity of nCDs could be N,N'-substituted-pyrrolo[2,3-b]pyrrole
(Fig. 4.6F). It can be concluded that formation of C‒N (Fig. 4.6) and increasing pyrrolic N
(Fig. S5) amounts are responsible for red-shifted fluorescence (Fig. 4.3).
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Figure 4.6 High-resolution C1s XPS analysis results of nCDs with amine/acid ratios of (A) 0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00. Increasing NH2/COOH ratio resulted
in an apparent C‒N bond formation. (F) Proposed formation mechanism for a possible product (N,N'-substituted-pyrrolo[2,3-b]pyrrole) contributing to red-emissivity of nCDs
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Table S2. summarizes the effect of molar ratio of reactants to pyrrolic N content and MW of
nCDs. Fig. S7A shows the linear relationship between the molar ratio of reactants to pyrrole
content (R2=0.99) thereby underscoring that the chemical moieties responsible for red
emission is associated with the pyrrole content. MW measurements, based on MALDI-TOF
analysis, shows a second order correlation (R2=1) (Fig. S7B) which suggests that increasing
the molar ratio of reactants further is not going to increase the MW of nCDs.
The quantum yield of nCDs in the red emission range of 590-720 nm was determined using a
comparative quantum yield measurement technique. The red-nCDs quantum yields were
found to be in the range of 7%-15% in deionized water (Table S3).

4.3.4 Cytotoxicity evaluation of nCDs
For ocular clinical applications, when the nanoparticles are introduced intravenously, they will
have to cross the blood-retinal barrier to reach the ocular tissues (Lavik et al. 2011).
Dysfunction in retinal epithelial cells leads to vascular leakage that could potentially lead to
vision-threatening conditions. Lens epithelial cells are associated with cataract formation, the
most common visual impairment. We, therefore, investigated the toxicity of nCD to retinal
(ARPE-19) and lens epithelial cells. Given the potential application of nCDs in cancer
theranostics, we also evaluated the nCDs toxicity to Chinese hamster ovarian (CHO) cells.
For the assessment of toxicity, three different independent end-point assays were used:
viability based on enzymatic activity in mitochondria; the percent of apoptotic cells based on
caspase 3/7 activity, and ROS generation, which is proportional to luciferase activity (see
Methods). The results indicated that for retinal and lens epithelial cells, the lethal dose
required to kill 50% of the cells (LD50) of nCDs was approximately 0.6 mg/mL (Fig. S8-9A).
Up to this critical concentration, more than 50% of the retinal and lens epithelial cells did not
initiate apoptotic cell death (Fig. S8-9B) but induced ROS generation (Fig. S8-9C). On the
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other hand, interestingly, CHO cells generated more than twice ROS than ocular epithelial
cells; however, their viability was not compromised up to 0.6 mg/ml exposure concentration
of nCDs (Fig. S10). Cancer cells, in general, are shown to have increased ROS levels in
comparison to normal cells to initiate cell death (Tafani et al. 2016). The increased ROS levels
are partly due to an enhanced metabolism and mitochondrial dysfunction in cancer cells
(Galadari et al. 2017).

4.3.5 In-vitro imaging of nCDs
To confirm the uptake of nCDs by the cells, we investigated the distribution of nCDs after
incubation using a nano-plasmonic confocal laser scanning microscope (LEICA TCS-SP8)
(see Methods). The above-mentioned cell lines were used for in vitro imaging analysis as
well. According to the images presented in Fig. 4.7, nCDs have demonstrated successful use
of fluorescence imaging in vitro, due to their excitability at multiple wavelengths in the
visible spectrum. Furthermore, we showed that nCDs could also fluoresce when excited at
635 nm thus minimizing the effect of autofluorescence and increasing the signal to
background ratio.
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λex = 405 nm
λem = 430-490 nm

λex = 488 nm
λem = 500-560 nm

λex = 532 nm
λem = 540-600 nm

λex = 635 nm
λem = 640-700 nm

A)

B)

C)

Figure 4.7 Confocal microscopy images of nCDs excited at four different wavelengths: 405, 488, 532, 635 nm,
exposed to (a) retinal pigment epithelial, (b) lens epithelial, (c) CHO cells.

91

4.4 Conclusions
We developed and optimized a scalable isolation-free microwave pyrolysis method for
synthesizing deep red-NIR emissive nitrogen-doped carbon dots from citric acid and
ethylenediamine. MALDI-TOF and DLS results respectively showed that as the amine to acid
ratio increased, both the MW and size of the nCDs increased. Based on the XPS analysis, the
formation of C‒N and the presence of pyrrolic N content appear to be keys to creating redemissive nCDs. Both of these critical elements maximized at an amine/acid ratio of 2.0.
Confocal images demonstrated that the nanoparticles could enter the cells, including cancer
cells. Excellent biocompatibility results support the potential application of nCDs in
nanomedicine.
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Chapter 5: Hyaluronate Conjugated
Nitrogen-doped Carbon Quantum Dots for
Use in Bioimaging

The results of this chapter have been compiled in Karakocak, B. B.; Liang, J..; Biswas, P.;
Ravi, N. (2018). Hyaluronate Conjugated Nitrogen-doped Carbon Quantum Dots for Use in
Bioimaging. In Preparation.
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Abstract
In this work, we demonstrate the application of hyaluronate conjugated nitrogen-doped
carbon quantum dots (nCQDs) for bioimaging and their potential use for targeted drug
delivery. nCQDs were synthesized by microwave-assisted pyrolysis of citric acid and
aliphatic diamines. The time of pyrolysis, the molar ratio of acid to amine, and the
concentration of reactants was optimized to yield high fluorescence in the red wavelength
range (optimum excitation at 550 nm, emission up to 700 nm). The HA-nCQD conjugate was
synthesized by a carbodiimide coupling of the amines on CQDs and the carboxylic acids on
HAs. The nCQDs and their conjugates fluoresced variously depending upon the excitation
wavelength. Three different cell lines were exposed to nCQDs and HA-nCQDs. Confocal
microscopy images showed enhanced internalization of HA-nCQDs, which was facilitated by
CD44 receptors. Further, ex-vivo (porcine eye globes) and post-mortem (mice) images were
obtained. Observations demonstrate the use of HA as a carrier for targeted drug delivery into
CD44 rich cells, and red emissive nCQDs can be used for both ex-vivo and in-vivo imaging.
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5.1 Introduction
Bioimaging, non-invasive visualization of a cell/tissue/organ is a crucial tool for diagnosis,
treatment of various diseases, including cancer. In the last two decades, various nanomaterials
were studied (Cherukula et al. 2016), and carbon dots have been shown to be promising for
bioimaging applications (Hola et al. 2014, Choi et al. 2016, Zhang et al. 2016). Carbon
quantum dots (CQDs) are one of the most promising bioimaging agents due to their unique
intrinsic properties such as wavelength dependent excitation/emission (Jiang et al. 2015, Ding
et al. 2016), long fluorescence lifetime (Dong et al. 2015), good stability (Zhang et al. 2015),
and high biocompatibility (Tao et al. 2012).
Various CQDs synthesis methods ranging from relatively simple to complex have been
reported (Hola et al. 2014). For practical applications and mass production, it would be ideal
to scale up the synthesis method (Wang and Hu 2014). Therefore, it is desirable to use a
simple synthesis method involving commercially available and environmentally friendly
reactants (Xu et al. 2014). Among the existing methods, the microwave method has distinct
advantages for its shorter reaction times, milder reaction conditions, lower energy
consumption, better stability, reproducibility, and higher product efficiency (Zhu et al. 2009,
Hu et al. 2013). We have successfully used a domestic microwave oven to synthesize nitrogen
doped CQDs (nCQDs) (Zhai et al. 2012, Hu et al. 2013, Xu et al. 2014). The reaction took
less than two minutes using citric acid and aliphatic diamines in water as raw materials. This
synthetic strategy is facile, fast, convenient, economical, and environmentally friendly.
For CQDs to be used as bioimaging agents, fluorescence emission above 600 nm is desired
(Hola et al. 2014, Ostadhossein and Pan 2017). In this study, we optimized a simple yet facile
method of synthesizing CQDs to achieve highly efficient red emissive nCQDs. We
synthesized nCQDs by microwave-assisted pyrolysis of citric acid and aliphatic diamines.
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Time of pyrolysis, the molar ratio of acid to amine, and the concentration of reactants were
optimized to yield high fluorescence, specifically above 600 nm. Moreover, we coated
nCQDs with hyaluronic acid (HA) to demonstrate receptor-targeted delivery applications. In
particular, the cells which express CD44 receptors, that are specific for hyaluronan, showed
increased uptake efficiency of HA-coated nCQDs. Finally, the nCQDs were exposed to
porcine eye globes and fresh post-mortem mice, respectively. The results showed that the
highly efficient red emissive nCQDs could be potentially employed as bioimaging agents and
can be functionalized to target cells which express CD44 receptors.

5.2 Methods
5.2.1 Materials
All chemicals were used as received. Sodium hyaluronate (HA) (MW = 200 kDa, cat# HA200K-1) was purchased from Lifecore Biomedical. N-hydroxysuccinimide (98%, cat#
130672), N-(3-dimethylaminopropyl)-N’-ethyl-carbodiimide hydrochloride (98%, cat#
E1769), and ethylenediamine (99%, cat# E26266) were purchased from Sigma-Aldrich. Citric
acid was purchased from J.T. Baker Chemical Co. Dulbecco’s modified Eagles’s
medium/nutrient mixture F-12 Ham (DMEM/F12), trypsin-ethylenediaminetetraacetic acid
(EDTA) solution 10x, and fetal calf serum (FCS), TritonTM X-100, phosphate buffer saline
(PBS) were obtained from Sigma-Aldrich (St. Louis, MO). SlowFade® Gold Antifade
Mountant with DAPI (cat# S36938) was purchased from Thermo Fisher Scientific (St. Peters,
MO). ARPE-19 (Retinal pigment epithelial) (ATCC® CRL¬ 2302™), Lens epithelial cells
(ATCC® CRL¬ 11421TM), and CHO (CCL¬ 61™) cells were purchased from American Type
Culture Collection (Manassas, VA). ApoTox-Glo™ (cat# G6320) and ROS GloTM H2O2 (cat#
G8820) assays were purchased from Promega Corporation (Madison, WI). All the chemicals
were used as received.
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5.2.2 Central-composite response surface design for synthesizing nCQDs
with desired properties
To investigate the effect of three factors – the molar ratio of amine to acid, the microwave
time, and the concentration of the reactants – a Central-Composite Design Response Surface
Methodology (CCD-RSM) design was utilized (Stat-Ease, Design-Expert® software, version
9.0). Each factor was varied at five levels: amine/COOH = 0.30, 0.48, 0.75, 1.02, and 1.20;
microwave time = 75s, 70s, 88s, 95s, and 100s; and concentration of citric acid=8.0%, 8.8%,
10.0%, 11.2%, and 12.0%. There were twenty runs, as tabulated below (Table 5.1):
Table 5.1 Experimental conditions (factors) of each synthesis of nCQDs using CCD-RSM design

Runs

CA wt%

NH2/COOH

Reaction Time

1

10.0

0.75

88

2

11.2

0.48

80

3

10.0

0.75

100

4

10.0

0.75

88

5

8.8

1.02

95

6

12.0

0.75

88

7

8.8

0.48

80

8

10.0

0.75

75

9

10.0

0.75

88

10

11.2

1.02

95

11

10.0

0.75

88

12

8.0

0.75

88

13

8.8

0.48

95

14

8.8

1.02

80

15

10.0

0.75

88

16

10.0

1.20

88

17

10.0

0.30

88

18

10.0

0.75

88

19

11.2

0.48

95

20

11.2

1.02

80

100

A stock 12 wt/v % solution of citric acid was made by dissolving 28.39 g of citric acid in 220
mL of water. The desired amount (according to Table 5.1) of this stock solution was added to
a 100-mL beaker, then DI water was added to make the volume up to 10 mL, and
ethylenediamine was added. The mixture was shaken and heated in a microwave oven
(General Electric, 1,100 watts) for one of the times listed in Table 5.1. The result was a solid
was obtained, whose color varied from yellow to brown. This solid was dissolved in 3 mL of
water and transferred to a 20 mL vial. The beaker was rinsed with another 2 mL of water, and
the liquids were combined. The solution was dialyzed against water (Molecular weight cut-off
(MWCO) = 500 Da).

5.2.3 Conjugation of nCQDs with hyaluronic acid
An aqueous solution of HA 1 w/v% was prepared by dissolving HA (0.10 g, 0.24 meq of
COOH) in 10 mL of water. The pH of the HA solution was adjusted to 4.5. 1-Ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC: 0.45 g, 2.4 mmol), and N-hydroxysuccinimide
(NHS: 0.14 g, 1.2 mmol) was added to the HA solution at 22 °C with stirring for 1 hour. CQD
solution (0.10 g, 5 mL) was added to the HA solution, and the reaction mixture was
continuously stirred for 18 hours. Thereafter, the reaction was terminated by adjusting the
final pH to 8-9. The excess EDC, NHS, and any free CQDs were removed from the reaction
mixture by dialysis (MWCO: 12,000-14,000) in H2O (three times). Then the solution was
lyophilized, yielding a powder.

5.2.4 Characterization of nCQDs and HA-CQDs
UltraViolet-Visible (UV-Vis) absorption spectra were recorded on a Thermo Fisher Biomate
3 UV-Vis spectrophotometer. Fluorescent spectra were measured on a SpectraMax Gemini
EM fluorescence reader at ambient conditions. Nuclear magnetic resonance spectrum (1H
NMR) spectra were obtained on a Varian Unity Inova 500 MHz (Palo Alto, CA) in D2O at 25
°C. The PL emission was determined with a Varian Cary 5000 spectrophotometer.
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5.2.5 Hydrodynamic size and zeta potential measurements with dynamic
light scattering analysis
A Malvern Zetasizer Nano ZS (Malvern Instruments, Westborough MA) equipped with a
backscattering detector (173º) was used for hydrodynamic size measurements of synthesized
carbon dots. Samples were dispersed in water, then sonicated for 15 min to homogeneously
disperse them in the solution, after which they were filtered through a prerinsed 0.22 μm
sterile filter, then equilibrated (typically for 5 min) at 25 °C. At least three measurements per
sample were taken. The hydrodynamic diameter and zeta potential of nCQDs in solution
before their exposure to cell culture medium was measured in batch mode using DLS.

5.2.6 In-vitro cytotoxicity measurements on Retinal Pigment Epithelial
(ARPE-19), NIH 3T3, and Chinese Hamster Ovary (CHO) cells with MTT,
ApoTox-GloTM, and ROS-Glo™ H2O2 assays
Cell metabolic activity, and hence the viability of cells in the presence of CQDs (0.01-0.6
mg/ml), was assessed with 3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl tetrazolium bromide
(MTT) assay. The relative amount of apoptotic cells and reactive oxygen species (ROS)
generation were measured, respectively, by ApoTox-Glo™ and ROS GloTM H2O2 assays. In
all biological and imaging tests, the cells without NP exposure served as a negative control.
Each test result (viability measurements, the relative amount of apoptotic cells, and ROS
generation) was compared with the corresponding negative (untreated cells) and positive (NPs
without the cells) control groups with Student’s t-test. P* < 0.05, the significance level, was
statistically acceptable.

5.2.7 In-vitro imaging of nCQDs and HA-nCQDs.
To confirm the presence of CQDs inside cells, we investigated the distribution of CQDs at
0.01-0.6 mg/mL, using a nanoplasmonic confocal laser scanning microscope (Leica TCSSP8). Three laser wavelengths (405, 532, and 635 nm) were used during confocal imaging.
The CQD detection range was 435-700 nm.
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ARPE-19, NIH 3T3, and CHO cells were separately seeded in CELLviewTM plates at 5 × 104
cells/well for 24 h. After 24 h of CQD exposure, the cells were fixed and washed with PBS
three times before imaging. All cells were fixed by immersion in 4% paraformaldehyde (PFA)
as the cross-linking solution for 10 min at room temperature. The cells were washed three
times with ice-cold 1x phosphate buffered saline (PBS) for 3 min each time. The fixed cells
were incubated in ice-cold 1x PBS buffer containing 0.1% Triton (permeabilization agent) for
10 min at room temperature, then washed three times with ice-cold 1x PBS for 5 min each
time. The CELLviewTM plates were then incubated with blocking buffer for 30 min at room
temperature. The cells were subsequently washed three times with ice-cold 1x PBS for 3 min
each. To stain the nuclei, SlowFade® Gold Antifade Mountant with DAPI (diluted 1:100 in 1x
PBS) was used. The cells were kept at 4 oC overnight. The cells were again washed three
times with ice-cold 1x PBS for 5 min each before being transferred to the confocal
microscope for visual analyses. The laser wavelengths were 405, 532, and 635 nm for DAPI
(nucleus staining) and for CQDs, respectively. During confocal imaging, several different
images were taken through different optical sections by collecting Z-stacks with a thickness of
35 nm. Based on the thickness of the cell, the number of images with the same Z-stack
thickness varied. A negative control sample (untreated cells) was prepared with cells in the
absence of CQDs.

5.2.8 Ex-vivo and post-mortem imaging of nCQDs and HA-nCQDs.
Fresh porcine ocular globes were obtained from Trenton Processing Center, Trenton, IL. The
excessive mass and fat tissue around the eyeballs were cleaned, and the eyeballs were placed
in 1% antibiotic-antimycotic in1x PBS. Intravitreal injections of nCQDs were performed at a
dose of 10 mg/ml with an injection volume of 50 µl. Ex-vivo fluorescence imaging was
performed on the same day on Bruker Multispectral FX 470/600 for 10 sec exposure, bin 2x2,
the field of view (FOV) 50 cm.
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Post-mortem mice were shaved prior to nCQD injection and imaging. The nCQDs and HAnCQDs were injected into dead mice subcutaneously on the left shoulder and upper back,
respectively, at a dose of 0.40 mg∕kg. Animals (n = 3) were imaged at 2 minutes post-injection
using the Pearl Small Animal NIR fluorescence imaging system (LICOR Biosciences,
Nebraska), λex∕em 785∕820 nm

5.3 Results and Discussion
5.3.1 Conjugation of hyaluronic acid with carbon quantum dots
In the second part of the study, we conjugated CQDs with HA to enable the CQDs to target
cells with CD44 receptors. In addition, the HA conjugation was also expected to increase the
biocompatibility of the CQDs.(Pomper and Fisher 2014) An EDC-coupling method was used
to form amide bonds between the carboxyl groups of HA and the amine groups of CQDs
(Figure 5.1). Since CQDs contain both amine and carboxyl groups, amide bonds may also be
formed between two CQDs. To minimize crosslinking between CQDs, the carboxyl-activators
EDC and NHS were reacted with HA for one hour before adding CQDs.

NH2

Figure 5.1. HA-CQD conjugation chemistry
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We used 1H NMR spectra of CQDs, HA, and HA-CQD conjugates (Figure 5.2) to
demonstrate the conjugation. The peaks at 1.88 ppm and 4.3-4.4 ppm (labeled with asterisks
in Figure 5.2A) identify the presence of HA, and the peaks at 4.05 ppm and 5.7-5.9 ppm
(marked with triangles in the Figure 5.2B) identify CQDs. In the 1H NMR spectrum of the
HA-CQD conjugate (Figure 5.2C), we were able to detect all the peaks corresponding to HA
and CQD. Thus, the 1H NMR spectra showed successful conjugation of HA and CQDs.
(A)

(B)

(C)

Figure 5.2. A comparison of the 1H NMR spectra of (A) HA, (B) CQDs, and (C) HA-CQD conjugate confirms
the presence of HA and CQD peaks in the HA-CQD conjugate.
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We also compared the fluorescence spectra of CQD and HA-CQD conjugates at an excitation
wavelength of 540 nm (Figure 5.3). The emission peaks of the HA-CQD conjugates remained
at the same wavelength as the CQDs before conjugation, which suggested that the chemical
conjugation did not alter the fluorescence property of the CQDs. In addition, the PL intensity
of the HA-conjugates was about half of that the native CQDs at the same concentration,
which is consistent with 1:1 conjugation ratio of HA and CQD.
(A)

(B)

Figure 5.3 PL emission spectra of CQDs with an amine to acid ratio of (A) 0.5 and (B) 2.0 and their HA-CQD
conjugates when excited at 540 nm.
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5.3.2 In-vitro imaging of nCQDs and HA-nCQDs
To confirm the presence of nCQDs inside cells, we investigated the distribution of nCQDs
using a nano-plasmonic confocal laser scanning microscope (LEICA TCS-SP8) (see
Methods). Three different cell lines were used for in-vitro imaging analysis as well: Retinal
epithelial cells, NIH 3T3 cells, and CHO cells. According to the results, nCQDs have
demonstrated successful use of fluorescence imaging in vitro, due to their excitability at
multiple wavelengths in the visible spectrum (Figure 5.4B). Furthermore, we showed that
nCQDs also fluoresce when excited at 635 nm, unlike previous reports where the exact same
synthesis method was used but the nCQDs were excitable up to an excitation wavelength of
488 nm (Zhai et al. 2012, Hu et al. 2013). On the other hand, the HA-CQDs were also
excitable up to 635 nm, and no signal loss was observed (Figure 5.4C). The HA conjugation
significantly increased the intracellular concentration of nCQDs (Figure 5.4C). Therefore, it
can be inferred that HA does not only enable CD44 receptor-targeted delivery but also
increased the amount of nCQDs which entered the cells.
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Excitation: 405 nm
Emission: 420-480 nm

Excitation: 532 nm
Emission: 540-600 nm

Excitation: 635 nm
Emission: 640-700 nm

Control

(A)

CQDs
Nascent

(B)
(B)

CQDs

(C)

HA conjugated
CQDs

Figure 5.4 Confocal microscopy images of retinal pigment epithelial cells exposed to 0.6 mg/ml CQDs with and
without HA conjugation.
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5.3.3 Cytotoxicity evaluation of nCQDs and HA-nCQDs
We next studied the biocompatibility of nascent and HA-coated CQDs with retinal pigment
epithelial (ARPE-19) cells. Three different independent end-point assays were used: viability
based on enzymatic activity in mitochondria; the percent of apoptotic cells based on caspase
3/7, and activity ROS generation, which is proportional to luciferase activity (see Methods).
The results indicated that nCQDs were biocompatible up to 0.5 mg/ml (Fig. 5.5A), more than
50% of the cells did not initiate apoptotic cell death (Fig. 5.5B), and induced ROS generation
(Fig. 5.5C). However, at 0.6 mg/ml exposure dose, the critical LD50, the lethal dose required to
kill 50% of the cells, the level was achieved, and same cells started to show an increased
amount of ROS generation which may trigger apoptosis (Al Sulti et al. 2015, Karakocak et al.
2018). Also, the viability results confirmed the increase in cell death. On the other hand, once
the particles were conjugated with HA, their biocompatibility with retinal cells significantly
increased. HA is known to be a natural antioxidant. When the carbon dots induce ROS
generation, the HA acts as a ROS scavenger and reduces the intracellular ROS concentration
(Balogh et al. 2003, Rinaudo et al. 2014, Karakocak et al. 2018). This phenomenon is also
proven by our ROS measurement results, where HA-CQDs induced significantly less amount
of ROS (Figure 5.5C).

(A)
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(B)

(C)

Figure 5.5 Biocompatibility results of nCQDs and HA-nCQDs with ARPE-19 cells. (A) % Viability (B) ROS
generation (C) Apoptotic cell percentage measurement results after incubation with nCQDs for 24 h at
concentrations up to 0.6 mg/mL. Data are expressed as mean ± SD from three independent experiments (*P <
0.05).

5.3.4 Ex-vivo and post-mortem imaging of nCQDs and HA-nCQDs
Ex-vivo fluorescence imaging was performed on the days indicated on Bruker Multispectral
FX 470/600 for 10 sec exposure, bin2x2. Post intravitreal injection images of 50 µl of nCQDs
with the highest amine/acid ratio showed that the nCQDs were excitable at 470 nm and
emitted light at 600 nm (Figure 5.6). This behavior proves that nCQDs are good candidates
for ocular bioimaging applications.
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(A)

(B)

Nascent
nCQDs

(C)

Nascent
nCQDs

HA-nCQDs

Figure 5.6 Ex-vivo pig eyes images of 50 µl intravitreal injections of nascent and HA-coated CQDs. Excitation:
470 nm, Emission: 600 nm. (A) Control, no particle injection. (B) Post-injection of nascent CQDs at 2 minutes.
(C) Post-injection of HA-CQDs at 2 minutes.

Next, in-vivo fluorescence imaging was performed on Pearl Imager (LiCor), excitation: 685
nm, emission: 720 nm for post-mortem imaging analysis of nCQDs, a local administration
way (subcutaneous injection) was adopted, which is expected to avoid nCQDs entering into
the bloodstream. For especially small animal imaging applications, imaging agents which are
excitable at near-infrared region are desirable due to the possible interactions of the shortwavelength light with tissue and capability of the light diffusing through multiple tissues. 100
µl of nCQDs with the highest amine/acid ratio were injected subcutaneously into CD-ICR
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mice. It was observed that a fluorescence area was formed around the injection site (Figure
5.7). The images proved that both unconjugated and HA-conjugated nCQDs were excitable at
685 nm and gave an emission signal at 720 nm. Thus both nCQDs and HA-nCQDs can be
used for whole animal imaging applications.

(A)

(B)

(C)
injection
site

injection
site

Figure 5.7 Post-mortem mouse images of 100 µl subcutaneous injections of nascent and HA-coated CQDs.
Excitation: 685 nm, Emission: 720 nm. (A) Control, no particle injection. (B) Post-injection of nascent CQDs at
2 minutes. (C) Post-injection of HA-CQDs at 2 minutes.

5.4 Conclusions
We optimized a very simple yet facile method of synthesizing nCQDs to obtain red emissive
carbon dots using CCD-RSM. Further, we conjugated nCQDs with HA to target cancer cells
and cells which overexpress CD44 receptors. Confocal images proved that the nCQDs could
enter the cells, including cancer cells, and the HA conjugation enhanced the intracellular
concentration significantly. Nascent nCQDs had fair compatibility up to 0.6 mg/ml; however,
once they were conjugated with HA, they showed even better biocompatibility with the tested
cells. Ex-vivo pig eye images showed that HA-nCQDs could effectively diffuse through
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vitreous and post-mortem whole-body mouse images also proved that the HA-nCQDs are
suitable for bioimaging applications. The results imply the suitable application of HA-nCQDs
in nanomedicine both for targeted drug delivery and imaging applications4.5
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Chapter 6: Assessing the Nanoparticle
Transport through the Biological Barriers
in the Eye

The results of this chapter have been compiled partially in Karakoçak B. B., Santeford A., Lee
T. J., Biswas P., Apte R. S., Ravi, N. (2018) Crossing the Blood-Retinal Barrier: A
Quantitative Study on Targeted Delivery of Gold Nanoparticles. In preparation.
Also, the results of this chapter have been partially published in Karakocak, B. B.; Liang, J.;
Kavadiya, S.; Berezin, M. Y.; Biswas, P.; Ravi, N. Optimizing the Synthesis of Red-Emissive
Nitrogen-doped Carbon Dots for Use in Bioimaging. ACS Appl. Nano Mater. DOI:
10.1021/acsanm.8b00799. Copyright 2018 American Chemical Society
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Abstract
Rapid progress in nanotechnology has led to its implementation for in-vivo diagnosis and
therapy. As an example, recent studies have shown that gold nanoparticles (Au NPs) can be
used as both delivery and imaging agents. Carbon dots (CDs) also hold promise as potential
imaging agents because they have much higher quantum yields than Au NPs. When
nanoparticles are administered in-vivo, the systemic circulation distributes them to all body
organs and to the targeted tissue. Precise characterization of nanoparticles’ distribution and
accumulation in different body parts in preclinical models has been investigated; however, the
eye remains an unexplored exception. For nanoparticles to be considered successful
bioimaging and drug delivery agents in ophthalmology, an adequate dose must reach the
target tissue. Coating nanoparticles with hyaluronic acid (HA), a biocompatible CD44
receptor-ligand increases the delivered dose in the eye. In this work, HA was conjugated to
both 20 nm Au NPs and to 5 nm carbon dots to enhance their delivered dose. This study tested
intravitreal and intravenous injections of both nascent and HA-coated Au NPs (HA-S-Au
NPs) and quantified their distribution in the retina and cornea. Next, nitrogen doped CDs
(nCDs) were tested as imaging agents in ex vivo eye globes and a post-mortem whole-body
mouse model. The results showed that following intravenous injections, Au NPs and HAcoated Au NPs reached their maximum concentrations in the retina at 20 and 25 minutes,
respectively. Twice as many HA-Au NPs reached the retina than nascent Au NPs. After 24
hours, 8.55% of the Au NPs were left in the retina, whereas 12.06% of the HA-Au NPs
remained. Finally, the ex-vivo imaging of porcine ocular globes and post-mortem imaging of a
whole mouse demonstrated the utility of nCDs.
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6.1 Introduction
Gold nanoparticles (Au NPs) can deliver ocular drugs to specific target sites in the eye, where
they can also be used as imaging agents due to their unique surface plasmon resonance
(Boisselier and Astruc 2009, Jeong Hun et al. 2009, Yanai et al. 2012, Pan et al. 2013, Su et
al. 2013, Zhou et al. 2013). Since Au NPs can be exploited as both imaging and drug delivery
agents, they hold promise to revolutionize the detection and treatment of many eye diseases.
With their capability to target a specific ocular region, Au NPs can more readily deliver the
desired therapeutic dose (Bakri et al. 2008, Choonara et al. 2010, Christoforidis et al. 2012,
Gabriele Sandrian et al. 2012, Gan et al. 2013, Ferenchak et al. 2014). Numerous recent
studies have suggested that ocular medicine will benefit enormously from the use of
nanoparticles, and gold nanoparticles are one of the most promising agents (Bakri et al. 2008,
Hayashi et al. 2009, Jeong Hun et al. 2009, Jin Hyoung et al. 2011, Williams and Klebe 2012,
Skala et al. 2013, Cho et al. 2015).
Carbon dots (CDs), which measure less than 5 nm in diameter, are also the subject of several
recent studies in bioimaging (Liu et al. 2017, Lin et al. 2018, Liu et al. 2018). As of May
2018, well-known chemical suppliers can provide commercially available but expensive
blue/green emissive CDs (Aldrich 2018). Despite their expense ($3/mg), these CDs are
particularly interesting for their wavelength-dependent excitation/emission behavior (Gan et
al. 2016), long fluorescence lifetime (Dong et al. 2015), good photostability (Miao et al.
2017), and relatively high biocompatibility (Zhang et al. 2015) as discussed in previous
chapters. With this unique combination of properties, CDs have demonstrated promise for
bioimaging applications, where high quantum yield and red/near-infrared excitability are key
properties. In this dissertation, we have optimized a facile method of synthesizing redemissive CDs. We have demonstrated their usefulness both in their nascent form (Chapter 4)
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and HA-conjugated form (Chapter 5) for in-vitro imaging. However, it is also vital to
demonstrate their usefulness in animal models as a prerequisite to clinical trials.
Intravitreal injections are one of the most common methods to treat retinal diseases.
Additionally, intravenous injections would be advantageous in ophthalmology if the NPs were
designed to cross the blood-retinal barrier (BRB). It is worth noting that the BRB and the
blood-brain barrier (BBB) have similar natures due to the similarity of their structure (Runkle
and Antonetti 2011). Both barriers consist of an inner and outer barrier, which makes
diffusion highly selective, due to the presence of tight junctions between the cells (London et
al. 2013). However, if nanoparticles can cross the BRB, there is a high possibility of
delivering a drug or gene to the brain as well.
Intravenous injections are advantageous over intravitreal injections due to their reproducible
results, ease of their application, and ready patient compliance (Bourges et al. 2003, Diebold
and Calonge 2010, Cho et al. 2015). The entire administered dose reaches the systemic
circulation immediately, and the delivered dose can be accurately calibrated against the
response of the target organ.
There have been several attempts to coat NPs with different conjugates to increase their
delivered dose to the target organ/tissue. Many coating conjugates, ranging from synthetic
ligands to natural biomolecules, have been used to improve the stability of particles and the
efficiency of their delivery to specific cells or tissues (Manson et al. 2011, Lowe et al. 2015,
Yilmaz et al. 2016, Lin et al. 2017). As discussed in Chapter 3, we chose hyaluronic acid
(HA) as a coating material because it can prevent adsorption of proteins on the surfaces of
biomaterials (Hans and Lowman 2002) and has an antifouling effect that arises from its
hydrophilic and polyanionic characteristics (Lee et al. 2008, Santhanam et al. 2015). HA also
scavenges free radicals and chelates pro-oxidant metals (Glucksam-Galnoy et al. 2012). It
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exhibits many desirable physiological properties: For example, it can be either antiinflammatory or pro-inflammatory, depending on its molecular weight. On the other hand, as
demonstrated in Chapter 3, HA coating can increase the intracellular concentration of NPs
because specific cell membrane receptors, specific to HA, will recognize the HA coating and
facilitate endocytosis.
The main reason why intravenous injections are not preferred over other administration
techniques is that the therapeutic agent has to cross at least two barriers (the BRB and BBB),
which are very selective and do not allow the passage of large molecules. Thus, an effective
concentration in the target organs (specifically the eye and the brain) is achievable.
Intravenously injected nanoparticles must escape elimination through the reticuloendothelial
system to maintain a prolonged effective concentration. In addition, for the delivery agent to
reach the target tissues/cells in the brain and the retina, the agent should overcome both
barriers. The BBB and inner BRB are composed of endothelial cells lining the brain and
retinal vasculatures as illustrated in Figure 6.1 (Petros and DeSimone 2010, Jo et al. 2015).
The inner BRB is a dynamic structure consisting of retinal endothelial cells, pericytes, and
astrocytes, and the outer BRB consists of tight junctions between retinal pigment epithelium
(RPE) cells (Kim et al. 2006, Runkle and Antonetti 2011). Similarly, the BBB consists of the
same structures except for the presence of the basal lamina, which can be considered as an
additional membrane inside the BBB. In addition to the fact that the BRB is critical in
physiological and pathological processes in the retina, the structure of the BRB is the limiting
factor in targeted drug and gene delivery applications when the target organ is the eye.
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Figure 6.1 Structure of Blood Retina Barrier (BRB) and Blood Brain Barrier (BBB) (Adapted from (London et
al. 2013)).

Nanoparticles administered into the body are eventually cleared by organs in the mononuclear
phagocyte system which contains phagocytic cells in reticular connective tissue, such as the
liver and spleen. Nanoparticles remain in these organs for a long time after being taken up by
the macrophages, which increases the likelihood of unintended acute or chronic toxicity.
However, very few studies (Jeong Hun et al. 2009, Hirn et al. 2011) showed accumulation of
Au NPs in the eye, despite the bio-distribution of gold nanoparticles being well studied
(Sonavane et al. 2008, Terentyuk et al. 2009, Johnston et al. 2010, Khlebtsov and Dykman
2011). Figure 6.2 illustrates the detailed structure of the blood-retinal barrier, with the
absolute thicknesses of each section. The NP has to travel at least 11 µm to reach the rods and
cones.
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Figure 6.2 Detailed structure of the Blood Retina Barrier (BRB) and thicknesses of each section. The NP has to
travel at least 11 µm while passing at least two layers of cells with tight junctions having an opening of 60 nm.

So far, one study has reported that Au NPs can cross the BRB, depending on their size (Jeong
Hun et al. 2009). The authors reported that intravenously administered 20 nm spherical Au
NPs with an exposure concentration of 1g/kg could pass through the blood-retina barrier and
did not cause ocular toxicity. However, only TEM images of the retina were presented, and
quantification was presented from only one representative TEM image. The fate, location, and
concentration of the Au NPs which crossed the blood-retina barrier are unknown, and just one
bioassay was performed (TUNEL), in which the apoptotic cell death count was found to be
only eight cells, seven days following the intravenous injection.
It is clear that there is an urgent need for a comprehensive study reporting the quantification
data on ocular locations of intravenously and intravitreally injected Au NPs. Further, for
targeted drug and gene delivery applications, not only the fate of the NPs following
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intravenous injection, but also the accumulated dose after a period of time (i.e., a minimum of
24 hours post-injection) must be reported before suggesting Au NPs as potentially safe agents.
In this Chapter, we aim to demonstrate that both nascent and HA-S-Au NPs cross the BRB
while reporting the location and the accumulated amounts of Au NPs in different sections of
the eye (cornea and retina).
The final part of this chapter describes a demonstration of the potential usefulness of redemissive nCDs as bioimaging agents. The nCDs developed in Chapter 4 were injected
intravitreally into ex-vivo porcine ocular globes and subcutaneously in euthanized mice,
where they were readily detected.

6.2 Materials and Methods
6.2.1 Animals
The mouse eye has a long-established history in ophthalmology, specifically in retinal
research, and is an appropriate model for our short-term study. We utilized C57BL/6 male
mice from Jackson Laboratory (Bar Harbor, ME, USA) 6-8 weeks old, with a weight of 20-25
grams.
Care, use, and treatment of all animals in this study were in strict agreement with the
Association for Research in Vision and Ophthalmology (ARVO) statement for the Use of
Animals in Ophthalmic and Vision Research. An animal protocol (20170241) was established
accordingly and approved by the Washington University in St. Louis Institutional Animal
Care and Use Committee in November of 2017.
There were two main in-vivo studies. The first study demonstrated intravenous injections of
both gold nanoparticles and carbon dots, and the second study consisted of intravitreal
injections of the same nanoparticles.
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6.2.2 Mimicking the blood-retinal barrier: Cell inserts
Prior to the intravenous injections, a preliminary study was conducted to test the ability of Au
NPs to cross the tight junctions between the retinal pigment epithelial cells. Transwell®
permeable supports with 6.5 mm inserts were used. There are two chambers (bottom and top)
present in one Transwell®, and they are separated by a Coster 3450-polyester membrane,
which has pore openings of 0.4μm in diameter. The retinal pigment epithelial cells (ARPE19) are plated on these membranes at a concentration of 20,000 cells per transwell where the
upper chamber volume is 200 μL, and the bottom chamber volume is 1000 μL.
In our previous cell attachment study (Chapter 4), the electrical impedance (ECIS)
measurements showed that the time required for the ARPE-19 cells to reach over 90%
confluency is approximately 24 hours. To reach a nice monolayer of cells ensuring the
formation of tight junctions between them, the cells were grown inside the transwells for 72
hours, prior to the Au NP addition. We chose Au NPs with a diameter of 20 nm to observe
NPs’ ability to cross the tight junctions. After 72 hours, aliquots were collected from the
bottom plate for inductively coupled plasma mass spectrometry (ICP-MS) analysis. The
presence of Au NPs in the bottom chamber will serve as the evidence that the Au NPs are able
to pass through the ARPE-19 cells’ tight junctions. Cells attached to the transwell membrane
will be fixed and examined with 3-D confocal microscopy to quantify the Au NP
concentration within a cell.

6.2.3 Intravitreal and intravenous injections of Au NPs and CDs
The mice were anesthetized with Avertin (250 mg/kg), followed by intravenous and
intravitreal injections of Au NPs or CDs. Au NPs with a diameter of approximately 20 nm
were used either in end-thiolated hyaluronate coated (HS-HA) form or uncoated. The carbon
dots (HA-conjugated and conjugated) were smaller than 5 nm. Information regarding
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conjugation and a detailed physicochemical characterization was provided in Chapters 3 and 4
for Au NPs and CDs, respectively.
Intravitreal injections of Au NPs and CDs
C57BL/6 male mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA). The
eye was proposed using forceps, and an incision was made at the limbus by inserting and
withdrawing a 30-gauge needle. A second 30-gauge hypodermic needle fitted on a Hamilton
700 series microsyringe (Hamilton, Reno, NV) was then inserted into the incision site to
administer a 2 μl intravitreal injection of Au NPs (0.05 mg/ml). The procedure was performed
under a surgical microscope on both eyes of each animal. Phosphate-buffered saline (PBS)
was used for sham injections.
Fresh porcine ocular globes were obtained from Trenton Processing Center, Trenton, IL. The
excessive muscle and fat tissue around the eyes were excised, and the globes were placed in
1% antibiotic-antimycotic in 1x PBS. Intravitreal injections of nCDs were performed at a dose
of 5 mg/ml with an injection volume of 50 µL. The ocular globes (n=3) were imaged at the 6th
and 30th minutes using the Multispectral FX Pro Imager (Bruker Biospin, Woodbridge, CT), λ
ex∕em: 650 ∕ 700 nm. The contrast based on the signal of nCDs was quantified and compared
among ocular globes with and without the injection of nCDs with NIH ImageJ software
(National Institutes of Health, Bethesda, MD).
Post-mortem imaging of nCDs
The nCDs were injected subcutaneously on the dorsal side of fresh mice cadaver (n = 3) for
small-animal whole-body imaging. Deceased mice were shaved prior to nCD injection and
imaging. Injections of nCDs in water (100 µL solution per injection) were administered
subcutaneously on left shoulder and right hip, at a dose of 33 µg/g. Animals were imaged at
10 minutes post-injection using the Multispectral FX Pro Imager (Bruker Biospin,
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Woodbridge, CT), λ ex∕em: 550-600 nm ∕ 600-750 nm. The contrast based on the signal of
nCDs was quantified and compared versus the negative control with NIH ImageJ software
(National Institutes of Health, Bethesda, MD).
Intravenous injections of Au NPs to in-vivo mouse
Both nascent and HA-coated Au NPs at a concentration of 0.05 mg/ml were injected
intravenously through the lateral saphenous vein of C57BL/6 mice. The injected nanoparticles
were allowed to circulate for up to a maximum of 24 hours to ensure crossing the bloodretinal barrier. The mice were sacrificed at 5, 10, 15, 20, 25, 30, 60 minutes and finally at 24
hours post-injection. Next, eyes were harvested for ex-vivo imaging following cervical
dislocation of the animal. The enucleated eyes were transferred into 4% paraformaldehyde
(PFA) in 1x PBS as the cross-linking solution overnight. The eyes were then embedded in
paraffin and sectioned at a thickness of 4 µm.
Histology staining and imaging of eye tissue sections with coated and uncoated Au NPs
The 4 µm tissue sections were stained with Mayer’s hematoxylin and eosin Y (H&E; RichardAllan Scientific, Kalamazoo, MI). Bright-field imaging was performed using a research light
microscope (Olympus BX51, Lombard, IL) equipped with a color camera (D5-Fi1, Nikon)
and a 10/0.30 Plan Fluor objective lens (Nikon).
Confocal microscopy imaging of eye tissue sections with coated and uncoated Au NPs
The 4 µm tissue sections were incubated in ice-cold 1x PBS buffer containing 0.1% Triton
(permeabilization agent) for 10 min at room temperature, then washed three times with icecold 1X PBS for 5 min each time. The tissue sections were then incubated with blocking
buffer for 30 min before the addition of Alexa Fluor® 633 phalloidin (diluted 1:200 in
blocking buffer) to stain the tight junction proteins, cadherin. The cells were subsequently
washed three times with ice-cold 1X PBS for 3 min each time. To stain the nuclei,

126

SlowFade® Gold Antifade Mountant with DAPI (diluted 1:100 in 1X PBS) was used. The
slides containing tissue sections were incubated overnight at 4 oC.
Electroretinogram analysis
ERG was performed as previously described (Ban et al. 2017) using the UTAS-E3000 Visual
Electrodiagnostic System running EM for Windows (LKC Technologies, Gaithersburg, MD,
USA). In brief, we extracted quantitative measurements from the ERG waveforms using an
existing Microsoft Excel macro that defines the a-wave amplitude as the difference between
the average pre-trial baseline and the trough of the average trace and defines the b-wave
amplitude as the difference between the trough to the peak, without subtracting oscillatory
potentials. Statistical analyses were performed using the paired t-test to analyze variance and
pattern electroretinographic variables. A P-value of 0.05 was considered statistically
significant. Results were expressed as mean (SD).

6.3 Results and Discussion
6.3.1 Demonstration of 20 nm Au NPs crossing the tight junctions of retinal
pigment epithelial (RPE) in-vitro
We successfully demonstrated that 20 nm Au NPs were able to cross the tight junctions
formed between the ARPE-19 cells. According to the results obtained (Figure 6.3), by the end
of 24 hours, 70.3% of the Au NPs accumulated inside the cells. 7.2% of the Au NPs could
cross the cell insert membrane and the tight junctions between the ARPE-19 cells. 22.4% of
the NPs could not enter the cells and could not pass the membrane.
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Figure 6.3 ICP-MS quantification results for the Au NPs that could cross both the tight junctions formed in
between the RPE cells and the insert membrane. The amount that is detected in the bottom chamber of the inserts
is denoted as % of NPs that can cross the BRB, as this in-vitro experimental design is a widely expected in-vitro
model as proof of concept for the NPs crossing the BRB.
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6.3.2 Distribution of intravitreally injected HA-coated and uncoated Au
NPs in the cornea
Figure 6.4 displays optical images with H&E staining of a typical mouse eye section. All the
sections of both the cornea and retina are labeled in Figures 6.4.A and 6.4.B, respectively.
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40X

Back of the
eye

Corneal
Endothelium

Front of the
eye

40X

Figure 6.4 H&E stained optical microscopy images of the eye. (A) The whole cross-section. (B) 40X
magnification of the front of the eye, where the cornea is present. (C) 40X magnification of the back of the eye,
where the retina is located. The parts of the cornea and retina are labeled.

Figure 6.5 displays an optical image of a paraffined section of an eye after an intravitreal
injection of 2 µl Au NPs. As can be seen, there is retinal detachment, which can be due to the
invasive nature of the intravitreal injection. The eye globe is small (3.4±0.2 mm in equatorial
diameter, and 22±5 µl in volume) (Wisard et al. 2010) and the injection needle was a
relatively large microsyringe.
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Figure 6.5 Optical microscopy images of a paraffined section of an 8-week old C57BL/6 mouse eye. The main
eye sections ‒ cornea, lens, retina, along with RPE cells are labeled. Following the intravitreal injection of Au
NPs, the retina was detached.

Next, the distributions of uncoated Au NPs and HA-S-Au NPs in the eye are displayed
(Figure 6.6). Confocal microscopy detected the Au NPs because they are inherently
fluorescent, and they absorb light in 480-600 nm region (Boisselier and Astruc 2009, Zhou et
al. 2013, Linlin et al. 2015), depending on their size.
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Figure 6.6 Confocal microscopy images of the cornea of an 8-week-old C57BL/6 mouse 24 hours post-injection
of (A) nascent Au NPs, (B) HA-S-Au NPs. The nucleus is stained with DAPI and blue in color, and Au NPs are
green. There are more HA-coated Au NPs detected in all sections of the cornea. (C) ImageJ analysis quantified
the amounts of Au NPs in each section.
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ImageJ analysis revealed that the HA coating consistently enabled significantly more Au NPs
to enter the cornea (Figure 6.6C). In the stroma, approximately 850% more Au NPs were
detected when they are coated with HA (0.019% vs. 0.18% of the NPs injected into the mouse
eyes). Moreover, 360% more HA-coated Au NPs were detected in the corneal endothelium
cells (0.039 vs. 0.18%), and finally, 700% (0.047 vs. 0.38%) more HA-Au NPs were detected
in the corneal epithelial cells, where the maximum amount of NPs was detected. This
consistent difference can be attributed to enhanced endocytosis of HA-coated Au NPs,
because HA is recognized by the CD44 receptors expressed on the corneal epithelial cell
membranes (Contreras-Ruiz et al. 2011, Karakocak et al. 2018). The distribution of Au NPs
was not analyzed, because the retinal detachment would render results inaccurate.

6.3.3 Distribution of intravenously injected uncoated and HA-coated Au
NPs in the eye
Several series of confocal images were taken for mouse tissue sections. As explained in the
statistical analysis section, at least three replicas were used for each time point of sacrifice.
There were eight time points (5, 10, 15, 20, 25, 30, and 60 minutes, and 24 hours), and both
HA-coated and uncoated Au NPs were injected intravenously (30-50 µl, depending on the
weight of the mouse). Sham injections were done with 1X PBS.
Distribution analysis of Au NPs in the cornea
Figure 6.7 displays confocal images of Au NPs post injection for all the time points tested.
The signal from the second channel, where only the Au NPs can be detected (488 nm
excitation λ, 500-550 nm emission λ) was the highest at the 15th minute.
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Figure 6.7 The red staining corresponds to cadherin, a tight junction protein; the nucleus is stained with DAPI
and blue, and Au NPs are green. The fourth image in each time point is a merged version of the previous three
images. The amount of Au NPs that reached the cornea peaked at 15 minutes post injection, as can be seen. Scale
bars are 50 µm.

Next, the amount of Au NPs in each part of the cornea was quantified using ImageJ analysis,
with the results shown in Figure 6.8. The NPs were most internalized by the endothelial cells,
reaching a peak concentration at minute 15 post-injection. On the other hand, the least amount
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of NPs was detected in the stroma, followed by the corneal epithelial cells. The corneal
stroma, the nutrition source of the cornea, is composed of collagen fibril assemblies and
maintains the corneal transparency where growth factors and cytokines are produced (Mohan
et al. 2012, Williams and Klebe 2012, Zhang et al. 2017). The extracellular matrix is also
mainly composed of collagen (Zhang et al. 2017). Unlike the corneal epithelium and corneal
endothelium, the cell number concentration is relatively less in the stroma. Hence it can act as
a void space where the transport of NPs is diffusion driven, is mainly by a concentration
gradient. As a result, NPs may tend to move faster in the stroma than in the epithelium and
endothelium. Thus, their residence time in the stroma will be much shorter than in the other
parts of the cornea, which can explain the relatively less accumulation observed in the stroma.

(B)

(A)

(C)

Figure 6.8 Au NP quantification results in the cornea. (A) The amount of Au NPs accumulated in each main
section of the cornea: endothelium, stroma, and epithelium. (B) The results plotted as a function of time. (C) The
cumulative amount of NPs found in the cornea as a function of time. It took more than 5 minutes, and less than
10 minutes for NPs to reach the cornea. The delivered amount of NPs reaching the cornea peaks at minute 15.
After minute 25, the amount remaining in the cornea significantly decreases. By the end of 24 hours, only 3.74%
of the peak Au NP concentration remains in the cornea.
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Distribution analysis of HA-S-Au NPs in the cornea
Figure 6.9 displays confocal images of HA-S-Au NPs post injection for all the time points
tested. At 60 minutes post-injection, the signal from the second channel, where only the Au
NPs can be detected (excitation λ: 488 nm, emission λ: 500-550 nm) was the highest. This
finding means that HA coating slows down the NP transport significantly.
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Figure 6.9 The red staining corresponds to cadherin, a tight junction protein, the nucleus is stained with DAPI
and blue; and Au NPs are green. The fourth image in each time point is the merged version of all three previous
images. The intensity of the signal coming from the second channel is proportional to the amount Au NPs
present. The amount of Au NPs that reached the cornea peaked at 60 minutes post injection, as it can be clearly
seen. Scale bars are 50 µm.

Next, the amount of HA-S-Au NPs in each part of the cornea was quantified using ImageJ
analysis. Figures 6.10 summarizes the quantification analysis results. The HA-coated Au NPs
were most internalized by the epithelial cells, unlike the nascent Au NPs, reaching a peak
concentration at minute 60 post-injection. This behavior can be attributed to HA-CD44
receptor interactions on the corneal epithelial cell membrane. This result is in accordance with
our findings in Chapter 3, where we showed that CD44 receptors significantly increased the
intracellular concentration of HA-Au NPs for cells that express CD44 receptors on their cell
membrane. As before, the least amount of NPs was detected in the stroma, which can again be
explained by the rate of the diffusion concentration gradient driven transport of NPs. Overall,
the total amount of HA-S-Au NPs was approximately 14% more than the total uncoated Au
NPs reaching the cornea. By the end of 24 hours, 17.10% of the peak Au NPs concentration
remained in the cornea. These results prove that HA facilitated Au NP transport and was able
to carry the Au NPs through the tight junctions more efficiently.
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Figure 6.10 HA-S-Au NP quantification results in the cornea. (A) The amounts of Au NPs accumulated in each
section of the cornea: endothelium, stroma, and epithelium. (B) The precise amounts in each section of the
cornea are plotted as a function of time. (C) The cumulative amount of NPs found in the cornea as a function of
time. It took the first NPs less than 5 minutes to reach the cornea. The amount of HA-S-Au NPs reaching the
cornea peaks at minute 60. After minute 60, the amount left in the cornea significantly decreases. By the end of
24 hours, 17.10 % of the peak HA-S-Au NP concentration remains in the cornea.

Distribution analysis of Au NPs in the retina
Figure 6.11 displays confocal images of Au NPs post injection for all the time points tested.
25 minutes post injection, it was observed that the signal from the second channel, where only
the Au NPs can be detected (488 nm excitation λ, 500-550 nm emission λ) was the highest,
similar to the time point where the amount Au NPs accumulated in the cornea peaked.
10 minutes
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Figure. 6.11 The red staining corresponds to cadherin, a tight junction protein, the nucleus is stained with DAPI
and blue; and Au NPs are green. The fourth image in each time point is the merged version of all three previous
images. The intensity of the signal coming from the second channel is proportional to the amount of Au NPs
present. The amount of Au NPs that reached the retina was peaked at 20 minutes post injection, as it can be
clearly distinguished from the images. Scale bars are 50 µm.

Figures 6.12 summarizes the quantification analysis results of Au NPs accumulated in the
retina. According to the results obtained, the NPs were internalized the most in the outer
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retina where outer nuclear layer and outer plexiform layer are the regions of interest, reaching
to a peak concentration at minute 20, post-injection. On the other hand, it was found that the
least amount of NPs was detected in retinal epithelial cells, followed by inner retina where
inner ocular layer, inner plexiform layer, and ganglion cells are present. This finding can be
explained by the following behavior: As a result of the intravenous injections, the only way
the NPs to enter the eye is via the blood flow and the first port of their entry is the choroid. As
illustrated in Figure 6.2, the RPE is the second set of cells with tight junctions that NPs need
to pass. As there is no flow present in the rest of the eye apart from the choroid, the NP
transport is diffusion driven, where the concentration gradient is the main driving force.
Therefore, the amount of NPs is expected to be less in RPE as they are prone to diffuse
through the deep layers of the retina where the concentration is less.

(A)
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Figure 6.12 Au NP quantification results in the retina. (A) The amount of Au NPs accumulated in each main
section of the retina: retinal epithelium, the outer retina, and the inner retina. The outer retina consists of the
outer plexiform layer and outer nuclear layer, whereas the inner retina is composed of the inner plexiform layer,
inner nuclear layer and the extension of the ganglion cells. (B) The results are plotted as a function of time for
each central section of the retina. (C) The cumulative amount of NPs found in the retina as a function of time.
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The amount of Au NPs reaching the cornea peaks at minute 20. After the end of one hour, the amount remaining
in the retina significantly decreases. By the end of 24 hours, 8.55% of the peak Au NP concentration remains in
the retina.

Distribution analysis of HA-S-Au NPs in the retina
Figure 6.13 displays the confocal images of HA-S-Au NPs in the retina post injection for all
the time points tested. 25 minutes post injection, it was observed that the signal from the
second channel, where only the Au NPs can be detected (excitation λ: 488 nm, emission λ:
500-550 nm) was the highest. Unlike the results for the cornea, the HA coating did not slow
down the NP transport significantly (only by 5 minutes retardation for the NPs to reach their
peak concentration).
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Figure 6.13 The red staining corresponds to cadherin, a tight junction protein, the nucleus is stained with DAPI
and blue; and Au NPs are green. The fourth image in each time point is the merged version of all three previous
images. The intensity of the signal coming from the second channel is proportional to the NPs present. The
amount of HA-S-Au NPs that reached the retina was peaked at 25 minutes post injection, as it can be clearly
distinguished from the images. Scale bars are 50 µm.

Figures 6.14 summarizes the quantification analysis results of HA-S-Au NPs accumulated in
the retina. According to the results obtained, similar to the results of uncoated Au NPs, the
NPs were most internalized in the outer retina where outer nuclear layer and outer plexiform
layer are the regions of interest, reaching to a peak concentration at minute 25 post-injection.
On the other hand, it was found that the least amount of NPs was detected in retinal epithelial
cells, followed by inner retina where inner ocular layer, inner plexiform layer, and ganglion
cells are present. Overall, the amount of HA-S-Au NPs that reached the retina was
approximately twice as more than the uncoated Au NPs that reached the retina. This means
that the HA coating can significantly enhance the amount of payload that can be delivered to
the retina. The HA coating not only improved the delivery of Au NPs but also increased the
amount that remained after a day by approximately 5% (8.55% vs. 12.06%).
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Figure 6.14 HA-S-Au NP quantification results in the retina. (A) The amount of HA-S-Au NPs accumulated in
each main section of the retina: retinal epithelium, the outer retina, and the inner retina. The outer retina consists
of the outer plexiform layer and outer nuclear layer, whereas the inner retina is composed of the inner plexiform
layer, inner nuclear layer and the extension of the ganglion cells. (B) The results are plotted as a function of time
for each main section of the retina. (C) The cumulative amount of NPs found in the retina as a function of time.
The amount reaches the retina peaks at minute 25. After 24 minutes, the amount remains in the retina
significantly decreases. By the end of 24 hours, 12.06% of the peak Au NP concentration remains in the retina.

Imaging of nitrogen-doped CDs in ex-vivo porcine ocular globes
Clinically, the particles need to diffuse through the layers of the eye to reach the desired part
within for specific ocular treatments and bioimaging (Kompella et al. 2013). On the other
hand, systemic administration of nanoparticles as drug nanovesicles and bioimaging agents
are also of interest due to enhanced tumor uptake (Huang and Hainfeld 2013, Wang et al.
2013). For bioimaging applications, imaging agents, which optically active in the deep-red
and NIR region are desirable due to their lower energy and reduced scattering interactions as
compared to the short-wavelength light.
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Post intravitreal injection images of 50 µl of nCDs with the highest amine/acid ratio showed
that the nCDs were excitable at a corresponding longer wavelength, for example, 650 nm with
an emission at 700 nm (Figure 6.15).

A)

C)

B)

Figure 6.15. Ex-vivo ocular globe images obtained with a small animal imager (excitation λex = 650 nm, λem =
700 nm). Porcine ocular globes with nCDs injections. (A) No injection of CDs, control. (B) Post-injection at 6
minutes. (C) Post-injection at 30 minutes.

Contrast based on the intensity density calculations conducted with ImageJ software showed
that the normalized signal per region of interest (ROI) area was 1.63, 38.21, and 49.39 for
Figs. 6.15A, 6.15B, and 6.15C, respectively. Also, it was observed that the nCDs diffused
through the vitreous to cornea within half an hour (Fig. 6.15) suggesting that nCDs are
suitable, low-toxicity (vide supra) candidates for ocular bioimaging applications.

6.3.4 Post-mortem imaging of CDs
The nCDs were injected subcutaneously into fresh mice cadaver (n = 3) for small-animal
whole-body imaging. Deceased mice were shaved prior to nCD injection and imaging.
Injections of nCDs in water (100 µL solution per injection) were administered subcutaneously
on left shoulder and right hip, at a dose of 33 µg/g. Animals were imaged at 10 minutes postinjection using the Multispectral FX Pro Imager (Bruker Biospin, Woodbridge, CT), λ ex∕em:
550-600 nm ∕ 600-750 nm. The contrast based on the signal of nCDs was quantified and
compared versus the negative control with NIH ImageJ software (National Institutes of
Health, Bethesda, MD).

143

For post-mortem imaging analysis of the nitrogen-doped CDs (nCDs) developed in Chapter 4,
a local administration route (subcutaneous injection) was adopted, which is expected to avoid
nCDs entering the bloodstream. The nCDs with the highest amine/acid ratio (2.0) were
injected subcutaneously (100 µL per injection) into post-mortem mice at two different
locations. We observed that a fluorescence area was formed around both injection sites
(Figure 6.16).
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Figure 6.16. Post-mortem images of mice with nCDs obtained with the small animal imager, Bruker spectral FX.
(A) No injection of CDs, control. λex = 550 nm, λem = 600 nm. With nCD injections (B) After first injection,
λex = 550 nm, λem = 600 nm. (C) After second injection, λex = 550 nm, λem = 600 nm. (D) λex = 550 nm, λem
= 700 nm. (E) λex = 600 nm, λem = 750 nm.

The images generated sufficient contrast to be quantified with ImageJ software based on
intensity density calculations normalized with respect to the ROI (9.29, 35.00, 54.89, 33.33,
and 31.02, for Figs. 6.16A, B, C, D, and E, respectively) at 550 and 600 nm excitation
wavelengths. The images prove that the nCDs could be used for whole animal imaging
applications.

6.3.5 Electroretinogram analysis of intravenously injected uncoated and
HA-coated Au NPs in the eye
In-vivo studies are necessary to assess the ocular toxicity of nanoparticles since the response
of the target cell/organ may be influenced by interactions between different types of cells;
additionally, defense mechanisms might be different at the organ level. Electroretinogram
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(ERG) analysis is a well-established technique that can record the electrical activity of the
retina triggered by light and therefore is a suitable method for assessing the toxicity of the
NPs. The ERG signal is generated mainly by voltage changes caused by radial currents (along
the axis of photoreceptors and bipolar cells) flowing in the resistive extracellular space of the
retina (Jaakko and Plonsey 1995).
The first ERG signal was recorded in 1865 by Holmgren from the surface of a fish eye
(Armington 1974). Einthoven and Jolly (Einthoven and Jolly 1908) divided the ERG response
to the onset of light into three different waves, called a- (Penn and Hagins 1969), b- (Stockton
and Slaughter 1989), and c- (Steinber.Rh et al. 1970) waves, that are now known to reflect
mainly the activity of photoreceptors, bipolar cells, and pigment epithelium cells,
respectively. The applied amplitude depends on the stimulating and physiological conditions,
but ranges are in several hundred of a microvolt.
We carried out ERG analysis for 8-weeks old mice both at Day 1 and Day 7 post injection of
Au and HA-S-Au NPs (Figure 6.17). The results showed no significant difference between the
signals among the control, nascent, and HA-S-Au NPs. This means neither Au NPs nor HAS-Au NPs caused toxicity at the injection doses tested.
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A)

B)

C)

D)

E)

F)

Figure 6.17. ERG analysis of nascent and HA-S-Au NPs: 1-day post-injection (A) scotopic a-wave (B) scotopic
b-wave (C) phototopic b-wave and 1-week post-injection (D) scotopic a-wave (E) scotopic b-wave (F)
phototopic b-wave. The results showed no significant difference among all the measurements obtained.
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6.3.6 Histology staining and imaging of eye tissue sections with uncoated Au
NPs and HA-S-Au NPs
For concision, the results of this section are provided in Appendix V.

6.4 Conclusions
Intravitreal injections of Au NPs caused retinal detachment, and therefore, were not
investigated further. The amount reaching the cornea was quantified for both coated and
uncoated Au NPs. HA coating enabled significantly more Au NPs to enter and remain in the
cornea. In the stroma, approximately 850% more Au NPs were detected when they are coated
with HA (0.019% vs. 0.18% of the NPs injected to the mice). Similarly, approximately 360%
more HA-coated Au NPs were detected in corneal endothelium cells (0.039 vs. 0.18%), and
finally, 700% (0.047 vs. 0.38%) more HA-Au NPs were detected in the corneal epithelial
cells.
As a result of intravenous injections, 20 nm Au NPs not only reached the eye and crossed the
blood-retinal barrier, but also were able to reach all the way to the cornea. By conjugating Au
NPs with HS-HA, we were able to increase the delivered dose to the cornea and retina by
approximately 14% and almost 100%, respectively. The amounts of uncoated and coated Au
NPs that reached the retina peaked at 20 and 25 minutes, respectively. The amounts of
uncoated and coated Au NPs remaining in the retina at the end of 24 hours were 8.55% and
12.06%, respectively.
Without and with HS-HA coating, the Au NP amounts reaching the cornea peaked at 15
minutes and 60 minutes, respectively. For delivery to the cornea, the HA coating significantly
retarded the time for the NPs to reach their maximum concentration; however, this effect was
not apparent for the delivery of NPs to the retina. By the end of 24 hours, the amounts of
nascent and HS-S-Au NPs remaining in the cornea were 3.74% and 17.10%, respectively.
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Following intravenous injections, both the ERG analysis and histology analysis showed no
apparent toxicity induced by either Au NPs or HA-S-Au NPs at this injection dose (0.05
mg/ml).
Ex vivo porcine eye images showed that intravitreally injected nCDs could effectively diffuse
through the vitreous to the cornea, and post-mortem whole-body mouse images also
demonstrated that the nCDs provide suitably strong signals for bioimaging applications.
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Chapter 7: Conclusions and Suggestions for
Future Work

The results of this chapter have been partially compiled in Karakoçak, B. B., Biswas, P., and
Ravi N. (2018). Applications of Gold Nanoparticles in Ophthalmology. Prog. Retin. Eye Res.
In preparation.
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7.1 Conclusions
This section summarizes the major findings of this dissertation.

7.1.1 Assessing the biocompatibility of Au NPs with retinal cells and
providing a solution for their toxicity (Chapters 2 and 3)
While Au NPs are widely explored in various biomedical fields, including ophthalmology,
their toxicity to ocular cells has not been investigated. The first part of this dissertation
(Chapter 2) assessed the in-vitro toxicity of different sizes and shapes of Au NPs with a
retinal pigment epithelial cell line. The results showed that the toxicity is dependent on both
the size and shape of the nanoparticles. Au nanocubes were not detected in the cells, so their
toxicity, if any, could not be assessed. Au nanorods and nanospheres did enter the cells,
although nanospheres larger than 50 nm could not enter. The critical observation, however, is
that for particles small enough to enter, when the concentration is expressed as a function of
surface area per unit volume, size has no effect on consequent toxicity. For similar surface
area concentrations, spherical Au NPs in the range of 5-30 nm had almost the same
biocompatibility. The observed toxicity was a result of surface interactions inside the cell,
which are directly correlated to the surface area concentration of the NPs.
The toxicity of Au NPs arises from ROS activity, which was shown to be correlated to the
total available surface area (Pan et al. 2007, Jiang et al. 2008). Hyaluronic acid (HA), as
discussed in Chapter 3, is a free radical quencher that is natural and consequently
biocompatible (Balogh et al. 2003). We sought a way to mitigate the toxicity of Au NPs by
coating them with end-thiolated hyaluronate (HS-HA). The homogenous coating was
facilitated by the thiol group’s affinity to the Au surface. We successfully coated different
sizes of Au NPs (5, 10, 20, 50, and 100 nm) with HS-HA and both verified and quantified the
coating amount with thermal gravimetric and total organic carbon analysis. As expected, the
HS-HA coating significantly enhanced the biocompatibility of Au NPs; unexpectedly, the
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coating also considerably improved the internalization of larger Au NPs (50 and 100 nm),
which in their nascent form could not enter the cell. HA acted as a Trojan horse to carry in
larger Au NPs without triggering apoptosis and generating ROS. The outcomes of this study
could be valuable in treating inflamed, proliferating, or cancer cells that express CD44
receptors.

7.1.2 Creating biocompatible red-emissive carbon dots for use in
ophthalmology (Chapters 4 and 5)
For the first time, we developed and optimized a facile and economical synthesis of deep red
to near-infrared (600-700 nm) emissive nitrogen-doped CDs (nCDs) that uses simple dialysis to
isolate the product (Chapter 4). A central-composite design response surface methodology

(CCD-RSM) design was utilized (Stat-Ease, Design-Expert® software, version 9.0) to
optimize the effect of three factors in the synthesis of nCDs – the molar ratio of amine to
acid, the duration of pyrolysis (microwave exposure time), and the concentration of the
reactants. The characterization results respectively showed that as the amine to acid ratio
increased, both the MW and size of the nCDs increased. Based on high-resolution XPS
analysis, the formation of C‒N bonds and the presence of pyrrolic N content appear to be
keys to creating red-emissive nCDs. Both of these critical parameters reached a maximum at
an amine/acid ratio of 2.0. We hypothesize that, based on the structure of citric acid, one of
the most probable products (or moieties) contributing to deep-red-emissivity of nCDs could
be N,N'-substituted-pyrrolo[2,3-b]pyrrole. The quantum yield of the nCDs was found to be
15% in DI water. Next, a detailed cytotoxicity analysis found that up to 0.6 mg/ml exposure
concentration, the nCDs induced no apparent toxicity. However, there is still motivation for
enhancing their biocompatibility because repetitive injections may be required for highresolution imaging.
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Using the HA conjugation technique for enhancing the biocompatibility and intracellular
concentration of Au NPs, we conjugated CDs with HA by a carbodiimide coupling of the
amines on CDs and the carboxylic acids on HAs (Chapter 5). Confocal imaging analysis
revealed that the nCDs and their conjugates fluoresced at different wavelengths, depending
upon the excitation wavelength without a loss in the emitted signal. Three different cell lines
were exposed to nCDs and HA-nCDs. Confocal microscopy images showed enhanced
internalization of HA-nCDs, which was facilitated by CD44 receptors. Although the
intracellular concentration was increased, a biocompatibility assessment revealed that ROS
production was reduced by a factor of two, while apoptosis initiation was decreased by more
than an order of magnitude. HA is known to be a natural antioxidant. When carbon dots
induce ROS generation, the HA acts as a ROS scavenger and reduces the intracellular ROS
concentration, thus reducing the incidence of apoptosis. These observations suggest the use of
HA as a conjugate carrier for CDs into CD44 rich cells.
The formation of C‒N bonds and presence of pyrrolic nitrogen on the surface of the nCDs are
critical parameters in creating red-emissive carbon dots. In the complementary work, we
found that HA conjugation not only enhances the payload delivered to the cells but also
significantly decreases the signs of toxicity. This work also yielded a recipe for creating
biocompatible red-emissive CDs, ruling out the effects of pyrolysis time and citric acid
concentration and emphasizing the amount of nitrogen.

7.1.3 Demonstration of the usefulness of gold nanoparticles and carbon dots
in-vivo (Chapter 6)
Upon completing the in-vitro toxicity assessment of both nanomaterial products, we
conducted in-vivo studies (Chapter 6). In-vivo studies are necessary to assess the ocular
toxicity of nanoparticles, since the response of the target cell/organ may be influenced by
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interactions between different types of cells; additionally, defense mechanisms might be
different at the organ level.
Prior to any in-vivo tests, a preliminary in-vitro study tested the ability of Au NPs to cross the
tight junctions between retinal pigment epithelial cells. Transwell® permeable supports were
used to simulate the blood-retinal barrier (BRB). The results showed that 20 nm Au
nanospheres successfully crossed the permeable supports covered with confluent retinal
pigment epithelial cells. Based on this finding, we used 20 nm Au nanospheres in the
following experiments and coated them with HS-HA. We used intravitreal and intravenous
injections to deliver Au NPs in a C57BL/6 mouse model.
Following the intravitreal injections, histology and confocal imaging analysis revealed retinal
detachment. Therefore, we quantified the amount of Au NPs with and without the HA coating
only in the cornea. The HA coating revealed a almost one-fold increase in the amount of Au
NPs detected in all three layers of the cornea: the corneal endothelium, stroma, and
epithelium. For both nascent and coated Au NPs, no sign of toxicity was observed in the
entire cornea. Next, we injected both nascent and coated Au NPs intravenously through the
lateral saphenous vein of C57BL/6 mice. Using confocal imaging, we quantified the amount
of Au NPs as a function of time in all layers of the retina and cornea. The Au NPs reached the
eye in less than 5 minutes and achieved a maximum concentration within approximately 20
minutes in the retina. On the other hand, the amount of HA-S-Au NPs in the retina peaked at
25th minute. Due to the enhanced permeabilization and retention (EPT) effect of NPs, 8.55
and 12.06% of the uncoated and HA-coated Au NPs that reached the retina remained after 24
hours. The thicknesses of the inner and outer retina were measured and compared among the
control animals. Although the thicknesses of the inner and outer retina were highly variable
from animal to animal, there were no signs of toxicity for both uncoated and coated Au NPs.
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For nitrogen-doped carbon dots (nCDs), we used the best performing nCDs with the highest
amine to acid ratio, 2.0. The nitrogen-coated carbon dots, whose sizes are typically below 5
nm, were injected into porcine eye globes and post-mortem C57BL/6 mice. Ex-vivo porcine
eye images showed that 50 µL of intravitreally injected nCDs could efficiently diffuse
through the vitreous to the cornea. Post-mortem whole-body mouse images also demonstrated
that 100 µL of nCDs which were injected subcutaneously on the dorsal side of the mice, was
sufficient to generate a strong signal upon excitation by Bruker spectral FX small animal
imager built-in laser at a wavelength of 600 nm. This result proved that the nCDs created in
this study are suitable for bioimaging applications.

7.2 Suggestions for Future Work
7.2.1 Selecting a disease model to demonstrate the usefulness of the Au NPs
as targeted drug delivery agents
Angiogenesis, the growth of new capillaries from blood vessels, and vascular maintenance
are essential for proper organ development and functioning, particularly in the metabolically
demanding eye, a part of the CNS. The mouse retina is a direct extension of the brain and
serves as a useful model system for studying angiogenesis in the CNS because the mouse
retina vascularizes after birth within a couple months.
Neovascularization, the natural formation of new blood vessels in response to pathological
stimuli, is a typical characteristic of vision-threatening retinal diseases. Examples include
proliferative diabetic retinopathy (PDR) and neovascular AMD, which are the leading causes
of blindness in the Western world (Farjo and Ma 2010, Honda et al. 2013, Kompella et al.
2013). Other examples include retinopathy of prematurity (ROP), retinal vein obstruction
(RVO), pathogenic myopia, uveitis, and neovascular glaucoma (Williams and Klebe 2012,
Monika et al. 2013). In these diseases, intraretinal or choroidal neovascularization is initiated
by ischemia, a potent trigger for the local production of angiogenic factors, which induce the
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growth of new capillaries from an existing vessel (Folkman and Shing 1992, Carmeliet 2003,
Usui et al. 2015). As stated in this dissertation, Au NPs are inherently anti-angiogenic, which
makes them potential treatment agents for angiogenesis-related ocular diseases, even without
carrying an additional drug. On the other hand, it has been shown that Au NPs can also be
used to image blood vessels with optical tomography (OCT), because certain shapes, such as
Au nanorods, depending on their aspect ratio, can be excited in the near-infrared region
(Lapierre-Landry et al. 2017). Hence, it would be valuable to study how inherently antiangiogenic Au NPs could effectively eliminate new blood vessel formation. Specifically, Au
nanorods with high aspect ratios, along with Au nanospheres, could be used to image the
angiogenic progress in real-time, if they can be excited in the near-infrared region. A
fundamental study of the inhibition mechanism, using at least two sizes and shapes of Au
nanoparticles, could be conducted in a similar manner to that described in Chapter 6, such a
fundamental study would be a prerequisite to a clinical trial.

7.2.2 Controlled dose-dependent in-vivo studies
In our in vivo work, we found that the dose delivered to the retina via intravenous injections
was less than 5%, and thus a design to increase the delivered dose is needed. In chapter 5, the
transport through the retinal layers was studied; however, only one injected dose was tested.
A dose-dependent study would help to identify the critical dose for different disease models
without causing toxicity. The levels of administered and delivered doses during the
experiments in Chapter 5 suggest that the administered dose can be increased further, because
both coated and uncoated Au NPs did not induce toxicity at 0.05 mg/ml. Furthermore, it was
observed that the NPs peak in the retina at the 20th minute and then gradually decrease. By
the end of 24 hours, the amount remained was still low (8.55% of the peak concentration in
the retina), therefore a controlled release methodology could also be proposed to prevent
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repetitive invasive injections. For example, engineered nanoparticles could be designed to
maximize the delivered dose in the eye.

7.2.3 Long-term toxicity analysis of engineered gold nanoparticles as a
prerequisite to clinical trials
The safety profile of Au NPs remains largely undefined. Gold, a chemically inert material, is
generally considered biocompatible at low doses and has been used in some routine clinical
practices, such as in treating rheumatoid arthritis, for many years (Ellman et al. 1940). Also,
there is an ongoing clinical trial on using PEG-coated silica-gold nanoshells for near-infrared
facilitated thermal ablation (Anselmo and Mitragotri 2016). Several studies have reported no
significant short-term toxicity of Au NPs (1 day to 3 months) (Connor et al. 2005, Chen et al.
2013, Axiak-Bechtel et al. 2014, You et al. 2014). On the other hand, other studies have
reported that at the cellular level, Au NPs induce toxicity by causing actin stress (Pernodet et
al. 2006) and initiating apoptosis (Cho et al. 2009). At the organ level, Au NPs were shown to
cause inflammation in the liver (Sadauskas et al. 2009). To better understand the combined
cellular responses to NP exposure, systematic long-term in-vivo studies are required. In-vitro
studies and short-term in-vivo studies are necessary to provide data for a proof of concept.
Subsequently, in order to take it to the next level, clinical trials, long-term in-vivo tests are
mandatory.
Based on their anatomical and physiological similarities with humans, domestic pigs (Sus
scrofa) and various minipig breeds are considered important animal species in translational
research (Gutierrez et al. 2015). For example, the Göttingen minipig (Bode et al. 2010), the
most widely used experimental minipig breed, shares physiological similarities with humans,
in particular with regards to the cardiovascular, urinary, integumentary, and digestive
systems, as well as the size of the eye (3/4 scale compared to human eye) (Vezina 2018).
These features, along with the lower mature body weight of minipigs and their earlier sexual
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maturity compared to other nonrodent species, have led to the increasing use of minipigs as
species in preclinical safety testing. Across various marketed drug products, safety studies
with minipigs have shown good accordance between the effects seen in this non-clinical
model and clinical outcomes in patients (Ganderup 2012). Future work could focus on
developing systematic long-term (6 months and beyond) in-vivo studies using Göttingen
minipigs to ensure the safe use of Au NPs.

7.2.4 Synthesis of red-emissive carbon dots with ultrahigh quantum yield
Quantum yield, the ratio of the photons absorbed to photons emitted, is an essential parameter
in determining the usefulness of a fluorescent material. As discussed earlier, fluorescent
carbon dots with high quantum yields have emerged as a new class of phosphors for various
applications. Specifically, for bioimaging applications, synthesis of red-emissive, thermally
and photocatalytically stable, biocompatible carbon dots with high quantum yield is highly
desired. Although blue and green emissive CDs with high QYs have been obtained
(Bourlinos et al. 2008, Zhu et al. 2009, Wang et al. 2010, Bourlinos et al. 2012, Sun et al.
2012, Zhu et al. 2013, Hola et al. 2014, Sun et al. 2014, Xu et al. 2014, Yang et al. 2015), the
synthesis of red emissive CDs with high QYs still stands as a significant challenge. The
larger size of the sp2 π-conjugation domains makes them more susceptible to defect formation
and more vulnerable to environmental perturbation. According to the literature (Sun et al.
2012, Sun et al. 2016, Wang et al. 2017) and our own study, the intense absorption band of
the red-CDs could be tentatively ascribed to the n → π* transition of π systems containing C‒
N/C=N or C‒O structures. However, the obtained quantum yields are relatively lower than
the theoretical maximum, so a more in-depth study is still required to clarify this issue and
increase the quantum yield further. Parameters that may contribute to the quantum yield have
not been thoroughly evaluated, specially for creating red fluorescence emission. Additionally,
concerns have been raised regarding the validity of the quantum yield measurements for red
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fluorescence, especially in such a minuscule size range (3-5 nm), where the dots
photoresponse may be very unstable.
Reduction with NaBH4 has been introduced as one strategy to increase the QY of CDs
(Zheng et al. 2011, Zhang et al. 2015). Reducing the carbon dots led to a decrease in the
number of carbonyl groups but increased hydroxyl related defects, and hydroxy carbon has
been shown to increase the quantum yield of CDs in other studies (Liu et al. 2017, Liu et al.
2018). Zn conjugation can also potentially increase the fluorescence intensity of carbon dots,
but the excitation wavelength is shifted towards the blue region (Miao et al. 2017). Taken
together, a method to promote hydroxy carbon and, as we identified in this thesis, to increase
the pyrrolic nitrogen amount on the surface of the CDs could create highly efficient redemissive carbon dots.
Future work could focus on the design and evaluation of methods for creating red-emissive
carbon dots with high quantum yield. Zn involvement, the use of different nitrogen sources to
promote C‒N bonding and hydroxy carbon formation on the surface of CDs, and the use of
reducing methods could all be further investigated. Some preliminary work on evaluating
quantum yield measurements of red emissive carbon dots is discussed in Appendix V.
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(A) Materials and Methods
Table S1. Summary of experiments performed
Section

Description

Details of the
measurement
performed

Instruments/methodology
used

1

Synthesis of NPs

Au NPs

Seed-mediated approach

Morphological study
and Optical absorption
of Au NPs

TEM and UV-Vis

2

3

4

Characterization of Au
NPs and exposure to
ARPE-19 cell line

Toxicity assessment of
the ARPE-19 cell line

Investigation for the
internalization of NPs

Hydrodynamic
diameter
measurements
Surface chemistry,
zeta potential
measurements

Comparative toxicity study of different shape
and size of the Au NP
Confirmation of the shape and physical
dimension of NPs by TEM and supporting
information on morphology using UV-Vis
measurements was collected

DLS

Confirmation of the size of NPs in DI water and
DMEM and 31.6 μM HCl.

DLS

Determination of the ionic strength effects on
dispersion characteristics

Plating the cells and
NP exposure study

Determination of the
concentration in the media
using ICP-MS
Microbial growth on basal
nutrient medium

MTT assay

Colorimetric cell viability
measurement

ECIS measurements

Cell attachment measurement

Confocal Microscopy

Confocal Microscopy,
nanoplasmonic imaging
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Objective

Determination of the exposure concentration of
the NPs for ARPE 19
Test the sterile (free from microbial
contamination) nature of the synthesized NPs
Studying the viability of the cells after different
NP exposure concentrations
Studying the role of size of the Au nanoparticles
Detecting the effect of shape of the Au
nanoparticles
Confirmation of the presence of NPs inside
ARPE-19 cells
Monitoring the cell attachment behavior as the
cells are exposed to Au NPs
To confirm the internalization of the Au NPs

1. Synthesis of Au Nanoparticles
Gold (Au) nanoparticles were synthesized using seed-mediated approach. Details of the synthesis
method for each nanoparticle are given below.
Au nanospheres were synthesized in two steps by seed-mediated approach (Wu et al. 2010) using
cetyl trimethyl ammonium chloride (CTAC) as a surfactant. In the first step, seed solution was
prepared by vigorous mixing (500 rpm for 1h at 30°C) of 10 mL of HAuCl4 (2.5 × 10-4M)
aqueous CTAC (0.1 M) solution with 0.45 mL of ice cold NaBH4 (0.02 M). The seed solution
was aged for 60 minutes (at 30°C) to decompose the excess of NaBH4. In the second step, the
growth solution was prepared by adding 514 µL of HAuCl4 (4.86 mM), 10 µL of NaBr (0.01 M)
and 90 µL of ascorbic acid (0.04M) to 5 mL of aqueous CTAC (0.1 M) solution. To this
colorless solution, 25 μL of seed solution was added under vigorous agitation and left
undisturbed overnight at room temperature. The size of the sphere was controlled by varying the
molar ratio of ascorbic acid to seed solution.
Gold nanocubes were synthesized in three steps. In the first step, the seed solution was prepared
similarly to the gold nanospheres. Two growth solutions were prepared by adding of 5 ml of
aqueous CTAC (0.1 M), 514 µL of HAuCl4 (4.86 mM), 10 µL of NaBr (0.01 M), 4625 μL of
ultrapure water and 90 µL of ascorbic acid (0.04M). The total solution volume of each growth
solution was 10 mL. The 25 μL of prepared seed solution was added to the first growth solution
with immediate vortex for a few seconds from this 25 μL of solution was added to the second
growth solution and kept overnight at room temperature without disturbing.
Gold nanorods were synthesized using a seed-mediated approach (Jana et al. 2001) in which seed
solution was prepared by adding 0.6 mL of an ice-cold solution of 10 mM sodium borohydride
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into 10 mL of magnetically stirred 0.1M CTAB and 2.5×10−4 M HAuCl4 aqueous solution at
room temperature. The color of the seed solution changed from yellow to brown as an indicator
of Au nanoparticle formation. Simultaneously, growth solution was prepared by mixing 10 mL
of 0.1M CTAB, 0.8 mL of 10 mM AgNO3, 5 mL of 10 mM HAuCl4, and 0.11 mL of 0.1M
ascorbic acid in the same order. The solution was homogenized by gentle stirring. To the
resulting colorless solution 0.024 mL of freshly prepared seed solution was added, and the
mixture was set aside in dark for 14 h at room temperature.
2. Characterization of nanoparticles and exposure to ARPE-19 cell line
2.1.Morphological study by transmission electron microscopy (TEM) and UV-Vis
analysis
TEM micrographs were obtained using an FEI Spirit TEM (Hillsboro, OR, USA) operated at 120
kV. A 400-mesh Formvar® carbon-coated copper grid was glow-discharged in a vacuum
evaporator (Denton, Moorestown, NJ, USA) for 30 seconds to make the grid hydrophilic and,
thus, attractive to particles. The sample was prepared by placing 2 μL of sonicated colloidal NP
solution onto the grid and wicking off the excess sample with filter paper after 30 seconds. To
further confirm the size, UV-Vis measurements were performed. Cary 50 Bio UV-Vis
spectrophotometer (Varian, Palo Alto, CA) was used for recording of absorption spectra of NPs.
2.2.Hydrodynamic diameter, agglomeration, and sedimentation profile
Malvern Zetasizer Nano ZS (Malvern Instruments, Westborough MA, and USA) equipped with a
backscattering detector (173º) was used for hydrodynamic size measurements of the synthesized
nanoparticles. Samples were dispersed in water, followed by sonication for 15 minutes to
homogeneously disperse them in the solution; they were then filtered through a pre-rinsed 0.2
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μm filter followed by equilibration (typically 5 minutes) at 25 °C. A minimum of three
measurements per sample was taken. The NP sedimentation rate was visually quantified up to
72 hours in both dispersant solvents, i.e., water and cell culture media.
2.3.Surface chemistry: zeta potential measurements
A Malvern Zetasizer Nano ZS was used to measure the zeta potential at 25 °C for all samples.
Samples were loaded into a pre-rinsed folded capillary cell for the zeta potential measurements.
An applied voltage of 100 V was used for the NP colloids, and a minimum of three
measurements was performed per sample. The surface zeta potential of NPs dispersed in
deionized (DI) water as well as in the cell culture medium, i.e., Dulbecco’s modified Eagle’s
medium (DMEM), and in 8.3mM Hydrochloric acid solution was measured. Zeta potential of
the cell culture media (C-DMEM/F12) was measured as − 8.09 mV. Thus, it was confirmed that
changing the solvent (from DI water to C-DMEM/F12) plays a critical role in zeta potential of
the NPs.
2.4.Validation of NP concentration
Quantitative determination of Au (Gold) concentrations in stock solutions were performed by an
inductively coupled plasma-mass spectrophotometer, also referred to as an ICPMS (Elan DRC II, PerkinElmer, Norwalk, CT). Synthesized NPs were dispersed in water as a
stock solution for the preparation of ICP-MS analysis. Then, 100 μL of stock solution was
digested in triplicates using an equal volume of aquaregia (3 mL of HCl: 1 mL of HNO3).
Aqueous dilutions of the stock suspension were subjected to analysis using direct nebulization
into the ICP-MS and were quantified against external calibration curves.
3. Toxicity assessment of the ARPE-19 cell line
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3.1.Establishment of ARPE-19 cell line
ARPE-19 cells were maintained at 37 °C in a humidiﬁed atmosphere of 5% CO2. Cells were
grown in 75 mm flasks and maintained with DMEM, composed of a nutrient mixture F12 (1:1)
supplemented with 10% FBS, 2 mL-1 glutamine, 100 UmL-1 penicillin, and 100 UmL-1
streptomycins. Cell media were changed every 3 days. Cultures were passaged by dissociation
in 0.25% (w/v) trypsin-EDTA in Hanks’ balanced salt solution (HBSS). Cells were seeded in
100 mm x 20 mm plates. All the cells in the same passages were grown to 70–90% conﬂuence
before seeding on a 96-well plate for assay.
3.2.Cell attachment study: ECIS measurements
In this technique, cells were plated in wells containing gold electrodes connected to an ECIS
system. As the cell morphology and attachment to the electrodes present in the bottom of the
well changed, the resistance across the electrodes also changed. The change in resistance at
different frequencies from 400 to 64,000 Hz can be measured over time. At high frequencies,
current couples through the insulating cell membrane with minimal current passing through the
solution channel under and between adjacent cells. The impedance (capacitive reactance) of the
membrane is relatively small and, hence, can be used to monitor the establishment of a confluent
cell layer. On the other hand, at low frequencies, current predominantly flows through the
solution channel under and between adjacent cells, and the membrane impedance is high. As a
result, low-frequency impedance can be used to monitor the solution paths around the cells and,
hence, the layer’s cell to cell barrier functions (Arndt et al. 2004). The addition of Au NPs
further complicates the impedance of the system. However, at a frequency of 4000 Hz, the
contribution of resistance from cells was dominant over the contribution of resistance from Au
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NPs with media (Kandasamy et al. 2010). Hence, a frequency of 4000 Hz was chosen to monitor
cell growth and biocompatibility. The time required for retinal cells (bot primary RPE and
ARPE-19 cells) was determined via impedance measurements. As can be seen in Figure S1., by
the end of the first day, the ARPE-19 cells did reach confluency; however, pRPE cells required
more time to become confluent.

Figure S1. ARPE-19 and primary retinal (pRPE) cells attachment behavior for more than six
weeks were monitored real time via ECIS measurements. By the end of the 24th hour, the
ARPE-19 cells reached confluency; however pRPE required more than 26 hours to transition
from logarithmic growth phase to stationary phase (become confluent).
4. Investigation for the internalization of NPs
4.1.Nucleus staining and sample preparation for confocal imaging
ARPE-19 cells were fixed by immersion in a 4% paraformaldehyde (PFA), as the cross-linking
solution, for 10 minutes at room temperature. The cells were then washed three times by
immersion in ice-cold 1X PBS (phosphate buffer saline) for five minutes each time. The fixed
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cells were incubated in ice-cold 1X PBS buffer containing 0.1% Triton (permeabilization agent)
for 10 minutes at room temperature. After that, the cells were washed three times again with icecold 1x PBS for five minutes each. The cell slides were then incubated with blocking buffer for
30 minutes before addition of slow fade. The cells were subsequently washed three times with
ice-cold 1X PBS for five minutes each. For the staining of the nucleus, SlowFade® Gold
Antifade Mountant with DAPI (diluted 1:100 in 1X PBS) was used, and the cells were incubated
with the above cell slides overnight at 4 0C. Then the cells were again washed three times with
ice-cold 1X PBS for five minutes each. Finally, the cell slides were transferred to a confocal
microscope for optical analyzes. The used laser wavelengths were 488 and 533 nm for DAPI
(nucleus staining) and for Au NP detection respectively.
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(B) Results
1. UV-Vis characterization of synthesized ENP
Nanoparticles were also characterized by UV-Vis absorption spectroscopy. The distinct band
maxima for Au spheres (5, 10, 20, and 30 nm) were measured at 510-540 nm. For Au cube (50
nm) and Au spheres (50 and 100 nm), peaks were detected at 556, 536, and 573 nm, respectively.
Au nanorods showed two absorption peaks at 517 and 761 nm due to their morphological aspect
ratio.
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Figure S2. UV-Vis absorption spectra of synthesized Au NPs
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Table S2. Influence of exposure media on physicochemical properties of NPs

pH

NP type

Zeta Potential (mV)

Hydrodynamic Diameter (nm)

Sedimentation %
(after 72 hours)*

DI water

DMEM

DI water

DMEM

DI water

DMEM

DI Water

DMEM

Au S 5

3.2

7.5

37.5 (±0.38)

0.12 (±0.46)

4.83 (±1.52)#

8.27 (±2.66)

NO

NO*

Au S 10

3.3

7.6

33.5 (±0.14)

0.18 (±0.28)

8.89 (±2.80)

17.81 (±5.77)

NO

NO*

Au S 20

3.2

7.8

24.8 (±0.08)

1.72 (±0.52)

14.57 (±4.54)

29.11 (±9.16)

NO

NO

Au S30

3.2

7.6

21.4 (±0.50)

1.58 (±0.46)

29.39 (±7.55)

42.62 (±13.34)

NO

NO

Au S 50

3.4

7.6

42.1(±1.72)

-11.9 (±1.27) 45.57 (±14.27)

66.83 (±22.37)

NO

<33

Au S 100

3.3

7.8

28.1(±1.60)

98.25 (±31.38)

120.15 (±39.85)

NO

<33

Au cube

7.6

7.7

40.6 (±0.72)

-6.33 (±0.16) 50.25 (±16.74)

60.12 (±21.26)

~33

~33

Au rods

3.8

7.7

36.9 (±0.21)

-7.40 (±0.09) 120.25 (±44.99) 130.45 (±51.85)

~33

~33

DMEM

7.7

7.7

-8.09 (±0.06) -8.09 (±0.06)

NO

NO

-12 (±0.58)

#

NM

NM

Standard deviation
*values presented in %, based on visual appearance; NO: Not observed; NM: Not measured
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Figure S3. 3D Confocal microscopic images of nanoparticles inside cells after 72 h of exposure. All figures are from the same stack
of cells, in which nuclei are present. Included are (a) cells without nanoparticle exposure, (b) ARPE-19 cells exposed to 5-nm Au
spheres (LD50: 0.030 mg/ml) with green dots representing Au NPs inside cells in the vicinity of the nucleus and voids (exact areas are
shown with white arrows) representing loss of cytoplasm on the observed layer. (c) Void like structures can be seen at ARPE-19 cells
exposed to 5-nm Au spheres (LD50: 0.030 mg/ml) (d) ARPE-19 cells exposed to 10-nm Au spheres (LD50: 0.057 mg/ml, with
particles inside cells and nuclei. (e) ARPE-19 cells exposed to 20 nm Au spheres at a critical concentration of LD50: 0.113 mg/ml; the
presence of particles inside cells and nuclei is confirmed. (f) ARPE-19 cells exposed to 0.129 mg/ml of 30-nm Au spheres. (g)
LD50:0.050 mg/ml of 10×90 nm Au nanorods inside cells and nuclei. (h) 0.129 mg/ml of 50- nm Au spheres. (i) 0.129 mg/ml of 100nm Au spheres. Internalization of 50- and 100-nm Au spheres may be hindered by their large size. The available surface area, the key
metric for biocompatibility, is much less for 50- and 100-nm Au spheres compared than for ARPE-19 cells exposed to smaller Au
nanospheres. (j) 0.129 mg/ml of Au nanocubes.
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Figure S4. Inductively coupled plasma mass spectrometer (ICP-MS) measurement results for
the aliquots collected after the washing procedure prior to Confocal microscopy imaging.
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1H

NMR, FTIR, and GPC analysis of end-thiol modified HA (HS-HA). The HS-HA was

characterized using 1H NMR spectroscopy. 1H NMR spectrum was obtained on a Varian
Unity Inova 500 (Palo Alto, CA). HS-HA samples were dissolved in D2O (8 mg/mL) with
NaOD (20 mol). Each sample was scanned for 128 times at 25 oC. The infrared spectra of
HS-HA was obtained using a fourier transsform spectroscopy (Spectrum GX, PerkinElmer,
USA). The infrared spectra of the samples were measured over a wavelength range of 4000 500 cm−1. Transmission spectra was taken in the spectral range by the accumulation of at
least 64 scans with a resolution of 4 cm−1. The GPC system used a VE 1122 pump with a VE
7510 degasser (Viscotek/Malvern, Houston, TX) equipped with a TDA302 triple detector
system that measured the refractive index (RI), multi-angle laser light scattering, and
viscosity. The column used was a G5000PWXL (Tosoh Biosep, Montgomeryville, PA).
Viscotek Omnisec software was used to calculate the RI area, weight-averaged molecular
weight, intrinsic viscosity, and hydrodynamic radius. Samples (100 μL) were injected at a
concentration of 2 mg/mL. The column buffer (pH 7.6) contained 20 mM of sodium
phosphate and 100 mM of NaCl. The flow rate was 0.8 mL/min. Measurements were
conducted at 37 °C.
Particle size measurements. The morphologies and the size of the synthesized uncoated Au
NPs were examined by high-resolution transmission electron microscopy (HR-TEM, Tecnai
TM Spirit, FEI Co.), operated at 200 kV accelerating voltage. A 400 mesh TEM grid (CF400Cu-UL, Electron Microscopy Sciences, PA) was used. A Malvern Zetasizer Nano ZS
(Malvern Instruments, Westborough MA) equipped with a backscattering detector (173º) was
used for hydrodynamic size measurements of synthesized nanoparticles. Samples were
dispersed in water, then sonicated for 15 min to homogeneously disperse them in the solution,
after which they were filtered through a prerinsed 0.22 μm sterile filter, then equilibrated
(typically for 5 min) at 25 °C. At least three measurements per sample were taken. The
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hydrodynamic diameter and zeta potential of NPs in solution before and after their exposure
to cell culture medium was measured in batch mode using DLS.
Ellman’s reaction. The amount of thiol content of end-thiolated hyaluronate (HS-HA) was
also determined spectrophotometrically, using an Ellman’s reagent as described by Ellman
(Ellman 1959). Briefly, 10 mg of lyophilized sample was diluted with 2 mL of N2-bubbled
water. To 100 mL of this sample, 500 mL of 0.1 M phosphate buffer (pH 8), 400 mL of water,
and 50 mL of Ellman’s reagent were added. Samples were incubated for 15 min at room
temperature in dark and their absorbance measured at λ = 412 nm in a Varian Cary 5000
spectrophotometer. Thiol content was calculated as per the equation:
SH (moles) / HA (g) = (Ab/13,600) × (Vtotal / Vsample) × (1/HAconc)

(1)

where Ab is the absorbance and Vtotal is the total volume, whereas Vsample is the sample
volume and 13,600 is the extinction coefficient. The concentration of the HA (HA conc) is in
mg/mL.
Total organic carbon (TOC) measurements. We used a Shimadzu TOC-VWP to determine
the carbon content of HS-HA-Au NPs in the solid phase. Lyophilized samples were weighed
before pretreatment with acid to remove and measure all inorganic carbon. During the TOC
analysis, the sample underwent combustion heating to 680 oC. During decomposition, the
CO2 generation was recorded. The inorganic carbon (IC) was measured by acid digestion of
the sample, followed by nitrogen sparging (CO2 isolation). Subtracting the inorganic carbon
from the total carbon yield the total organic carbon, corresponding to the HA content of the
sample.
Thermal gravimetric analysis (TGA). A TA Q5000 thermal gravimetric analyzer was used.
Any change in sample mass, a function of increasing temperature and time, was measured.
HA is known to decompose at 220-280 oC (Jiang et al. 2015, Ahire et al. 2016). On the other
hand, Au NPs under 150 nm in diameter possess lower melting temperature (above 426-976
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o

C) compared to bulk gold (1027 oC) (Buffat and Borel 1976). Taking bound water content

into account from the TGA curves, the explicit Au content was determined by calculating the
difference between the total mass of the sample and the HA content.
In-vitro cytotoxicity measurements on ARPE-19 MTT, ApoTox-GloTM, and ROS-Glo™
H2O2 assays. For all three assays, the cells were distributed in a flat-bottom 96-well plate
with a 150 μL volume (1.5 × 106 cells per 20 ml). After plating, cells were incubated for 48 h
(37 °C, 5% CO2), then exposed to different concentrations of NPs. Physically characterized
particles were dispersed in DMEM to be used for cell exposure. For each size of Au NPs,
concentrations of the exposed solutions were 0.01, 0.05, 0.1, and 0.5 mg/ml. The upper limit
of exposure concentration was determined by the toxic potential of the NPs as reported in the
literature (Karakocak et al. 2016). NP exposure was maintained for 24 h before assay
measurements. In all biological and imaging tests, the cells without NP exposure served as a
negative control
For the MTT assay, following the exposure of NPs, 100 µL of MTT (1 mg/l in growth media)
were added to each well, and the plate was incubated for an additional 5 h at 37 °C in 5%
CO2. The resulting blue component, produced by the reduction of tetrazolium salt of MTT by
mitochondrial dehydrogenase enzyme, was dissolved in 100 µL dimethyl sulfoxide (DMSO).
The optical density of the colored product was read photometrically using a
spectrophotometer at 540 nm with a microplate reader (Molecular Devices Spectra Max 190).
The absorbance of untreated cells was used as a negative control. The percentage viability of
the cells was calculated from the ratio of the mean optical density of the sample to the optical
density of the negative control.
For all three assays, the cells were distributed in a flat-bottom 96-well plate with a 150 μL
volume (1.5 × 106 cells per 20 ml). After plating, cells were incubated for 48 h (37 °C, 5%
CO2), then exposed to different concentrations of NPs. Physically characterized particles
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were dispersed in DMEM to be used for cell exposure. For each size of Au NPs,
concentrations of the exposed solutions were 0.01, 0.05, 0.1, and 0.5 mg/ml. The upper limit
of exposure concentration was determined by the toxic potential of the NPs as reported in the
literature.44, 45 NP exposure was maintained for 24 h before assay measurements.
For the MTT assay, following the exposure of NPs, 100 µL of MTT (1 mg/l in growth media)
were added to each well, and the plate was incubated for an additional 5 h at 37 °C in 5%
CO2. The resulting blue component, produced by the reduction of tetrazolium salt of MTT by
mitochondrial dehydrogenase enzyme, was dissolved in 100 µL dimethyl sulfoxide (DMSO).
The optical density of the colored product was read photometrically using a
spectrophotometer at 540 nm with a microplate reader (Molecular Devices Spectra Max 190).
The absorbance of untreated cells was used as a negative control. The percentage viability of
the cells was calculated from the ratio of the mean optical density of the sample to the optical
density of the negative control.
The cells were cultured and treated with NPs in 96-well, clear-bottomed white plates for the
apoptosis and ROS detection experiments. Caspase 3/7 activity, the key indicator for
apoptosis, was evaluated using the ApoTox-Glo™ Triplex assay according to the
manufacturer’s protocol. The light output, measured with a luminometer, correlates with
Caspase-3/7 activation, and luminescence was measured using a microplate reader
(Molecular Devices Spectra Max 190).
ROS generation was evaluated with the ROS-Glo™ H2O2 assay according to the
manufacturer’s protocol. The light signal produced by recombinant Luciferase is proportional
to the level of H2O2 in the cells. The luminescence was measured using a microplate reader
(Molecular Devices Spectra Max 190).
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Confocal Microscopy. ARPE-19, NIH 3T3, and CHO cells were seeded in CELLviewTM
plates at 5 × 104 cells/well for 24 h. After 24 h of NP exposure, the cells were fixed and
washed with PBS three times before imaging. All cells were fixed by immersion in 4%
paraformaldehyde (PFA) as the cross-linking solution for 10 min at room temperature. The
cells were then washed three times with ice-cold 1x PBS for 3 min each time. The fixed cells
were incubated in ice-cold 1x PBS buffer containing 0.1% Triton (permeabilization agent) for
10 min at room temperature, then washed three times with ice-cold 1x PBS for 5 min each
time. The CELLviewTM plates were then incubated with blocking buffer for 30 min before the
addition of Alexa Fluor® 633 phalloidin (diluted 1:200 in blocking buffer). The cells were
subsequently washed three times with ice-cold 1x PBS for 3 min each time. To stain the
nuclei, SlowFade® Gold Antifade Mountant with DAPI (diluted 1:100 in 1x PBS) was used.
The cells were incubated overnight at 4 oC.
During confocal microscopy analysis, the laser wavelengths were 405, 525, and 633 nm for
DAPI (nucleus staining), for Au NP detection, and for actin visualization, respectively.
Several different images (based on the thickness of the cell, the number of images with the
same Z-stack thickness vary) were taken through different optical sections by collecting Zstacks with a thickness of 35 nm. A negative control sample (untreated cells) was prepared
with cells in the absence of nanoparticles.
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C-O-C

-COOH

CH stretching

- OH group

Stretching vibration of C-H group

Fig. S1. NMR spectrum of end-thiolated hyaluronate. Typical hyaluronate peaks are
presented in the spectrum. Extremely low level of the chain-end thiols caused its signals to be
buried among other peaks or noise.

Fig. S2. FTIR transmittance spectrum of end-thiolated hyaluronate. For hyaluronic acid, -OH
group is found at 3200-3700 cm-1. Stretching vibration of C-H and CH stretching can be seen
at 2915 cm-1 and 2845 cm-1, respectively. Carboxylic groups and C-O-C bonds can be
detected at 1660 cm-1 and 1045 cm-1, respectively. Typical the -SH signal (2560 cm-1) is
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buried in the noise due to the low amount of SH in the HA sample as quantified with
Ellman’s assay ([-SH]/[HA repeating units] = 0.025).

Fig. S3. HR-TEM images of different sizes of uncoated gold nanoparticles. Facets are
detected with the thicknesses of 0.21 nm and 0.23 nm.
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Table S1. The amount of HA molecules per unit Au surface area was calculated based on TGA and TOC analysis, respectively.
TGA

Au dp
(nm)

Amount
of HA
(g)

Amount of
Au
(g)

Total mass
of the
sample (g)

Mass of one
Au NP (g)

# of Au NPs
in the sample

Mass of one HA
# of HA
molecule (mg), MW: molecules in the
19.69 kDa
sample

Total surface area
of Au NPs in the
sample

# of HA molecules
per unit surface
area (nm2)

5

2.15E-02

6.32E-02

8.47E-02

1.08919E-18

5.80E+16

3.26E-20

6.59E+17

4.13E+18

0.16

10

7.27E-03

6.29E-02

7.02E-02

6.85845E-18

9.17E+15

3.26E-20

2.23E+17

2.22E+18

0.10

20

3.17E-03

1.10E-01

1.13E-01

9.21237E-17

1.20E+15

3.26E-20

9.74E+16

1.64E+18

0.06

50

1.71E-03

2.57E-01

2.58E-01

100

2.30E-04

7.80E-02

7.82E-02

1.49173E-15

1.72E+14

3.26E-20

5.25E+16

1.51E+18

0.03

1.34871E-14

5.78E+12

3.26E-20

7.06E+15

2.20E+17

0.03

Au dp
(nm)

Amont of
HA
(g)

Amount of
Au
(g)

Total mass
of the
sample (g)

Mass of one
Au NP (g)

# of Au NPs
in the sample

Total surface area
of Au NPs in the
sample

# of HA molecules
per unit surface
area (nm2)

5

1.82E-02

4.880E-02

6.700E-02

1.08919E-18

4.48E+16

3.26E-20

5.58E+17

3.19E+18

0.18

10

8.95E-03

8.605E-02

9.500E-02

6.85845E-18

1.25E+16

3.26E-20

2.75E+17

3.04E+18

0.09

20

2.05E-03

7.695E-02

7.900E-02

9.21237E-17

8.35E+14

3.26E-20

6.29E+16

1.15E+18

0.05

50

5.02E-04

7.850E-02

7.900E-02

1.49173E-15

5.26E+13

3.26E-20

1.54E+16

4.62E+17

0.03

100

1.72E-04

6.283E-02

6.300E-02

1.34871E-14

4.66E+12

3.26E-20

5.28E+15

1.77E+17

0.03

TOC
Mass of one HA
# of HA
molecule (mg), MW: molecules in the
19.69 kDa
sample
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B

A

D

C

E

Fig. S4. Particle size distributions for nascent and coated Au NPs obtained with DLS
measurements. (A) 5nm, (B) 10 nm, (C) 20 nm, (D) 50 nm, (E) 100 nm.
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Fig. S5. Physical characterization of nascent and coated Au NPs by DLS measurements in DI
water (A) particle size (B) zeta potential measurement results. The same particles exposed to
DMEM (C) particle size (D) zeta potential measurement results. When the HA-HA-Au NPs
are exposed to DMEM, the increase in particle size is much less compared to the nascent Au
NPs, due to HS-HA coating, which prevents protein adsorption on the NP surface.
Nascent 5 nm,

Coated 5 nm,

Nascent 10 nm,

Nascent 20 nm,

Coated 20 nm,

Nascent 50 nm,

Nascent 100 nm,

Coated 100 nm.
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Coated 10 nm,
Coated 50 nm,

A

Control

B

Nascent 5 nm

C

Coated 5 nm

D

Nascent 10 nm

E

Coated 10 nm

F

Nascent 20 nm

G

Coated 20 nm

Nascent 50 nm

191

Coated 50 nm

H

J

Nascent 50 nm

Nascent 100 nm

L

Coated 50 nm

I

K

Coated 100 nm

Pretreated with 10x
HS-HA, and then
exposed to 50 nm
HS-HA Au NPs

Fig. S6. The red staining corresponds to actin, the nucleus is blue, and Au NPs are green. 2D
confocal images for uncoated and HS-HA-coated Au NPs. (A) ARPE-19 cells without Au NP
addition, the control. The cells were exposed to (B) 5-nm nascent Au NPs, (C) HA-coated Au
NPs, (D) 10-nm nascent Au NPs, (E) HA-coated Au NPs, (F) 20-nm nascent Au NPs, and (G)
HA-coated Au NPs. The last six images indicate that the coating slightly affects the
internalized number of Au NPs. (H) 50-nm nascent Au NPs, (I) HA coated Au NPs, (J) 100nm nascent Au NPs, and (K) HA coated Au NPs. All the exposure experiments were
conducted at the lethal dose (LD50) of the nanoparticle of interest. The difference in the
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number of internalized NPs (indicated with arrows) increased significantly with the presence
of HA coating for the larger particles. Also, when the cells are exposed to coated NPs, the
actin density is not hindered, unlike the cells which are exposed to nascent NPs. (L) ARPE-19
cells were treated with 10x HS-HA prior to the addition of 0.5 mg/ml HS-HA coated 50-nm
Au NPs. The internalization of HS-HA-Au NPs was significantly more than for the cells
which were not pretreated with HA. This finding confirms the role of CD44 receptors on
receptor-mediated endocytosis of HA-Au NPs in retinal cells.
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Fig. S7. The red staining corresponds to actin, the nucleus is blue, and Au NPs are green. (A)
ARPE-19 cells without Au NP addition, the control. The ARPE-19 cells were exposed to (B)
5-nm nascent Au NPs, (C) 5-nm HS-HA Au NPs, (D) 10-nm nascent Au NPs, (E) 10-nm HSHA Au NPs, (F) 20-nm nascent Au NPs, (G) 20-nm HS-HA Au NPs, (H) Cells exposed to 50nm nascent Au NPs, (I) ARPE-19 cells with HS-HA Au NPs, where the size increased to
95.07±25.98, as shown by DLS results, (J) Cells exposed to 100-nm nascent Au NPs, (K)
ARPE-19 cells with HS-HA-coated Au NPs, where the size increased to 127.5±42.21, as
shown by DLS. Although the nascent and relatively smaller nanoparticles did not enter the
cells, when coated with SH-HA, the NPs presence in the cells was drastically increased. Also,
when the cells are exposed to coated NPs, the actin density is not hindered, unlike the cells
which are exposed to nascent NPs. (L) ARPE-19 cells treated with 10x SH-HA prior to the
addition of 0.5 mg/ml HS-HA Au NPs. The internalization of HA-Au NPs was significantly
less than for cells which were not pretreated with HA. This finding confirms the role of CD44
receptors on receptor-mediated endocytosis of HS-HA Au NPs. Scale bars are 20µm.
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Fig. S8. The red staining corresponds to actin, the nucleus is blue, and Au NPs are green. (A)
3T3cells without Au NP addition, the control, (B) 3T3 cells exposed to HA-Au NPs (dp=50
nm), (C) 3T3 cells treated with 10x end-thiolated HA prior to the exposure to 0.5 mg/ml HA
coated 50-nm Au NPs. The internalization of 50-nm Au NPs was not affected by the presence
of HA coating because 3T3 cells are known to have a fewer number of CD44 receptors which
is the analog for the CD44 receptor. Scale bars are 20µm.
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Fig. S9. The CHO cells were not stained for actin. The nucleus is blue and Au NPs are green.
CHO cells (A) without Au NP addition, the control. (B) cells exposed to nascent Au NPs
(dp=50 nm). (C) cells exposed to 50- nm HS-HA-Au NPs. (D) cells treated with 10x endthiolated HA prior to exposure to 50- nm HS-HA coated Au NPs. The internalization of 50nm Au NPs was affected drastically by the presence of HA coating because CHO cells are
known have CD44 receptors, and since they are cancer cells, the number of receptors
expressed is higher than normal cells. Scale bars are 20µm.
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Table S1. Experimental conditions (factors) of each nCDs synthesis using CCD-RSM design

Runs

CA wt%

NH2/COOH

1

10.0

0.75

88

2

11.2

0.48

80

3

10.0

0.75

100

4

10.0

0.75

88

5

8.8

1.02

95

6

12.0

0.75

88

7

8.8

0.48

80

8

10.0

0.75

75

9

10.0

0.75

88

10

11.2

1.02

95

11

10.0

0.75

88

12

8.0

0.75

88

13

8.8

0.48

95

14

8.8

1.02

80

15

10.0

0.75

88

16

10.0

1.20

88

17

10.0

0.30

88

18

10.0

0.75

88

19

11.2

0.48

95

20

11.2

1.02

80
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Reaction Time (s)

Table S2. The effect of molar ratio of reactants to pyrrolic N content and MW of nCDs.
Molar ratio of XPS results (intensity, au) Maldi-TOFF results
EA/CA
Pyrrole content
m/z
0.5

413.0

799.6

1.0

778.0

1215.0

2.0

1663.0

1512.0

Table S3. Quantum yield measurements of nCDs.
NH2/COOH

Quantum Yield, Φ (%)

0.25

7.0

0.50

15.0

1.00

10.7

1.50

13.9

2.00

10.3

1.1. Statistical Analysis.
For PL results at the short wavelength, the analysis of variance suggested that the quadratic
regression model was most appropriate among all polynomial regression models. First, the
sequential model sum of squares indicated that the quadratic regression was the highest order,
with the sequentially added terms being significant, and the model was not aliased (F-value =
14.06 and P-value = 0.001, when comparing the quadratic regression to the 2FI regression).
Second, the lack of fit F-value = 0.62, and the P-value = 0.67, which jointly imply that the
quadratic model fits well, while lower order models all indicated a significant lack of fit.
Thus, quadratic regression was used in this analysis, as below:
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PL (Ex 350 nm, Em 460 nm) = -2.21 × 106 + 4.38 × 105 × (amine/acid) + 4.89 × 104 ×
Time ‒ 815 × (amine/acid) × Time ‒ 2.27 × 105 × (amine/acid2) ‒ 277 × Time2

(Eq. S1)

This quadratic model is graphically represented in Fig. 1 by a three-dimensional response
surface. The model is statistically significant, with a model F-value = 13.23 and P-value =
0.0001. The coefficient of determination R2 = 0.84, and the adjusted R2 = 0.77, indicating a
good fit; further, the predicted R2 = 0.63 is in reasonable agreement with the adjusted R2,
suggesting the quadratic regression model also has high predictive ability for new
observations.
The normal probability plot in Fig. 1A shows points close to the diagonal, which means a
normal pattern was observed for the regression residuals. The residual plot shows no outlier
or special pattern for the data. Thus, there were no problems detected from the model
diagnostics.
As predicted by the model, CDs with the highest intensity of PL at λex∕em = 350 nm/460 nm
were produced with an amine/acid ratio of 0.75 and a reaction time 88.0 seconds.
The sequential model sum of squares indicates that the linear regression is the suggested
highest order, with the sequentially added terms being significant, and again the model is not
aliased (F-value = 63.07 and P-value < 0.0001 when comparing the linear regression to the
mean regression). Second, the lack of fit F-value = 1.42 and the P-value = 0.37, which jointly
imply no significant lack of fit relative to the pure error. Thus, the linear regression was used
in this analysis. The linear equation is listed below:
PL (Ex 540 nm, Em 600 nm) = -822 + 1.48 × 103 × (amine/acid) + 9.42 × Time ‒ 12.3 ×
(amine/acid) × Time

(Eq. S2)
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This linear model is graphically presented in Fig. 1B by a three-dimensional response
surface. The model is statistically significant, and again the model F-value = 93.45 and Pvalue < 0.0001. The coefficient of determination R2 = 0.95, and the adjusted R2 = 0.94,
indicating a good fit; the predicted R2 = 0.91 is in reasonable agreement with the adjusted R2,
suggesting the linear model also has high predictive ability for new observations. The normal
probability plot in Fig. 1B shows points close to the diagonal, which means a normal pattern
was observed for the regression residuals. The residual plot shows no outlier or special
pattern for the data. Thus, there were no problems detected from the model diagnostics.
In vitro Cytotoxicity Measurements on Retinal Pigment Epithelial (ARPE-19), Lens
Epithelial, and Chinese Hamster Ovary (CHO) cells with MTT, ApoTox-GloTM, and
ROS-Glo™ H2O2 assays.
For all three assays, the cells were distributed in a flat-bottom 96-well plate with a 150 μL
volume (1.5 × 106 cells per 20 ml). After plating, cells were incubated for 48 h (37 °C, 5%
CO2), then exposed to different concentrations of nCDs. nCDs exposure was maintained for
24 h before assay measurements. In all biological and imaging tests, the cells without NP
exposure served as a negative control
For the MTT assay, following the exposure of nCDs, 100 µL of MTT (1 mg/l in growth
media) were added to each well, and the plate was incubated for an additional 5 h at 37 °C in
5% CO2. The resulting blue component, produced by the reduction of tetrazolium salt of
MTT by mitochondrial dehydrogenase enzyme, was dissolved in 100 µL dimethyl sulfoxide
(DMSO). The optical density of the colored product was read photometrically using a
spectrophotometer at 540 nm with a microplate reader (Molecular Devices Spectra Max 190).
The absorbance of untreated cells was used as a negative control. The percentage viability of
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the cells was calculated from the ratio of the mean optical density of the sample to the optical
density of the negative control.
The cells were cultured and treated with nCDs in 96-well, clear-bottomed white plates for the
apoptosis and ROS detection experiments. Caspase 3/7 activity, the key indicator for
apoptosis, was evaluated using the ApoTox-Glo™ Triplex assay according to the
manufacturer’s protocol. The light output, measured with a luminometer, correlates with
Caspase-3/7 activation, and luminescence was measured using a microplate reader
(Molecular Devices Spectra Max 190).
ROS generation was evaluated with the ROS-Glo™ H2O2 assay according to the
manufacturer’s protocol. The light signal (luminescence) produced by recombinant
Luciferase is proportional to the level of H2O2 in the cells. The luminescence was measured
using a microplate reader (Molecular Devices Spectra Max 190).
1.3. In vitro imaging of nCDs
All cells were fixed by immersion in 4% paraformaldehyde (PFA) as the cross-linking
solution for 10 min at room temperature. The cells were washed three times with ice-cold 1x
PBS, for 3 min each time. The fixed cells were incubated in ice-cold 1x PBS buffer
containing 0.1% Triton (permeabilization agent) for 10 min at room temperature, then washed
three times with ice-cold 1x PBS, for 5 min each time. The CELLviewTM plates were then
incubated with blocking buffer for 30 min at room temperature. The cells were subsequently
washed three times with ice-cold 1x PBS for 3 min each time. To stain the nuclei,
SlowFade® Gold Antifade Mountant with DAPI (diluted 1:100 in 1x PBS) was used. The
cells were then kept at 4 oC overnight. The cells were again washed three times with ice-cold
1x PBS for 5 min each time before being transferred to the confocal microscope for visual
analyses.
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Figure S1. Hydrodynamic size measurement raw results of nCDs with amine/acid ratio of
(A) 0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00.
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Figure S2. Zeta potential measurement raw results of nCDs with amine/acid ratio of (A)
0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00.
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Figure S3. MALDI-TOF mass spectra of CDs with NH2/COOH ratios of (A) 0.5, (B) 1.0,
and (C) 2.0.
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Figure S4. Broad spectrum XPS analysis results of nCDs
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Figure S5. High resolution N1s XPS analysis results of nCDs with amine/acid ratio of (A)
0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00.
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Figure S6. High resolution O1s XPS analysis results of nCDs with amine/acid ratio of (A)
0.25, (B) 0.50, (C) 1.00, (D) 1.50, (E) 2.00.

A)

B)

Figure S7. Correlation of the molar ratio of reactants to (A) pyrrole content and (B) MW of
nCDs.
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Figure S8. Biocompatibility results of retinal pigment epithelial (ARPE-19) (a) cell
viabilities ((b) apoptotic cell percentage (c) ROS generation after incubation with nCDs for
24 h at concentrations up to 0.6 mg/mL. Data are expressed as mean ± SD from three
independent experiments (*P < 0.05).
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Figure S9. Biocompatibility results of lens epithelial (a) cell viabilities (b) apoptotic cell
percentage (c) ROS generation after incubation with nCDs for 24 h at concentrations up to
0.6 mg/mL. Data are expressed as mean ± SD from three independent experiments (*P <
0.05).
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Figure S10. Biocompatibility results of CHO (a) cell viabilities (b) apoptotic cell
percentage (c) ROS generation after incubation with nCDs for 24 h at concentrations up to
0.6 mg/mL. Data are expressed as mean ± SD from three independent experiments (*P <
0.05)
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Appendix IV.
Post Intravenous Injection Histology
Analysis for Uncoated and Coated Au NPs
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Post Intravenous Injection Histology Analysis for Uncoated and Coated Au NPs
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Figure 1. Histology analysis after intravenously administered Au NPs. (A) 5 minutes (B) 10
minutes (C) 15 minutes (D) 20 minutes (E) 25 minutes post injection.
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Figure 2. Histology analysis after intravenously administered HA-S-Au NPs. (A) 5 minutes
(B) 10 minutes (C) 15 minutes (D) 20 minutes (E) 25 minutes post injection. All the sections
of both cornea and retina are intact.
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Appendix V.
A Highly Sensitive Non-enzymatic Glucose
Sensor based on Cu/Cu2O/CuO Ternary
Composite Hollow Spheres Prepared in a
Furnace Aerosol Reactor

The results of this appendix have been reprinted with permission from Lin L. Y*.,
Karakoçak B. B*., Kavadiya S., Biswas P. A Highly Sensitive Non-enzymatic Glucose
Sensor Based on Cu/Cu2O/CuO Ternary Composite Hollow Spheres Prepared in a Furnace
Aerosol Reactor. 2018. Sens. Actuators B. Chem. 259: 745-752. Copyright 2018 Elsevier
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Abstract
A novel ternary composite, Cu/Cu2O/CuO hollow spheres (HSs), synthesized using an
aerosol furnace reactor (FuAR) was investigated for the first time as a non-enzymatic
electrochemical biosensor for glucose detection. The composite HSs were synthesized by
aerosolizing a mixture of copper nitrate, citric acid, and ammonia through a FuAR.
Interestingly, the addition of ammonia played a crucial role in the in-situ formation of hollow
Cu/Cu2O/CuO ternary composites. The HSs modified electrode was employed for nonenzymatic glucose detection where it exhibited a detection limit of 0.39 µM and an
outstanding sensitivity of 8726 μA cm-2 mM-1 which is superior to existing Cu/Cu2O HSs and
CuO HSs modified electrodes. The high sensitivity was attributed to the synergy arising from
the ternary composition’s interfacing with multiple Cu redox couples. The Cu/Cu2O/CuO
HSs modified electrode also showed excellent selectivity in detecting glucose in the presence
of interfering species, including chloride salts of Na+, K+, Ca2+, and anions of ascorbic acid
(AA), dopamine (DA), and uric acid (UA). This simple and scalable FuAR technique will
attract interest and enable in designing other high-performance metal/metal oxide composites
for commercial glucose sensing applications.
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1. Introduction
In the last few decades, the development of highly sensitive and selective glucose sensors
with wide detection ranges has received considerable attention in clinical diagnosis and the
food industry [1]. Currently, glucose oxidase (GOD)-based glucose biosensors comprise
more than 85% of the sensor market, owing to their simplicity, high sensitivity, good
selectivity, and reliability [2]. Nevertheless, the enzymes involved are quite sensitive to
temperature, pH, and humidity, which significantly impede further development of enzymebased biosensors. Given the inherent drawbacks of enzymes, non-enzymatic glucose
sensors based on the electrocatalytic oxidation of glucose by a variety of electrocatalysts
have been attracting much interest as promising alternatives.
Nanostructured metal/metal oxides are good candidates for electrocatalysts because of their
low cost, high stability, and excellent redox behaviors across various potential ranges under
a wide variety of reaction conditions [3]. Among the electrocatalysts for glucose sensors,
copper oxides (Cu2O and CuO) are of particular interest for their high activity in electrooxidation of glucose, and low overpotential for electron-transfer reactions [4,5]. Various
Cu-based metal oxides have been demonstrated as non-enzymatic glucose sensors and
showed varying sensitivity, selectivity, and stability during electro-oxidation of glucose
[4,6–8]. It has been demonstrated that the morphological characteristics of metal oxides
affect the electrochemical sensitivity of glucose biosensors [9,10]. In particular, hollow
structures can be an eﬀective morphological alternative to designing high-performance
electrode materials. Their unique properties – a high exposed surface area, hollow interior,
thin walls, and excellent permeability could enable electrodes to be exposed to a larger
electrode-glucose contact area and reduce the electron diﬀusion path, resulting in improved
electrochemical activity [4,11].
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The redox activation of the electrode materials in electrocatalytic processes is another
major factor contributing to the sensitivity of electrochemical glucose detections. A
composite material with multiple redox couples promotes redox reactions and enhances
electrocatalytic activity [12,13]. For example, compared with pure CuO, a CuO/Cu2O
composite showed superior electrocatalytic activity in glucose oxidation [14]. This
superiority is primarily attributed to the presence of a mixed-valence Cu2+/Cu+ system that
promotes redox reactions between electrode materials and glucose, thus improves the
performance of CuO/Cu2O. Also, the incorporation of metallic Cu into the Cu-oxide (e.g.,
Cu2O) has also been reported to be beneficial for enhancing electro-conductivity and
electrocatalytic activity toward glucose oxidation [15,16]. More recent studies emphasized
the synergistic effect of multiple oxidation species in improving the glucose detection
performance [17–20]. Therefore, designing a Cu-based composite material consisting of
mixed valences of Cu, Cu2O [Cu+], and CuO [Cu2+] may be a good strategy to improve the
sensitivity of the electrochemical glucose sensor further.
In this work, a single-step synthesis of Cu/Cu2O/CuO composite hollow spheres (HSs) as
non-enzymatic glucose sensors using an aerosol furnace reactor (FuAR) is presented for the
first time. A triple oxidation state system of the Cu/Cu2O/CuO composite HSs was
synthesized to promote redox reactions and improve electrochemical sensitivity. To the best
of our knowledge, this is the first study demonstrating the use of Cu/Cu2O/CuO composite
HSs as a non-enzymatic glucose sensor. The formation mechanism of the Cu/Cu2O/CuO
HSs was investigated in detail, and electrochemical studies to demonstrate the selectivity
and sensitivity to glucose were established. This sensitivity was compared to those of
Cu/Cu2O HSs and CuO HSs prepared using the same FuAR method, and the reasons for the
differences are elucidated.
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2. Experimental
2.1.

Reagents and Materials

All materials were of analytical grade and used as received without further purification.
Copper nitrate hemipentahydrate, citric acid, ammonia (NH3), glucose, ascorbic acid (AA),
uric acid (UA), dopamine (DA), sodium hydroxide (NaOH), potassium chloride (KCl),
sodium chloride (NaCl), calcium chloride (CaCl2), fetal calf serum (FCS) were obtained
from Sigma-Aldrich (St. Louis, MO). LIQUION™ Nafion™ containing solution was
purchased from Ion Power Nafion™ Store (Newcastle, DE). Alumina micropolish powder
(0.05 µm) was obtained from Buehler (Lake Bluff, IL).
2.2.

Preparation of Cu/Cu2O/CuO HSs

The Cu/Cu2O/CuO composite HSs were synthesized in a lab-built furnace aerosol reactor,
depicted in Fig. S1. To prepare the precursor solution, 1.86 g of copper nitrate
hemipentahydrate (8 mmol) and 0.845 g of citric acid (4.4 mmol) were dissolved in 40 ml
of DI water, followed by the addition of 1.9 ml of ammonia solution (28-30 wt. %) under
constant stirring. The precursor mixture was then nebulized into aerosol droplets by using a
collision nebulizer (BGI Incorporated) and delivered by a nitrogen flow (14 psi) through a 1
mm ID quartz tube 25 mm long surrounded by a furnace thermostatically controlled at 850
°C. The particle residence time inside the furnace aerosol reactor was calculated to be 1.2
seconds. The products were collected downstream of the reactor on a membrane filter,
washed thoroughly with DI water, and finally dried in an oven at 110 oC for 6 hours.
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2.3.

Material characterization

The morphologies of the synthesized hollow spheres were examined by field emission
scanning electron microscopy (FE-SEM, Nova NanoSEM 230, FEI Co.), and transmission
electron microscopy (TEM, Tecnai TM Spirit, FEI Co.). The crystal phase of the material
was determined by X-ray diffraction (XRD, D8 Advance, Bruker, USA) with Cu Kα
radiation (λ = 1.548 Å). The chemical composition of the material was determined with Xray photoelectron spectroscopy (XPS) analysis, performed on a PHI 5000 VersaProbe II
equipped with monochromatic Al Kα (1486.6 eV) X-ray source. The XPS peak fitting was
done in OriginLab, OriginPro (Northampton, MA) software using Lorentz distribution. The
surface area and pore size distribution were analyzed using the nitrogen physisorption
method (Autosorb-1, Quantachrome Instruments, Boynton Beach, FL). In total, 79
adsorption and desorption points were analyzed using the nitrogen physisorption method.
The surface area was calculated using the Brunauer–Emmett–Teller (BET) method, and the
pore size distribution was obtained from the desorption isotherm, which is more appropriate
than the adsorption isotherm for evaluating the pore size distribution of an adsorbent. For
the same volume of gas, the desorption isotherm exhibits a lower relative pressure,
resulting in a lower free energy state, i.e., one closer to true thermodynamic stability.
2.4.

Electrode fabrication and electrochemical measurement

An enzyme-free amperometric electrochemical sensor was prepared with a modified glassy
carbon electrode (GCE, 3 mm diameter) at room temperature. Before modification, the bare
GCE was polished to a mirror-like surface with 0.05 µm alumina slurry and then washed
ultrasonically in deionized water for at least two minutes. Electrochemical measurements
were performed with a lab-built three-electrode cell setup. For the working electrode, 10
mg of the material powder was dispersed in 5 ml of deionized water, followed by the
addition of 1 ml of Nafion solution (0.05 wt. %). After approximately 30 min of
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ultrasonication, 20 μl of the suspension, which contained 33 μg of the powdered material,
was dropped onto the pretreated GCE and dried at 60 oC for 20 min. A Pt wire was used as
the counter electrode and Ag/AgCl as the reference electrode. Cyclic voltammetry (CV)
measurements and chronoamperometry (CA) were performed using a CHI 760E
electrochemical workstation. For glucose detection experiments, the workstation was
operated at +0.55 V with continuous stirring to ensure efficient convective mass transport.
In the experiment, 200 µl of glucose was added incrementally to 2 ml of 0.1 M NaOH
aqueous solution. Then, interfering anion and cation experiments were conducted. Finally,
the short-term (1000 s) and long-term (21 days) stability of the electrode was tested. All the
measurements were carried out at room temperature in a normal atmosphere.
Electrochemical impedance spectroscopy (EIS) was performed using the same threeelectrode system in 100 mM KCl electrolyte solution containing equimolar (0.01 M/0.01
M) [Fe(CN)6]4-/3- at a bias potential of 0.55 V by applying an AC voltage with 5 mV
amplitude in a frequency range from 0.1 Hz to 1 MHz.
3. Results and Discussion
3.1.

Synthesis and characterization of Cu/Cu2O/CuO HSs

The formation of Cu/Cu2O/CuO HSs is illustrated in Fig. 1. The formation of mixedphased copper oxide HSs is based on an in-situ gas release mechanism in a single aerosol
droplet, where citric acid acts as a blowing agent. Further information regarding the
formation mechanism can be found in the Supporting Information (SI-2). The phase
composition of the aerosol-made materials was investigated by XRD, with the results
displayed in Fig. 2a. When using nitrogen as a carrier gas in the FuAR process, the powder
prepared from the precursor solution containing copper nitrate–citric acid is identified as
Cu/Cu2O [13]. The addition of ammonia in the precursor solution (copper nitrate–citric
acid–ammonia) results in the formation of Cu/Cu2O/CuO hybrids [21]. The peaks are
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identified with standard pdf card for Cu (pdf # 01-071-4611), Cu2O (pdf # 04-016-6875)
and CuO (pdf # 04-007-0518). It can be seen that the intensities of the Cu2O crystalline
phases decrease with corresponding increases in the intensities of the CuO peaks, implying
a growing amount of CuO at the expense of Cu2O. On the other hand, the pure CuO phase
is clearly identified in the CuO HSs sample obtained in airflow during the FuAR process.
The phase composition of Cu/Cu2O/CuO is determined by XPS analysis. High-resolution
XPS was performed to identify Cu peaks. The binding energy for Cu and Cu+1 peaks are
very close and therefore difficult to distinguish. There are satellite peaks corresponding to
electronic shake-up that are present for CuO. The ratio of Cu(II)/(Cu(0)+Cu(I)) present in
the composite HSs is calculated to be 2.47 based on the ratio of their XPS peak areas.

Fig. 1. The formation mechanism of Cu/Cu2O/CuO HSs. The aerosol droplet consisting
copper nitrate, and citric acid in ammonia enters the reactor. The increase in temperature
inside the reactor leads to evaporation of water and decomposition of the precursors. The
final product is the copper oxide particles in powdered form, which are collected on a
membrane filter.

The morphology of the synthesized Cu/Cu2O/CuO was investigated by SEM and TEM.
Most of the Cu/Cu2O/CuO particles are spherical with diameters ranging from 0.05 to 3
μm. Also, hollow as well as fractured particles are observed (Fig. 2b). The hollow structure
of the Cu/Cu2O/CuO spheres was further verified by the bright contour at the center of the
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sphere in the TEM image (Fig. 2c), and the shell thickness is estimated to be ~30 nm (Fig.
2d). Similar hollow morphologies are also found in both Cu/Cu2O HSs and CuO HSs
samples (Fig. S4). The Brunauer–Emmett–Teller specific surface area (SBET) and pore
volume (Vp) of Cu/Cu2O/CuO HSs measured using the nitrogen physisorption method were
determined to be 11.3 m2/g and 0.12 cm3/g, respectively. In comparison, the SBET and Vp
values of Cu/Cu2O and CuO HSs were 13.2 and 0.10 cm3/g, and 5.3 m2/g and 0.078 cm3/g,
respectively.

(b)

(a)

1 μm

(c)

(d)

1 μm

100 nm

Fig. 2. (a) Powder XRD patterns of CuO, Cu/Cu2O, and Cu/Cu2O/CuO HSs samples, (b)
SEM (scale bar 1 µm), and (c) TEM image (1 µm) of Cu/Cu2O/CuO HSs, (d) high-resolution
TEM image (100 nm) of Cu/Cu2O/CuO HSs showing the wall thickness of approximately 30
nm.
3.2.

Electrochemical performance analysis

All three aerosol-made HSs composites – Cu/Cu2O/CuO, Cu/Cu2O, and CuO – were
applied as a non-enzymatic glucose sensor by depositing an aqueous solution containing
powdered composite and Nafion on a glassy carbon electrode (GCE) surface. Cyclic
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voltammetry measurements were performed to investigate the modified electrode’s
electrocatalytic activity toward glucose oxidation. As shown in Fig. 3a, in the presence of
10 µM glucose, the oxidation of glucose started at an onset potential of 0.40 V for both the
Cu/Cu2O-GCE and the CuO-GCE. In comparison, an increasing current signal was
observed for the Cu/Cu2O/CuO-GCE starting at a lower positive onset potential of 0.30 V.
The current signal was 5.9 and 3.9 times higher than for the Cu/Cu2O-GCE and CuO-GCE,
respectively. Most notably, the combination of Cu, Cu2O, and CuO in a composite
significantly enhanced the electrochemical performance of the electrode, which may result
from the synergistic effect of improved electron transfer between the ternary compositions.
To prove this, we performed electrical impedance spectroscopy (EIS) measurement on
these electrodes (Fig. 3b). After modification of the GCE electrode with the composites,
the semicircle diameter, which represents the resistance to electron transfer of the modified
layer increases, indicating the attachment of material on the conductive GCE electrode
surface. It is observed that the order of electron transfer resistance is Cu/Cu2O/CuO < CuO
< Cu/Cu2O, with Cu/Cu2O having a very high resistance. EIS results show that the electron
transfer ability of the ternary composite (Cu/Cu2O/CuO) is very rapid.
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Fig. 3. (a) Cyclic Voltammetry (CV) curves at 50 mV/s of Cu/Cu2O/CuO, CuO, and
Cu/Cu2O-modified GCEs in 0.1 M NaOH with a glucose concentration of 10 µM. (b)
Electrical impedance spectroscopy (EIS) data recorded on bare GCE, Cu/Cu2O/CuO, CuO,
and Cu/Cu2O-modified GCEs. EIS parameters: frequency range of 0.1–106 Hz, and 5 mV
amplitude of sine voltage signal.
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Fig. 4a displays the CV curves of the Cu/Cu2O/CuO-GCE in a 0.1 M NaOH solution in the
presence of various concentrations of glucose at 50 mV/s. The electrode’s response was
very weak in the absence of glucose (black curve), but the electro-oxidation current
increases steadily with an increase of glucose concentration up to 100 µM. Furthermore,
CVs of the Cu/Cu2O/CuO-GCE were recorded in 100 µM glucose solution at different scan
rates (5 mV/s to 200 mV/s) (Fig. S5). It was found that anodic peak current increases with
the increasing scan rate potential. The inset shows anodic peak current is linearly correlated
to the square root of the scan rate, implying that the electrode surface oxidation reaction is
not electrocatalyst kinetics limited, but instead, a typical diffusion-controlled process.
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Fig. 4. (a) CV curves at 50 mV/s of Cu/Cu2O/CuO modified GCE in 0.1 M NaOH with
glucose concentrations from 0 to 100 µM. (b) Amperometric response at 0.55 V of the
Cu/Cu2O/CuO modified GCE to successive ~10 s additions of glucose to 0.1 M NaOH. The
inset is the corresponding calibration curve. (c) Calibration plot derived from the
amperometric responses at 0.55 V versus an Ag/AgCl reference electrode for all three
composites: Cu/Cu2O/CuO, Cu/Cu2O, and CuO. Cu/Cu2O/CuO-modified GCE showed
outstanding sensitivity.

For a healthy individual, the body’s homeostatic mechanism restores the blood glucose
level at 4.4-6.6 mM; whereas diabetic blood sugar can increase up to 15.0 mM [22,23]. In
light of this information, the amperometric response of the Cu/Cu2O/CuO-GCE to 0.5 µM –
30 mM glucose was tested. The amperometric responses of the modified electrode to 0 µM
– 100 µM glucose addition is presented in Fig. 4b and responses to higher concentrations
of glucose additions (1 mM – 30 mM) are plotted in Fig. S6. The responses of three
independent experiments were used to calculate the standard error. The results indicated a
sensitive amperometric response for the entire glucose concentration range tested. The
insets in Fig. 4b and Fig. S6 show the calibration curve of the modified electrode based on
the amperometric results. The clear stepwise linear increments over the entire concentration
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range indicate that the Cu/Cu2O/CuO-GCE can monitor glucose sensitively. The fitting
equation was I (mA/cm2) = 0.0087 C (µM) + 0.29, with a correlation coefficient of 0.99 for
the concentration up to 100 μM (Fig. 4b). The detection limit was found to be 0.39 µM, as
calculated by 3σ/S, where σ and S respectively denote the standard deviation of the
background current (1.1×10-3 mA/cm2) and the slope of the calibration curve (8.7×10-3).
Based on the amperometric results, the current density calibration curve results for the
modified GCE with all three composites – Cu/Cu2O/CuO, Cu/Cu2O, and CuO – in 0.1 M
NaOH with a glucose concentration of 1-100 µM at a scan rate of 50 mV/s was created
(Fig. 4c). For comparison, Table 1 lists the analytical performances of other existing Cubased composite modified GCE sensors along with our findings. The sensitivity of the
CuO-modified GCE was found to be 1234 µA mM-1 cm-2, similar to the values reported
previously on the CuO-modified electrodes [11,24]. Furthermore, similar to the results
reported for the Cu/Cu2O modified GCE [12], the sensitivity of the Cu/Cu2O modified GCE
was determined to be 1104 µA mM-1 cm-2. Although compared with previously reported
values, our results showed a slight enhancement in the sensitivity of GCEs modified with
either Cu/Cu2O or CuO, we wanted to take the modification composition recipe one step
further, and created the Cu/Cu2O/CuO composite. An outstanding sensitivity of 8726 µA
mM-1 cm-2 was achieved by the Cu/Cu2O/CuO-GCE, which is 7-fold higher than those of
the Cu/Cu2O and CuO modified GCEs (Fig. 4c).
The glucose sensing performance in this study and that of other non-enzymatic sensors
available in the literature are summarized in Table 1. Clearly, the Cu/Cu2O/CuO modified
GCE developed in this study had the highest sensitivity among all non-enzymatic glucose
sensors under comparable conditions, except for Ag-carboxylate functionalized SiO2. The
sensitivity of Ag-carboxylate functionalized SiO2 (potential, 0.62 V; electrolyte, 0.1 M
NaOH; sensitivity, 9091 µA mM-1 cm-2) is slightly higher than that of the Cu/Cu2O/CuO
252

ternary composite HSs (potential, 0.55 V; electrolyte, 0.1 M NaOH; sensitivity, 8726 µA
mM-1 cm-2). Nevertheless, the need for an expensive noble metal precursor as well as the
multi-step synthesis procedures (thermal treatment, refluxing, filtration, and washing) and
long reaction time (100 h) of Ag-carboxylate functionalized SiO2 might limit its potential
use for practical applications. As a result, our sensor is successful in detecting the glucose
concentration for the entire range tested (0.5 µM to 30 mM) with a detection limit of 0.39
µM.
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Table 1. Analytical performance comparison of non-enzymatic electrochemical sensors for glucose detection.

Cu/Cu2O/CuO HSs/GCE

Applied
potential
(V)
0.55

Cu/Cu2O nanohybrids

0.55

Cu/CuxO

0.5

NaOH

1620

0 - 6 mM

49 µM

[12]

Hollow Cu2O nanospheres

0.6

NaOH

2038

1.25 - 37.5 µM

0.41 µM

[4]

Cu2O nanourchin

0.5

KOH

2682

0.1 - 3 mM

1.52 µM

[32]

Cu2O/Cu

0.5

NaOH

6681

1 µM - 1.8 mM

0.67 µM

[33]

Anneal shrinked Cu2O
dendrites
Cu/CuO

0.45

NaOH

5040

0.001 - 1.4 mM

0.13 µM

[8]

0.6

NaOH

1887

2 µM -3.56 mM

0.05 µM

[34]

CuO nanowires/carbon cloths

0.55

NaOH

2973

Up to 1.12 mM

1 µM

[35]

CuO nanospheres/carbon

0.55

NaOH

4902

Up to 1 mM

1 µM

[35]

Sandwich structured CuO

0.6

NaOH

5343

Up to 3.2 mM

~1 µM

[36]

Ag-carboxylate functionalized
SiO2
Nano Ni/Ti electrode

0.62

NaOH

9091

0.004 - 5.5 mM

0.33 µM

[37]

0.5

NaOH

7320

0.05 - 0.6 mM

1.2 µM

[38]

Cu-Ag/nanofiber

0.55

NaOH

7746

0.005 - 3.5 mM

0.08 µM

[28]

Cu-Cu2O/TiO2

0.65

NaOH

4895

0.1 - 2.5 mM

8.6 µM

[17]

3D graphene-Co3O4

0.58

NaOH

3390

Up to 0.08 mM

< 0.025 µM

[39]

Pd-CuO/reduced graphene
oxide/screen printed electrode

0.6

NaOH

3355

0.006 - 22 mM

0.03 µM

[40]

Electrodes

Electrolyte

Sensitivity (µA
mM-1 cm-2)

Linear range

Detection
limit

Reference

NaOH

8726

0.5 µM - 30 mM

0.39 µM

Current work

1434

Up to 40 mM

1.6 µM

[18]

CuSO4+Lactic
Acid+NaOH/KOH
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Currently, the mechanism for glucose electrooxidation on the Cu-based electrodes in an
alkaline medium is not entirely clear; nevertheless, it is believed that a Cu3+ species, rather
than Cu+ or Cu2+, serve as the electron-transfer mediator [25]. Also, it was demonstrated
that the electro-oxidation of glucose in an alkaline medium requires the presence of oxide,
hydroxide, and/or oxyhydroxide groups [26]. That is, the electro-oxidation of glucose on
the Cu or Cu composite occurs through reaction with CuOOH to form Cu(OH)2. Based on
this assumption, a possible mechanism for glucose detection on the Cu/Cu2O/CuO modified
GCE is proposed in Fig. 5. During electrochemical measurements, Cu(0), Cu(I) and Cu(II)
would be oxidized to Cu(III), which could catalyze glucose oxidation to generate
gluconolactone.

Fig. 5. The schematic representation of the mechanism of glucose sensing with
Cu/Cu2O/CuO composite HSs.
Recent studies showed that improved electrocatalytic activity could be achieved by the
synergistic effect of binary composition interfaces, in which the electrons are rapidly
transferred between the redox couples [27,28]. Hassan and Hamis [29] found that the
electrocatalytic activity toward glucose oxidation of a Cu electrode can be significantly
enhanced by the co-deposition of CuO. The same study also mentioned that CuO facilitates
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the transformation of the Cu3+/Cu2+ redox couple. In the case of the Cu/Cu2O/CuOmodified GCE, CuO may facilitate the conversion of Cu3+/Cu2+ redox pairs, so, rapid
electron transfer occurs between the Cu, Cu2O, and CuO species. The highest electron
transfer ability of the Cu/Cu2O/CuO composite was also verified by the EIS results (Fig.
3b). Moreover, the high surface area of the Cu/Cu2O/CuO (Section 3.1) could also play
another crucial role in its superior electrocatalytic activity. It is widely accepted that highly
efficient electrocatalysis often results from a large active surface area [13–15]. Hence, even
though the electron transfer resistance of Cu/Cu2O/CuO and CuO are similar, the high
surface area and large pore volume of the Cu/Cu2O/CuO provide more active sites and
facilitates the glucose oxidation process. The surface area of Cu/Cu2O is the highest, which
might allow the glucose molecules access to the active sites more easily. However,
Cu/Cu2O’s highest electron transfer resistance resulted in poor electrocatalytic
performance. Overall, to achieve a remarkable sensing performance, the material should
have not only low electron transfer resistance but also a high surface area, as achieved in
the case of Cu/Cu2O/CuO.
3.3.

Interference and Stability Studies

To evaluate the selectivity of the Cu/Cu2O/CuO-modified GCE sensor, we examined the
effects of possibly interfering ions such as anions of chloride, uric acid (UA), ascorbic acid
(AA), and dopamine (DA) which typically coexist with glucose in human blood. To test the
Cl- ion interference, chloride was added in the form of NaCl, KCl, and CaCl2. According to
blood test reference charts [22], for a healthy individual, the relative ratios of glucose to
Na+, K+, Ca2+ are 1:26, 1:1, 1:2. The ratios of AA, DA, and UA to glucose are 1:69, 1:13,
1:423, respectively [22]. As a result, for the interference study, the ratio of glucose to
possibly interfering Cl salts was conservatively selected to be 1:30, higher than the highest
healthy ratio; whereas the proportion of potentially interfering anions to glucose was
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chosen to be 1:10, lower than the lowest healthy ratio. According to the amperometry
results (Fig. 6), current signals from interfering ions is insignificant, and a clear response
from glucose is obtained in the presence of these ions. The observations confirm that the
Cu/Cu2O/CuO modified GCE demonstrates excellent detection specificity for glucose in
the presence of selected anions, which may hinder glucose selectivity. The high selectivity
of the sensor towards glucose may be attributed to the negative sulfonate groups present on
the Nafion that hinder the attachment of the interfering anions on the electrode surface and
secure the surface for glucose attachment [16,30].

Fig. 6. Amperometric response of the Cu/Cu2O/CuO-modified GCE to the successive
additions of 50 and 100 µM of glucose in the presence of (a) 3 mM Na+, K+, and Ca2+,
respectively. (b) 10 µM of UA, AA, and DA, respectively.
The stability of the hollow Cu/Cu2O/CuO-GCE was investigated by measuring its
amperometric response to 50 µM glucose for an extended period, for this case, 21 days. The
electrode was exposed to air, and the amperometric response was measured at Day 1, Day
7, Day 14 and Day 21 (Fig. S7 and Table S1). The efficiency dropped by ~24% by the 14th
day and then remained stable until the end of the 21st day. Ultimately, the Cu/Cu2O/CuOGCE preserved a high sensitivity of 6545 µA mM-1 cm-2 until the end of the 21st day.
Cu/Cu2O/CuO was further characterized following the glucose sensing test by both TEM
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and XRD analyses. As shown in Fig. S8(a), the hollow spherical structure was still well
retained over the used Cu/Cu2O/CuO sample. However, the used Cu/Cu2O/CuO sample
shows a different phase composition compared to the fresh Cu/Cu2O/CuO (Fig. S8(b)). The
intensity of the Cu2O phases decreases to a certain extent with corresponding increase in
the intensity of the CuO peaks, implying a growing amount of CuO at the expense of Cu2O.
As explained earlier, the sensing performance also diminishes with time and number of
measurements. A simultaneous decrease in the sensing performance and change in the
material composition indicate that the electrocatalytic performance of the Cu/Cu2O/CuO is
affected by the ratio of each component. Accordingly, it is expected that engineering the
phase composition of the Cu/Cu2O/CuO composite could further enhance its
electrocatalytic performance and stability. Based on the formation mechanism of these HSs
described in the Supporting Information, we have also briefly discussed the synthesis
parameters that can be used to control the composition, but the synthesis of material
(Cu/Cu2O/CuO) with exact controlled composition is out of the scope of this paper.
Next, we studied the short-term stability of the Cu/Cu2O/CuO-modified GCE. As shown in
Fig. S9, there is nearly no loss in the current signal over a period of 17 minutes for 100 µM
glucose on 0.1 M NaOH at 0.55 V, showing the excellent stability of the electrode.
Moreover, the inset displays that it takes approximately 3 seconds to achieve a steady-state
current, indicating the relatively rapid response of our sensor to glucose. Furthermore, to
verify its workability with blood, we have tested our sensor’s response to glucose in fetal
calf serum (FCS), which is the blood fraction remaining after the natural coagulation of
blood, followed by centrifugation to remove the remaining red blood cells. The serum
perfectly mimics real blood due to its composition [29]. Fig. S10 displays the results of the
response to 5 mM glucose addition. The current response at 0.55 V from the proposed
glucose sensor is in good agreement with the value obtained at pH 7, which indicates a
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potential application in practice. Finally, we compared the sensing responses of electrode
materials, specifically Cu/Cu2O/CuO, synthesized in two different batches and the
performance of modified GCEs were compared (Fig. S11). Both amperometric responses
and CV analysis showed consistent sensing performance for detection of glucose.
4. Conclusions
Cu/Cu2O/CuO ternary composite HSs were successfully synthesized by a facile FuAR
method and were used as a non-enzymatic sensor for electrochemical detection of glucose.
The performance of a Cu/Cu2O/CuO-modified glassy carbon electrode (GCE) for the
detection of glucose over a concentration range of 0.5 µM - 30 mM was established. The
results showed that the modified electrode had an outstanding sensitivity of 8726 µA cm-2
mM-1, with a low detection limit of 0.39 µM. The Cu/Cu2O/CuO hollow spheres (HSs)
modified GCE exhibited not only remarkable selectivity but also showed strong short-term
stability and a fast and excellent selective response for glucose detection. We hypothesize
that the outstanding sensing performance of the Cu/Cu2O/CuO HSs modified electrodes
originate from minimum resistance in the electron conduction between the electrode
materials and availability of high surface area.
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Experimental

Fig. S1. The furnace aerosol reactor (FuAR) experimental setup. The setup consists of a
controlled gas supply, a precursor solution, a collision nebulizer, an electric furnace, and a
membrane filter for particle collection.

SI-1. Preparation of Cu/Cu2O HSs and CuO HSs
Cu/Cu2O HSs were synthesized using copper nitrate and citric acid (dissolved in DI water)
as the precursors using nitrogen (14 psi) as the carrier gas. The preparation of CuO HSs
was performed using copper nitrate, citric acid and ammonia (dissolved in DI water) as the
precursors, while compressed air (14 psi) was the carrier gas in the FuAR process. The
subsequent aerosol process for the preparations of Cu/Cu2O HSs and CuO HSs was the
same as that for Cu/Cu2O/CuO HSs. Detailed synthetic parameters of the aerosol-made
materials are summarized in Table S1.
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Table S1. Detailed synthetic parameters of Cu/Cu2O/CuO, Cu/Cu2O, and CuO.
Sample

Precursor

Carrier gas (14 psi)

Cu/Cu2O/CuO

Copper nitrate, citric acid and ammonia

Nitrogen

Cu/Cu2O

Copper nitrate and citric acid

Nitrogen

CuO

Copper nitrate, citric acid and ammonia

Air

Results and Discussion
SI-2. Formation mechanism of Cu/Cu2O/CuO HSs
The formation of mixed-phased copper oxide HSs is based on an in situ gas release
mechanism in a single aerosol droplet, where citric acid acts as a blowing agent [1]. As the
droplet containing the precursors enters the heated zone, the rapid water evaporation results
in a temperature gradient within the aerosol droplet. The surface of the aerosol droplets is
heated first, and then heat is transferred to the core. Further, the decomposition of citric
acid results into hot gasses including CH4, H2, CO, CO2, NH3, NO2, and H2O[2,3], which
then creates an outward “blowing force,” leading to the formation of a hollow sphere. The
gasses heating of the droplet proceeds, a CuO shell forms as a result of supersaturation,
precipitation, and decomposition of copper nitrate at the droplet surface. It is important to
note that the hollow sphere formation does not occur with only copper nitrate precursor
(Fig. S2), but with the presence of citric acid.
Recently, Trusov et al. [4] demonstrated the synthesis of metallic Cu and Cu/Cu2O hollow
microspheres, using copper nitrate and glycine as precursors in a spray solution combustion
method under an argon atmosphere. Their study showed that at a high temperature (600750 oC), the decomposition of glycine resulted in the evolution of NH3 gas that further
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reduced the pre-formed CuO nano-grains to produce metallic Cu and Cu/Cu2O particles.
We believe the formation of Cu/Cu2O HSs in our work occurred by a similar mechanism
where pre-formed CuO is reduced to Cu/Cu2O from the decomposition of citric acid. The
decomposition of citric acid produced a large amount of gas including CH4, H2, CO, CO2,
NH3, NO2, and H2O [2,3], which acted as in situ gas releasing agents inside the particles.
These agents induced a high pressure inside the particles and promoted the formation of
hollow structures. Therefore, the in-situ reduction of CuO particles by strong reducing
gasses (e.g., CH4 and H2) under a nitrogen atmosphere led to the formation of Cu/Cu2O
HSs.
Interestingly, we found that the addition of ammonia in the precursor solution facilitated the
formation of a Cu/Cu2O/CuO system under a nitrogen atmosphere. During the preparation
of the precursor solution of copper nitrate, citric acid, and ammonia, soluble NH4NO3
crystallites formed, as revealed by the XRD results (Fig. S3). NH4NO3 is a strong oxidizer
[5], and the decomposition products from NH4NO3, including O2, N2O, and NO2, are also
strong oxidizers. In the presence of these strong gaseous oxidizers, the reduction of CuO by
the decomposition products of citric acid may, therefore, be hindered. As a result, not all
CuO is reduced, and this can lead to the formation of Cu/Cu2O/CuO composite during the
FuAR process. Overall, the formation of Cu/Cu2O/CuO ternary composite is a result of a
trade-off between reduction and oxidation reactions involving copper nitrate, citric acid,
and ammonia. On the basis of the above formation mechanism, the phase composition of
Cu, Cu2O, and CuO in the Cu/Cu2O/CuO ternary composite can, therefore, be controlled by
tuning the following parameters: (i) furnace temperature, (ii) citric acid/Cu ratio, and (iii)
the concentration of ammonia in the precursor mixture.
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Crystalline CuO was also identified in the copper nitrate–citric acid–ammonia precursor in
a strong oxidizing atmosphere (air and NH4NO3) during the FuAR process. To the best of
our knowledge, this is the first study demonstrating the preparation of Cu/Cu2O/CuO
composite HSs using an aerosol-based synthesis method.
Previous studies on preparing Cu-based electrode materials were typically performed in an
aqueous batch system (e.g., a hydrothermal method, electrospinning, and electrodeposition)
in which multiple synthetic steps and tens of hours of processing time are required [6–9]. In
contrast, the FuAR is a scalable method which ensures an easy, rapid and highly
reproducible synthesis; more importantly, it can be operated continuously, with a residence
time of only several seconds [10,11]. Also, the Cu/Cu2O/CuO composite HSs were
produced from an aqueous solution of copper nitrate, citric acid, and ammonia, all of which
are low-cost and readily available for mass production of HSs.
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Fig. S2. TEM image of CuO microspheres synthesized with copper nitrate only through
FuAR.

Fig. S3. XRD patterns of dried copper nitrate–citric acid and copper nitrate–citric acid–
ammonia precursors.
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Fig. S4. TEM images of (a) Cu/Cu2O HSs and (b) CuO HS
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Fig. S5. CV curves of Cu/Cu2O/CuO-modified electrode in 0.1 mM glucose and 100 mM
KCl electrolyte solution containing equimolar (0.01 M/0.01 M) [Fe(CN)6]4-/3- solution at
different scan rates. The inset is the corresponding calibration curve.
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Fig. S6. Amperometric response at 0.55 V of the Cu/Cu2O/CuO modified GCE to successive
~10 s additions of different concentrations of glucose to 0.1 M NaOH.

.
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Fig. S7. The long-term stability of the hollow Cu/Cu2O/CuO-modified GCE, measured by
its current response to 50 µM glucose. The measurements were taken at Day 1, 7, 14, and 21.
The left y-axis denotes the percentage of the measured current response to the initial current
at Day 1. The right y-axis displays the value of the measured current.

Table S2. The current responses to 50 µM glucose at 0.55V of Cu/Cu2O/CuO-modified GCE
on day 1, 7, 14 and 21.
Day

Current (A)

I/I0

1

74.2

100.0

7

62.3

83.9

14

55.1

74.2

21

55.0

74.2
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(a)

(b)

Fig. S8. (a) TEM image of the Cu/Cu2O/CuO sample after glucose detection. (b)
Comparative XRD patterns of Cu/Cu2O/CuO composite samples before and after reactions.
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Fig. S9. The short-term stability of the hollow Cu/Cu2O/CuO-modified GC electrode,
measured by its amperometric response 0.55 V to 100 µM glucose for more than 1000
seconds. The inset shows the response time of the electrode to reach a steady-state current. It
takes approximately 3 seconds for the electrode to respond to glucose addition.

.
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Fig. S10. CV curves at 50 mV/s of Cu/Cu2O/CuO modified GCE with glucose concentrations
of 5 mM in fetal calf serum (FCS), pH 7.4 and DI water, pH 7.0. The blank represents the CV
curve without the addition of glucose.
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(a)

(b)

Fig. S11. Two different batches of Cu/Cu2O/CuO HSs were synthesized, and the performance
of Cu/Cu2O/CuO-modified GC electrodes were compared. (a) Amperometric responses
measured at 0.55 V to 5 mM glucose for more than 120 seconds. (b) CV curves at 50 mV/s of
two different batches of synthesized Cu/Cu2O/CuO modified GCE with glucose concentrations
of 5 mM in 0.1 M NaOH.
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Appendix VI.
Investigating the Effects of Stove Emissions
on Ocular and Cancer Cells

The results of this appendix have been compiled as a full paper and submitted to Scientific
Reports. Karakoçak B. B., Patel S., Ravi N., Biswas P. Investigating the Effects of Cookstove
Emissions on Ocular Cells. 2018.

279

Abstract
More than a third of world’s population relies on solid fuels for cooking and heating, with
major health consequences. Although solid fuel combustion emissions are known to increase
the prevalence of illnesses such as chronic obstructive pulmonary disease and lung cancer,
however, their effect on the eyes is underexplored. This study assesses the acute toxicity of
solid fuel combustion emissions on healthy ocular cells and a cancer cell line. Three healthy
ocular cell lines (corneal, lens, and retinal epithelial cells) and a cancer cell line (Chinese
hamster ovary cells) were exposed to liquid and gas phase emissions from applewood and coal
combustion. Following the exposure, real-time cell attachment behavior was monitored for at
least 120 hours with electrical cell impedance spectroscopy. The viability of the cells, amount
of apoptotic cells, and generation of reactive oxygen species (ROS) were quantified with MTT,
ApoTox-GloTM, and ROS-GloTM H2O2 assays, respectively. The results showed that coal
emissions compromised the viability of ocular cells more than applewood emissions.
Interestingly, the cancer cells, although their viability was not compromised, generated 1.7 to
2.7 times more ROS than healthy cells. This acute exposure study provides compelling proof
that biomass combustion emissions compromise the viability of ocular cells and increase ROS
generation. The increased ROS generation was fatal for ocular cells, but it promoted the growth
of cancer cells.
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3. Introduction
Nearly three billion people still use solid fuels, such as biomass, coal, and cow dung cakes, in
inefficient stoves for cooking and heating. These stoves generate pollutants such as
particulate matter (PM), CO, and CH4. The resultant exposure to household air pollution
(HAP) has been associated with respiratory (Noonan et al. 2010) and cardiovascular diseases
(Pena et al. 2017), as well as formation of cataracts (Pokhrel et al. 2005, Pokhrel et al. 2013).
The World Health Organization (WHO) recognizes HAP as the single most significant health
risk, accounting for 4.3 million premature deaths in 2012 (World Health 2015).
Epidemiological studies have investigated associations between stove emissions and different
health indicators, such as cardiovascular risk, hypertension, and lung function (Pokhrel et al.
2005, Silva et al. 2009, Dutta et al. 2013, Pokhrel et al. 2013, Dutta and Ray 2014). However,
epidemiological associations between indoor air pollutants and morbidity and mortality are
often hindered by relatively small sample sizes, which are frequently not considered
representative, and by the logistical difficulties of fieldwork in developing countries. A truly
fundamental approach to understand and characterize the human health burden related to
indoor stove exposure would be to investigate effects both in-vitro and in-vivo.
Both in-vitro and in-vivo studies centered on the respiratory system have shown that
emissions from biomass fuels have carcinogenic and mutagenic properties (Danielsen et al.
2011, Mauderly et al. 2011, Corsini et al. 2013, Liberda and Chen 2013, Muala et al. 2015,
Dilger et al. 2016). However, on the cellular level, no study has investigated the possible
adverse effects of exposure to solid fuel combustion emissions on the eye, a part of the
central nervous system (Figure 1). Only a few in-vivo studies have explored the effects of
combustion smoke on the eye (Zou et al. 2009, Kunchithapautham et al. 2014). One in-vivo
study showed that combustion smoke inhalation injury is caused by hypoxia and particulate
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matter acting alone or in combination (Zou et al. 2009). How inhaling stove emissions causes
secondary injury to the eye has not been fully explored; however, there is evidence that in
response to smoke exposure from cotton burning, the permeability of the ocular blood vessels
increased, which resulted in edema in the retina (Zou et al. 2009).

Retina
Combustion
aerosols

Lens

Cornea

Figure. 1. Daily activities like cooking and heating pose a threat, especially to women and
children whose eyes are in direct contact with combustion smoke
Exposure to stove emissions can induce oxidative stress because it depletes the antioxidant
protection against cataract formation (Pokhrel et al. 2013). On the cellular level, oxidative
stress can lead to the subsequent release of reactive oxygen species (ROS), which damages
both nuclear DNA and mitochondrial DNA (Barrett et al. 1999, Elder et al. 2000, Guo et al.
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2013). Thus, biochemical and molecular changes occur which may lead to apoptosis (cell
death) or tumor initiation (Galadari et al. 2017). The ROS handling capacities of healthy cells
and cancer cells are different, and cancer cells are known to adapt well to oxidative stress
(Liou and Storz 2010). On the other hand, healthy ocular cells handle oxidative stress
differently. For example, unlike corneal and lens epithelial cells, retinal cells can cope well
with oxidative stress due to their unique ROS handling capacity, an evolutionary mechanism
for tolerating light exposure (Zou et al. 2009). In view of this information, and because
biomass and coal combustion is a repetitive daily activity for women, especially in
developing countries (Joshi et al. 2010, Hosgood et al. 2011, Anenberg 2012, Kumar 2012,
Hodnebrog et al. 2016), there are clear motives to investigate the effect of biomass and coal
combustion smoke at the cellular level first. The present study sought to determine whether
ocular cells, as well as cancer cells, would be affected by exposure to emissions from
applewood and coal combustion in a stove. To our knowledge, this is the first evaluation of
the in-vitro toxicity of biomass and coal combustion emissions on the eye.
Experimental Methods
Particulate matter collection and characterization. An improved gasifier cookstove,
described in a previous study (Patel et al. 2016), was used to burn applewood and coal.
Detailed physical and chemical characteristics of the cookstove emissions from applewood
and coal have also been reported in previous work (Patel et al. 2016), and therefore are not
repeated here. A forced-draft gasifier cookstove (Phillips, Model HD4012 LS) was used.
Applewood chips with no additives were purchased locally (St. Louis, MO) and bituminous
coal was procured from Brilliant, Alabama.
For gas phase exposure, cell culture plates were placed inside a chamber as illustrated in
Figure 2A. A minimum amount of medium was left in the wells to prevent the cells from
drying out and to create an air-liquid interface for the exposure experiment (inset of Figure
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2A). The humidity of the chamber was maintained at 67% by placing wet towels inside the
box. Air, either alone (as the control) or containing cookstove emissions, was passed through
the chamber for one hour at the same flow rate of 3 LPM as used for PM collection via a
filter (Figure 2). At the end of the exposure, the cell plates were removed from the chamber,
and the cell culture medium was replenished.
(A) Gas phase

(B) Liquid phase

Figure. 2. Schematic illustration of the experimental setup (A) Gas phase exposure. The inset
represents the air-liquid interface created for the gas phase exposure. (B) Liquid phase
exposure.
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For liquid phase exposure, the particulate matter (PM) emissions were first collected on a 47
mm Teflon filter (Sigma-Aldrich, St. Louis, MO) as illustrated in Figure 2B. To extract the
collected PM, the filter was submerged in 100 ml of deionized water and sonicated for 30
minutes. This extract was then further diluted to different strengths with Dulbecco’s modified
Eagle’s medium (DMEM F-12) (Sigma-Aldrich, St. Louis, MO) with 10% fetal calf serum
(Sigma-Aldrich, St. Louis, MO) and 1% antibiotic-antimitotic solution (Sigma-Aldrich, St.
Louis, MO). Particle suspensions (1000-200-50-20-10 µg/ml, denoted in the rest of the study
as dilution ratios of 1:1, 1:5, 1:20, 1:50, 1:100, respectively) were sonicated with a Branson
sonicator bath (Hach, Loveland, CO) for 30 seconds immediately before being added to cell
cultures. The cell media was removed prior to the applewood extract exposure in the liquid
phase. The volume of applewood extracts was verified to be 150 μl in each well.
Cell models. The selection criterion for cell lines was the likelihood of the cells being in
direct environmental contact with the biomass emission. As illustrated in Figure 1, biomass
smoke is expected to hit the cornea first. Epidemiological studies have reported a direct
correlation between cataract formation and biomass smoke exposure (Shalini et al. 1994,
Pokhrel et al. 2005, Pokhrel et al. 2013, Ravilla et al. 2016), so lens epithelial cells were also
included in this study. Further, retinal pigment epithelial cells have been reported to be
adversely affected by cigarette smoke exposure (Alcazar et al. 2007, Jia et al. 2007, Bertram
et al. 2009), so they were included in this study as the last healthy ocular cell line. On the
other hand, the in-vitro toxicity of biomass smoke to lung cancer cell lines is well
documented (Dogan et al. 2011, Dilger et al. 2016); therefore, lung cancer cells were not
assessed in this study. Instead, we chose an ovarian cancer cell line which has been shown to
have a high mitotic index (Tobey et al. 1967, Harada and Morris 1981) and also has not been
studied before for in-vitro toxicity assessment of biomass smoke emissions.
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Corneal epithelial cells (ATCC® PCS¬ 700-010TM), lens epithelial cells (ATCC® CRL¬
11421TM), retinal pigment epithelial cells (ATCC® CRL¬ 2302™), and Chinese hamster
ovary (CCL¬ 61™) cells were purchased from American Type Culture Collection (Manassas,
VA).
Cell culture conditions. In flat-bottom 96-well plates, 150 μl volumes of cells (2.0 × 104 cells
per well) were incubated at 37 °C in 5% CO2 until confluent, then exposed to biomass
emissions. For gas phase experiments, a minimum amount of cell medium was kept in each
well to prevent cells from drying, while also ensuring direct contact with the biomass
emission. For liquid phase experiments, biomass emission extracts were dispersed in cell
culture medium (DMEM/F12) to be used for cell exposure.
Assessment of cytotoxicity measurements with MTT, ApoTox-GloTM, and ROS-GloTMH2O2
assays. Cell metabolic activity, and hence the viability of cells in the presence of biomass
smoke, was assessed with MTT (3-[4, 5 dimethyl-thiazoly-2-yl] 2-5 diphenyl tetrazolium
bromide).
The apoptotic cell amount and ROS generation, respectively, were measured by ApoToxGlo™ and ROS GloTM H2O2 assays. In all biological and imaging tests, cells exposed to
filtered air alone served as a negative control. For the MTT assay, following the gas and
liquid phase exposures, 100 µL of MTT (1 mg/l in growth media) was added to each well,
and the plate was incubated for an additional 5 h at 37 °C in 5% CO2. The resulting blue
component, produced by the reduction of the tetrazolium salt of MTT by mitochondrial
dehydrogenase enzyme, was dissolved in 100 µL dimethyl sulfoxide (DMSO). The optical
density of the colored product was read photometrically, using a spectrophotometer at 540 nm
with a microplate reader (Molecular Devices Spectra Max 190). The absorbance of untreated
cells was used as the negative control. The percentage viability of the cells was calculated
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from the ratio of the mean optical density of the sample to the optical density of the negative
control (Karakocak et al. 2016).
For the apoptosis and ROS detection experiments, the cells were cultured and exposed to
liquid and gas phase biomass emissions in 96-well, clear-bottomed white plates. Caspase 3/7
activity, the key indicator for apoptosis, was evaluated using the ApoTox-Glo™ Triplex assay
according to the manufacturer’s protocol (Promega Biosciences San Luis Obispo, CA). The
light output, measured with a luminometer, correlates with Caspase-3/7 activation, and
luminescence was measured using a microplate reader (Molecular Devices SpectraMax 190).
ROS generation was evaluated with the ROS-Glo™ H2O2 assay according to the
manufacturer’s protocol (Promega Biosciences San Luis Obispo, CA). The light signal
produced by recombinant Luciferase enzyme is proportional to the level of H2O2 in the cells.
The luminescence was measured using a microplate reader (Molecular Devices SpectraMax
190).
Electrical Impedance Spectroscopy. The cell attachment behavior of the cells was analyzed
real-time using electrical impedance spectroscopy (ECIS), a noninvasive technique that
measures the impedance across gold electrodes at the bottom of tissue culture wells, using
frequencies of alternating current (Wegener et al. 2000, Arndt et al. 2004). Cells were plated
in a 96-well ECIS array (Applied Biophysics, 96W20idf PET, Troy, NY) similar to those
plated for the endpoint toxicity assays. The change in resistance at frequencies ranging from
400 to 64,000 Hz was measured over time. Low-frequency impedance can be used to monitor
the solution paths around the cells, and hence the layer’s cell-to-cell barrier functions
(Wegener et al. 2000). The addition of particles may complicate the impedance of the system.
However, at a frequency of 4,000 Hz, the contribution to resistance from cells was dominant
over the contribution to resistance from biomass extracts with the medium (Kandasamy et al.
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2010). Therefore, we chose a frequency of 4,000 Hz to monitor cell growth and
biocompatibility.
Statistical Analysis. Analysis of variance (ANOVA) was used to statistically compare ECIS
results with the negative control (untreated cells) and positive control (medium only). A
significance level of **P < 0.001 was deemed statistically acceptable.
ANOVA was also used to statistically evaluate endpoint biocompatibility testing results with
a negative control. A significance level of *P < 0.05 was deemed statistically acceptable. All
tissue culture data (MTT, ApoTox-GloTM, and ROS-GloTM H2O2) were expressed as the mean
± standard error of the mean (SEM) values of at least three independent culture experiments.
Eight replicates were performed for each separate cell culture experiment.
Data Availability
All data generated or analyzed during this study are included in this article.
Results
We conducted laboratory experiments to investigate the effects of stove emissions on ocular
and cancer cells exposed via two pathways: (1) gas phase and (2) liquid phase. In-vitro
models can be designed to closely mimic real exposure conditions; i.e., creating an air-liquid
interface (Mulhopt et al. 2016). When used with a direct particle-to-cell deposition system,
in-vitro models provide more physiologically relevant conditions for evaluating the cellular
reactions, i.e., apoptosis initiation and ROS generation, in response to environmental
pollutants (Seagrave et al. 2005, Hawley and Volckens 2013, Mulhopt et al. 2016). In the first
part of our study, to closely simulate ocular cell exposure to air pollutants, we performed gas
phase exposure to cells maintained in ‘‘air-liquid interface’’ conditions, where only a thin
layer of fluid separates the cells from the aerosols (Figure 2A). Unlike the liquid phase
exposure experiments, these conditions expose the target cells to both particulate and nonparticulate constituents of the exhaust in naturally occurring proportions. In the second part of
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the study, liquid phase exposure experiments were conducted where particulate matter
extracts were exposed to submerged cell cultures (Figure 2B).
Coal and applewood were the two fuels used in this study. A laboratory hood setup (Figure 2)
with an aspiration-based dilution system was used to capture the emissions from fuel burned
in a micro-gasifier stove. Comprehensive details about the stove, fuel properties, and their
combustion and emissions characteristics were reported in previous studies (Patel et al. 2016,
Leavey et al. 2017).
Acute toxicity: Gas phase exposure
To assess the cellular responses to gas phase exposure, at approximately the 47th hour of cell
growth the viability, apoptotic cell amount, and ROS production were measured before and
after exposing the cells to applewood and coal combustion emissions for one hour. The cell
attachment behavior, however, was monitored in real time for more than 120 hours.
Figure 3A compares the viability, amount of apoptotic cells, and the amount of ROS
generation for the four cells types exposed (gas phase) to emissions from applewood and coal
combustion. No significant difference was observed for the biocompatibility of corneal and
lens epithelial cells exposed to the emissions from the two fuels (Figure 3A). Both retinal and
CHO cells were more biocompatible with applewood emissions than coal emissions. The
viability of the CHO cells was not compromised; instead, when exposed to applewood
emissions, their biocompatibility was measured to be greater than 100%. However, coal
emissions adversely affected the CHO cells’ viability (89%). The apoptotic cell
measurements showed statistically significant differences in the responses to applewood and
coal combustion emissions (Figure 3B). Lens epithelial cells showed the highest apoptosis
signal, followed by corneal and retinal cells. The apoptotic signals recorded from retinal and
CHO cells were significantly less strong than the signals from corneal and lens epithelial
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cells. Similar to the apoptotic signal results, corneal and lens epithelial cells produced

ROS generation

Apoptotic signal

significantly higher amounts of ROS (Figure 3C) than retinal and CHO cells.

Figure. 3. Comparative biocompatibility of applewood and biomass combustion emissions
with corneal epithelial cells, lens epithelial cells, retinal pigment epithelial (RPE-19) cells,
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and Chinese hamster ovary (CHO) cells. (A) Viability results. (B) Amount of apoptotic cells.
(C) ROS. Values are expressed in mean ± SEM, with each condition tested (n = 4). *P < 0.05
ECIS allows monitoring the changes in cell morphology that are essentially evoked by
alterations in the architecture of the cell’s structural components, such as the cytoskeleton and
cell-cell and cell-substrate junctions (Stolwijk et al. 2015). Figure 4 illustrates the real-time
(120 hours) impedance measurements of all cell lines tested. Figure 4A shows the results for
the negative control group, the cells exposed to air only. All the cell types grew and reached
confluency without showing any disruption in the impedance measures. Figure 4B
demonstrates the cells’ response to applewood combustion emissions. Except for the cancer
cells, all the ocular cells were adversely affected by the exposure. Similarly, all the ocular cell
lines exposed to coal combustion emissions detached from the plate, resulting in a decrease in
impedance. On the other hand, CHO cells maintained their confluency, although their growth
rate was significantly less than that of the negative control group.

291

Exposure
Control

Applewood

Coal

Figure. 4. Real-time impedance measurements of corneal epithelial cells, lens epithelial cells,
retinal pigment epithelial cells, and Chinese hamster ovary (CHO) cells. Cells were plated at
20,000 cells/well and exposed to stove emissions for one hour. (A) Control (B) Cells exposed
to applewood combustion emissions. (C) Cells exposed to coal combustion emissions. Values
are expressed in mean ± SEM, with each condition tested (n = 8). Black vertical lines
represent the timing and the duration of exposure **P < 0.001.
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Acute toxicity: Liquid phase exposure
Our previous study showed that emissions from coal combustion exceeded those from
applewood on almost all characterization metrics, such as mass concentration, number
concertation, particle size, surface area concentration, organics concentration, and
carcinogenic polycyclic aromatic hydrocarbons (PAH) concentration (Patel et al. 2016).
Consistent with the above-mentioned results, the gas phase exposure study revealed that coal
combustion emissions were more toxic to all cell lines tested. Therefore, for the liquid phase
exposure study, only the effect of applewood combustion emission was investigated.
As shown in Figure 5A, overall viability declined with increasing emission exposure levels
(decreasing dilution ratio) for all healthy ocular cell types, but the viability of retinal
epithelial cells demonstrated the least sensitivity to the exposure levels. Conversely, cancer
cells were not affected until the exposure concentration was increased to a dilution of 1:1.
Interestingly, except for the 1:1 dilution, the cancer cells showed more than 100% viability,
i.e., their growth was promoted. Unlike the overall viability results, retinal cells sent the
strongest signals of impeding apoptosis until the exposure concentration was increased to a
dilution of 1:20 (Figure 5B). On the other hand, the amount of ROS generation in healthy
ocular cells increased with increasing exposure concentration (until a dilution of 1:20), and
similar to the apoptosis signaling results, retinal cells generated relatively more ROS than
corneal and lens epithelial cells (Figure 5C).
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Apoptotic signal
ROS generation

Figure. 5. Biocompatibility measures of applewood emission extracts in contact with corneal
epithelial cells, lens epithelial cells, retinal pigment epithelial (RPE) cells, and Chinese
hamster ovary (CHO) cells. (A) Viability results. (B) Amount of apoptotic cells. (C) ROS
generation. Values are expressed in mean ± SEM, with each condition tested (n = 8). *P <
0.05.
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In addition to the experimental endpoint toxicity evaluations of viability, apoptosis, and ROS
generation, electrical impedance spectroscopy (ECIS), a sensing technique for monitoring
cell motion and morphological changes real-time, was also used (Xiao et al. 2002, Karakocak
et al. 2018). Upon plating, cells start to attach to and spread out over the gold electrodes. As a
result, the impedance increases because the insulating cell membranes form tight junctions
that block the electrical current’s flow. Conversely, when cells are stressed and dying, cell-tocell junctions are disrupted. Moreover, changes in cell morphology, such as contractile
rounding of membranes and detachment of cells from the gold electrode, result in higher
electrical current passage, which leads to a decrease in impedance over time (Pennington and
Van de Walle 2017).
Figure 6 presents electrical impedance measurements for all cell types tested. Cells were
allowed to reach confluency (~97 hr) and then exposed to emission extracts twice, once at the
97th hour and again at 168th hour, when then had recovered and again reached confluency.
The real-time response behavior for corneal epithelial (Figure 6A) and lens epithelial cells
(Figure 6B) was similar. For both cell types, after the initial response to exposure, a sharp
decline was recorded in impedance during the first 20 hours post-exposure for all exposure
levels tested. The impedance level recovered following both the first and second exposures;
however, eventually, it dropped gradually. After the second exposure, the decline was
irreversible. The impedance levels of both cell types (Figures 6A and 6B) continuously
declined irreversibly below the initial impedance level, based on the data collected up to the
265th hour, the end of the experiment. It was also observed that the rate of the final decline in
impedance was higher for higher exposure levels. With higher exposure concentrations, it is
likely that the cells reacted more drastically. In what follows, it is evident that there is a
complex pattern of growth followed by retardation and resumption as a result of exposure to
biomass smoke. Most notably, however, the retinal cells were markedly less affected (Figure
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6C). The growth rate of the retinal cells was significantly affected; however, the cells still
maintained a confluent layer by the end of the experiment. Finally, for the cancer cells,
except at the highest exposure concentration, the impedance levels were higher than for the
control cells (Figure 6D). Interestingly, when the cells were exposed to the extracts with the
lowest dilution ratio, the impedance level of the cells was recorded to be 53% more than the
impedance level of the unexposed cells (the negative control) by the end of the experiment
(265th hour).
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Figure. 6. Impedance measurements of (A) corneal, (B) lens, (C) retinal epithelial, and (D)
CHO cells plated at 20,000 cells/well, exposed to applewood emission extracts with
different dilution rates. Note that after the cells become confluent, the medium was changed
only once throughout the rest of the lengthy exposure period. As compared to the control
cells, the healthy cells, which were exposed to the extracts, could not recover, except at the
highest dilution rate (1:100). Overall, the applewood emission extract did show a toxic
effect on ocular cells; however, the same concentrations that were toxic to healthy cells
accelerated the growth of CHO cells. Values are expressed in mean ± SEM, with each
condition tested (n = 8). **P < 0.001.
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Discussion
In short, biomass smoke generated ROS that retarded the growth of healthy ocular cells and
eventually killed them. Among the non-cancerous healthy cell lines tested, retinal cells
showed the greatest resistance to bio-induced ROS generation. In fact, the CHO cancer
cells stood out in their resistance: For both gas and liquid phase exposures, biomass smoke
promoted their growth. The specifics are discussed below.
Acute toxicity: Gas phase exposure
In-vitro studies with biomass and coal smoke can potentially generate toxic products from
reactions between the smoke components and cell media (Lee et al. 2015, Capistrano et al.
2017). Nevertheless, for both practical and ethical reasons, evaluating emissions on cells is
a logical precursor to in-vivo tests. In conformance with strict animal protocols, animals,
unlike cells, cannot be exposed to biomass and coal emissions for extended periods
(Capistrano et al. 2017). Furthermore, the specific way a cell reacts to its environment
varies with the set of receptor proteins on its cell membrane and according to their primary
role in the body (Epand and Ruysschaert 2017). Cell types have evolved to perform
different roles, and thus their responses to the same stimuli can be dissimilar (Hanley et al.
2009). In-vitro models can advantageously provide results for longer exposure periods and
multiple types of cells.
In Figure 3A, we compare the viability, amount of apoptotic cells, and the amount of ROS
generation for the four cells types exposed (gas phase) to emissions from applewood and
coal combustion. Corneal and lens epithelial cells exposed to the emissions from the two
fuels showed similar viability results, and the type of fuel did not show a statistically
significant difference (Figure 3A). On the other hand, both retinal and CHO cells were
more tolerant of applewood emissions than coal emissions. Surprisingly, when exposed to
applewood emissions, CHO cells actually grew, their viability was recorded as 109%
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(Figure 3A). Unlike applewood emissions, coal emissions did adversely affect the CHO
cells’ viability (89%). The apoptotic cell measurements showed statistically significant
differences in response to applewood and coal combustion emissions for lens epithelial and
CHO cells only (Figure 3B). The amount of apoptotic cells was highest among the lens
epithelial cells, followed by corneal and retinal cells. Simply put, cells succumb to
environmental stress differently (Reed 2000, Hanley et al. 2009). The concentration of
applewood and coal smoke that led to apoptosis in corneal and lens epithelial cells did not
result in the same level of apoptotic response in retinal and CHO cells. Our results also
showed that retinal pigment epithelial (RPE) cells can cope well with oxidative stress
(Figure 3C). This result may be attributed to their unique ROS handling capacity, an
evolutionary mechanism for tolerating light exposure (Qin and Rodrigues 2008). Similar to
the apoptotic signal results, corneal and lens epithelial cells produced significantly higher
amounts of ROS (Figure 3C). On the other hand, retinal and CHO cells showed relatively
less ROS generation as a result of gas phase exposure to biomass and coal emissions. As
expected, since the ROS generation was higher in corneal and lens epithelial cells,
apoptosis signal initiation was higher in those cells and evidently was reflected in the
eventual viability results (Figure 3). Overall, based on viability, apoptosis, and ROS
generation results, coal appears to show more adverse effects than applewood combustion
emissions on all cell lines tested.
Smoke from solid-fuel combustion is a complex mixture of hundreds of organic and
inorganic chemical species in both gaseous and particulate phases, making it very difficult
to associate health effects with a single component. More details on smoke constituents and
their associated health effects can be found in (Zhang and Smith 2007), where the authors
reviewed relevant studies from 1980 to 2016, with a focus on China. Detailed physical and
chemical characterizations of the PM emissions from the two fuels tested in this study have
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been published in our previous studies (Patel et al. 2016, Leavey et al. 2017), and therefore
are not included here. Emissions from coal combustion exceeded those from applewood on
almost all characterization metrics, such as mass concentration, number concentration,
particle size, surface area concentration, organics concentration, and polycyclic aromatic
hydrocarbons (PAH) concentration (Patel et al. 2016). Therefore, it is not possible to
comment on the role of any single metric in the trends observed in Figure 3. Systematic and
controlled laboratory studies are required to associate different specific emission
components and metrics with their health effects.
Figure 4A shows real-time cell attachment impedance measurements for all four cell types
when removed from incubation conditions and exposed to filtered air (negative control).
For all cell types except retinal cells, impedance levels decline sharply just after exposure to
filtered air, but eventually recover to their original value. The variations in the initial drop
in the impedance might be due to the cells’ varied abilities to compensate for and adapt to
the changes in the extracellular environment (Berg et al. 2002, Brooks et al. 2011). It is
clear that retinal cells are least affected by changes in, for example, the amount of carbon
dioxide and the temperature, and therefore their impedance level is least altered (Figure
4A).
Figures 4B and 4C show the responses of all cell types to applewood and coal emissions,
respectively. The initial post-exposure responses of cells were similar to those for the
control, i.e., a decline in impedance, followed by recovery. Again, this decline may be due
to the cells’ varied abilities to adapt to the extracellular environment. Unlike the control
experiments, the impedance dropped for retinal, lens, and corneal epithelial cells, starting at
the 73rd, 78th, and 81st hours, respectively. However, the impedance level of CHO cells
continued to rise until the end of the experiment (~120 hours) (Figure 4C). This increase is
a result of cell proliferation, triggered by the increased amount of intracellular ROS (Figure
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5C), as reported previously (Liou and Storz 2010, Sullivan and Chandel 2014, Galadari et
al. 2017). It can, therefore, be concluded that for CHO cells, the increased ROS caused
more cell proliferation (Zamkova et al. 2013).
Acute toxicity: Liquid phase exposure
The retinal cells withstood increased oxidative stress better than the corneal and lens
epithelial cells (Figures 5A and 5C). ROS production in cells is a double-edged sword
(Martin and Barrett 2002). ROS are created mainly as host defenses against infectious
agents; however, when a threshold is exceeded, increased ROS can lead to apoptosis
(Sullivan and Chandel 2014). We measured both the apoptotic cell amount as well as ROS
generation and found a direct correlation for healthy ocular cells (Figures 5B and 5C).
When the amount of ROS production exceeded the cells’ capacity to repair oxidative
damage, the cells initiated apoptosis, as was also reported in previous studies (Fiers et al.
1999, Lemarie et al. 2011). On the other hand, cancer cells adapted to oxidative stress.
Their viability results were significantly higher than for the healthy ocular cells (Figure
5A). Comparing the apoptosis onset values measured in RLU (Figure 5B) with the ROS
values in Figure 5C, it can be seen that cancer cells tolerate 1.7-2.7 times greater
concentration of ROS than healthy ocular cells. This finding is consistent with previous
studies that reported significantly higher ROS generation in cancer cells than healthy cells
(Fiers et al. 1999, Sullivan and Chandel 2014). Notably, our apoptosis measurement
technique is based on Caspase 3/7 activity measurement, which is detectable only during
apoptosis, not during necrosis (Denecker et al. 2001). Apoptotic cell death is a programmed
cell death as a result of increased oxidative stress (ROS generation); therefore, there is a
strong correlation between ROS generation and the apoptotic cell amount (Figure 5).
Unlike the corneal and lens cells (Figures 6A and 6B), the real-time impedance results for
retinal epithelial cells did not show a sharp decline following the exposure events (Figure
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6C). The first exposure did not affect the impedance; however, after the second exposure,
the impedance decreased slightly. The cells did not crash by the end of the experiment
because, as explained previously, retinal cells can cope with oxidative stress better than
other ocular cell types. Interestingly, the impedance measurements of the cancer cells
revealed an unexpected behavior. The CHO cells which were exposed to cookstove
emissions extracts grew more than the control cells, displaying the same unexpected
behavior found with gas phase exposure, which suggests that exposure to biomass exhaust
can promote tumor growth.
Although we do not fully understood exactly how inhaling stove emissions causes
secondary injury to the eye and other organs (Zou et al. 2009, Hawley and Volckens 2013),
extended exposure to smoke efficiently transfers environmental pollutants to the
bloodstream (Pappas 2011, Schulze et al. 2017). Due to their high metabolic activity, tumor
cells need more oxygen and nutrients than normal cells (Amoêdo et al. 2013). It has been
shown that tumor cells can grow their own blood vessels (Jain 2005), and as a result,
tumors receive more blood than normal cells (Carmeliet and Jain 2000, Chambers et al.
2002). Once environmental pollutants enter the bloodstream, their constituents inevitably
reach tumor cells. Our in-vitro study demonstrates that once tumor cells are in direct
contact with biomass emissions, their growth is promoted. Based on our findings, it is
reasonable to hypothesize that daily exposure to biomass smoke from stoves poses a risk
for cancer patients.
Conclusions
Our in-vitro study found a significant disturbance in healthy ocular cells’ attachment,
indicative of death, as a result of both liquid and gas phase biomass smoke exposure. On
the other hand, the growth of cancer cells was significantly promoted. The ROS amount
that led to ocular cell death did not destroy the cancer cells, but instead accelerated their
302

growth. Our in-vitro study connects cellular responses with epidemiological disease
findings, clearly underscoring the troubling implication that people exposed daily to
biomass-fueled stove smoke are at risk, especially considering that our findings were for a
limited exposure time. People who are regularly exposed to biomass combustion smoke are
more prone to developing eye diseases, either from direct exposure or secondary exposure
by inhalation. More importantly, everyday activities like cooking and heating using stoves
with biomass fuels may accelerate the growth of tumors. These findings emphasize that we
should pay added attention to the environment of the person living with cancer, not only to
their genetic predisposition.
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